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ABSTRACT
α-Amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD) and αaminomuconate-ε-semialdehyde dehydrogenase (AMSDH) are two neighboring enzymes in the
L-tryptophan and 2-nitrobenzoic acid degradation pathways. The substrates of the two enzymes,
α-amino-β-carboxymuconate-ε-semialdehyde (ACMS) and α-aminomuconate-ε-semialdehyde
(2-AMS), are unstable and spontaneously decay to quinolinic acid and picolinic acid,
respectively.
ACMSD utilizes a divalent zinc metal as cofactor and is a member of the amidohydrolase
superfamily. In this dissertation work, we have identified an important histidine residue in the
active site that plays dual roles in tuning metal selectivity and activating a metal bound water
ligand using mutagenesis, resonance Raman, EPR, crystallography, and ICP metal analysis
techniques. The crystal structures of ACMSD from Pseudomonas fluorescens (PfACMSD) have
been solved as homodimers in our laboratory while human ACMSD (hACMSD) was annotated

as a monomer by another group. To resolve this structural difference, we used two conserved
active site arginine residues as probes to study the oligomeriztion state of ACMSD and
demonstrated that these two arginine residues are involved in substrate binding and that both Pfand h- ACMSD are catalytically active only in the dimeric state. Subsequently, we solved the
crystal structure of hACMSD and found it to be a homodimer in both catalytically active and
inhibitor-bound forms.
AMSDH is an NAD+ dependent enzyme and belongs to the aldehyde dehydrogenase
superfamily. Due to the high instability of its substrate, AMSDH has not been studied at the
molecular level prior to our work. We have cloned and expressed PfAMSDH in E. coli. The
purified protein has high activity towards both 2-AMS and 2-hydroxymuconate semialdehyde (2HMS), a stable substrate analog. We have successfully crystallized AMSDH with/without NAD+
and solved the crystal structure at up to 1.95 Å resolution. Substrate bound ternary complex
structures were obtained by soaking the NAD+ containing crystals with 2-AMS or 2-HMS.
Notably, two covalently bound catalytic intermediates were captured and characterized using a
combination of crystallography, stopped-flow, single crystal spectroscopy, and mass
spectrometry. The first catalytic working model of AMSDH has been proposed based on our
success in structural and spectroscopic characterization of the enzyme in five catalytically
relevant states in this dissertation work.
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CHAPTER 1

INTRODUCTION

Part of chapter 1 has been published in our two review papers: Amidohydrolase Superfamily.
Aimin Liu, and Lu Huo. (2014) Els. John Wiley & Sons, Ltd: Chichester. DOI:
10.1002/9780470015902.a0020546.pub2. Decarboxylation mechanisms in biological system.
Tingfeng Li, Lu Huo, Christopher Pulley, and Aimin Liu. (2012) Bioorg. Chem., 43, 2-14.
1.1 The Kynurenine Pathway
As the major route for L-tryptophan (TRP) catabolism, which takes place in the liver, kidney,
and brain of mammals, the kynurenine pathway (KP) has been found to be highly related with
numerous disease states, and thus has gained significant attention from the scientific field.
Studies in the past few decades have shown that the KP is a powerful regulator of
neurodegenerative disorders: Alzheimer’s disease, Huntington’s disease, anxiety, depression, and
epilepsy (1-7). This is because several neurologically active compounds including kynurenic
acid, 2-hydroxykynurenine, and quinolinic acid (QUIN) are metabolites generated by the KP.
QUIN is an agonist of N-methyl-D-aspartate receptors and could cause overexcitement of
neurons and cell death in the central nervous system (2,5,8,9). The precursor of QUIN is αamino-β-carboxymuconate-ε-semialdehyde (ACMS), which is an unstable metabolic
intermediate and spontaneously decays to QUIN with a t1/2 of 33 min at 20 °C, pH 7.0 (10). The
formation of QUIN in vivo is controlled by the enzyme ACMS decarboxylase (ACMSD) because
the decarboxylation reaction it catalyzes competes with the decay of ACMS. The product of
ACMSD is α-aminomuconate-ε-semialdehyde (2-AMS), which is even more unstable than
ACMS and decays to picolinic acid (PIC) with a t1/2 of 9 s at pH 7.4, 37 °C. The biological role
of PIC remains controversial. Several studies have shown various physiological effects when
using millimolar concentrations of PIC; however endogenous concentrations have been
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measured to be in the sub-micromolar range. The formation of PIC is controlled by the
downstream enzyme 2-AMS dehydrogenase (AMSDH) which oxidizes the unstable aldehyde to
a stable acid, 2-aminomuconic acid (Scheme 1.1). This dissertation focuses on structural and
mechanistic studies of two consecutive enzymes of the KP, ACMSD and AMSDH.
1.2 The 2-Nitrobenzoic Acid Degradation Pathway
The toxic organic compound 2-nitrobenzoic acid (2-NBA) is biodegradated by a bacterial
strain KU-7, identified as Pseudomonas fluorescens (11), which can utilize 2-NBA as the sole
source of carbon, nitrogen, and energy (11). The initial two steps catalyze the transformation of
2-NBA to 3-HAA, at which point the 2-NBA degradation pathway “borrows” part of the
kynurenine pathway as shown in Scheme 1.1. These two pathways share three enzymes, nonheme Fe2+ dependent 3-hydroxyanthranilinic acid 3,4-dioxygenase (HAO), ACMSD, and
AMSDH, and also the mechanism to regulate nonenzymatic production of QA and PA. This
discovery suggests that the genes for these three enzymes of the kynurenine pathway are
evolutionarily conserved genome segments which are important for at least two independent
catabolic pathways. Before our work, human ACMSD can only be expressed as insoluble
inclusion body in E. coli, and human AMSDH had not been identified. ACMSD and AMSDH

Scheme 1.1 The L-tryptophan and 2-NBA degradation pathways share an enzyme trio system.

3
from the 2-NBA pathway had been used as model enzymes for structural and mechanistic studies
before our recent progresses on the human analog enzymes.
1.3 ACMSD is a Member of the Amidohydrolase Superfamily
ACMSD was initially thought to be a cofactor-free enzyme (12,13). A comprehensive in
vitro study on ACMSD from Pseudomonas fluorescens (PfACMSD) demonstrated that this
enzyme is actually critically dependent on transition metal ions (14). Further sequence analysis
and mutagenesis studies suggest that ACMSD belongs to the amidohydrolase superfamily (15),
which is a structure-based cluster of metalloenzymes that contain a sturdy and versatile
triosephosphate isomerase (TIM)-like (β/α)8-barrel fold embracing the catalytic active site. Later
on, the crystal structure of PfACMSD was solved with a zinc metal center and a TIM-barrel
overall fold, supporting that ACMSD is a new member of the amidohydrolase superfamily.
1.3.1

The concept of amidohydrolase superfamily

Up to date, the amidohydrolase superfamily has grown into one of the largest families of
enzymes, with tens of thousands of members catalyzing a wide range of hydrolytic and
nonhydrolytic metabolic reactions which are important in amino acid and nucleotide metabolism
as well as biodegradation of agricultural and industrial compounds. Previously, presence of a
mono- or di-nuclear d-block metal cofactor in the active site was thought to be one of the main
characters for the members in this superfamily. Recently, new members that contain trinuclear
metal cofactor or no cofactor were also discovered. It has become evident that activating a wellordered water molecule by an active site residue for nucleophilic attack on the organic substrate
is a common mechanistic feature for all members of the superfamily.
Amidohydrolase superfamily is one of the largest enzyme families. The concept of the
‘amidohydrolase superfamily’ was introduced by Holm and Sander. The sbtriking similarities of
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the three-dimensional structures of adenosine deaminase (ADA), phosphotriesterase (PTE) and
urease (URE) inspired the unification of a broad set of d-block metal-dependent hydrolase
enzymes into a unique enzyme superfamily (16). The amidohydrolase superfamily is more than
just a group of hydrolase enzymes. It is a functionally diverse enzyme group. Members of this
enzyme superfamily catalyze the cleavage of not only C–N but also C–C, C–O, C–Cl, C–S and
O–P bonds of organic compounds. Most of the characterized members of the amidohydrolase
superfamily are important enzymes for histidine, tryptophan and lignin derived compounds
metabolism, de novo biosynthesis of purine and pyrimidine nucleotides, and biodegradation of
agricultural and industrial materials including rubber chemicals, herbicides, leather, paper and
others. Some members of this enzyme superfamily are medically relevant. For instance, ADA
catalyzes ammonia elimination from the heterocyclic nitrogenous base of the substrate. The
deficiency of this enzyme is linked to a common form of severe combined immunodeficiency
(SCID). Since the superfamily is not function-designated, an enzyme with amidohydrolase in its
name is not necessarily a member of the amidohydrolase superfamily. For instance, penicillin
amidohydrolase (also known as penicillin acylase, EC 3.5.1.11) contains neither a catalytic metal
ion nor a TIM-barrel domain; thus, it is not a member of the amidohydrolase superfamily.
The amidohydrolase superfamily contains more than five related subfamilies in the Pfam
database annotation (17). The Amidohydrolase_1 subset (accession number: PF01979) contains
a large group of 18,418 protein sequences (http://pfam.janelia.org). Its members catalyze the
hydrolysis of a wide range of substrates bearing amide, ester, halogen or other functional groups
at carbon and phosphorus centers. This family includes well-characterized enzymes such as
ADA, PTE, URE, cytosine deaminase (CDA), D-amino acid deacetylase (AAD), dihydroorotase
(DHO), N-acetylglucosamine-6-phosphate deacetylase (AGD) and renal dipeptidase (RDP).
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Among them, DHO and URE also belong to MEROPS peptidase family M38 (β-aspartyl
dipeptidase, clan MJ), where they are classified as nonpeptidase homologues.
The Amidohydrolase_2 subset (accession number: PF04909) contains 6,287 aligned protein
sequences. These proteins are related to the metal-dependent hydrolases but they appear to be
either structurally or functionally divergent from the Amidohydrolase_1 group. Members of this
branch are known to catalyze nonhydrolytic reactions including decarboxylation and hydration
(18). The prototypic member of the Amidohydrolase_2 is ACMSD (EC 4.1.1.45), which
converts ACMS to 2-AMS in a nonhydrolytic C-C bond cleavage process (14). Despite the
similar tertiary structures, it is not clear if members of the Amidohydrolase_2 subset have arisen
from a single evolutionary origin with those in the Amidohydrolase_1 because of their very low
overall sequence similarities.
The Amidohydrolase_3 subset (accession number: PF07969) consists of 5,270 protein
sequences, most of which are hypothetical proteins. Some, including D-aminoacylase,
formyltransferase/hydrolase complex Fhc subunit A, are amidohydrolase-like enzymes. This
branch of the amidohydrolase superfamily contains the most diverse set of sequences, including
a high proportion of outlier sequences that have only low levels of sequence identity to their
closest superfamily relatives.
The Amindohydolase_4 subset (accession number: PF13147) consists of 10,639 protein
sequences. The representative member of this subset includes allantoinase, D-hydantoinase
(DYH), dihydropyrimidinase (DHPase), imidazolonepropionase (IPase), and a latent form of
dihydroorotase.
The Amidohydrolase_5 subset (accession number: PF13594) is a relative small group of
enzymes with 3,712 sequences to date. Isoaspartyl dipeptidase is its representative member.
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More than thirty additional new subsets of amidohydrolases are being added, most of which are
based on the functional distinctions. These include Creatininase (accession number: PF02633,
1,362 sequences), which is a group of urease-related amidohydrolases hydrolysing creatinine to
creatine, FGase (accession number: PF05013, 1,531 sequences) which consists of a group of Nformylglutamate amidohydrolases, and TatD_DNase (accession number: PF01026, 8,430
sequences) which is a rapidly growing subgroup of DNAse.
1.3.2

Structural features of members in the amidohydrolase superfamily

Most members of the amidohydrolase superfamily consist of a central (β/α)8 barrel in which
eight parallel β strands flanked on the outer face by eight α helices (Figure 1.1). Members

Figure 1.1. Metal cofactor and the TIM-like parallel barrel core in ADA (PDB entry 1A4M). The
metal ion is depicted as CPK sphere, metal ligands are shown in sticks and the propeller structural
fold is highlighted in blue colour in the representation. Substrate nalogue 6-hydroxy-1,6-dihydro
purine nucleoside is represented in scaled ball and stick.
contain a trinuclear metal center instead possesses a distorted (β/α)7 barrel fold. This gives rise to
a prominent architectural feature: a sturdy pocket with an internal cavity adjacent to the active
site. The pocket has a propeller-like shape made by the seven or eight β strands with a depth of
around 15-18 Å and a diameter of about 14-16 Å that forms a compact thermo-stable core. The

7
(β/α)8-barrel fold is a common structural platform found in about 10% of all proteins with known
three-dimensional structures and in about 33 superfamilies in the SCOP database
(http://scop.mrc-lmb.cam.ac.uk/scop). It is also known as the TIM-barrel fold because it was first
defined from the three-dimensional structure of TIM. Containing a d-block metal cofactor with
one or two metal ions conjunction with the TIM-barrel used to be another structural character for
the amidohydrolase superfamily. Recently, several new members have been identified either
with a trinuclear metal center or cofactor free. However, four active site residues, three histidine
and one aspartate/glutamate, serve as metal ligands in the metal containing amidohydrolase
superfamily proteins are still conserved in the metal independent members with new catalytic
roles. Figure 1.2 shows examples of the TIM-barrel along with active site that contains no-,
mono-, di- or tri- nuclear metal cofactors. There are currently 25 functionally annotated unique
members of the amidohydrolase superfamily for which high-resolution X-ray crystal structures
are available (Table 1.1).

Figure 1.2. The crystal structures of TIM-barrel along with different metal center. (A)
BmulJ_04915 (PDB entry 4DNM, cofactor free), (B) ADA (PDB entry 1A4M, mononuclear
metal cofactor), (C) PTE (PDB entry 1HZY, dinuclear metal cofactor) and (D) HPP (PDB entry
4GC3, trinuclear metal cofactor). Metal ions are shown as yellow spheres. Metal ligandresidues
are shown in sticks and the propeller structural fold is highlighted in purple.
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Table 1.1. Functionally annotated and structurally characterized members of the amidohydrolase
superfamily

a

Enzyme
α-Amino-β-carboxymuconate-εsemialdehyde decarboxylase
Adenosine deaminase
Adenine deaminase
N-acetylglucosamine-6-phosphate
deacetylase
Allantoate amidohydrolase
Adenosine 5′-monophosphate
deaminase
Cytosine deaminase
D-Aminoacylase
Dihydroorotase
Dihydropyrimidinase (Lhydantoinase)a
Guanine deaminase
D-Hydantoinase
Isoaspartyl dipeptidase
Imidazolonepropionase
Phosphotriesterase
Renal dipeptidase
γ-Resorcylate decarboxylase
Urease
5-Methylthioadenosine/Sadenosylhomocysteine deaminase
4-Oxalomesaconate hydratase
2-Pyrone-4,6-dicarboxylic acid
hydrolase
N-Acyl-D-glutamate
deacylase
N-Isopropylammelide isopropyl
amidohydrolase
Enamidase
Isoorotate decarboxylase
L-Histidinol phosphate phosphatase
Atrazine chlorohydrolase

Abbreviation

E.C. number

PDB code

ACMSD

4.1.1.45

2HBV

ADA
ADase

3.5.4.4
3.5.4.2

1A4M
2ICS

AGD

3.5.1.25

1O12

ATase

3.5.2.5

1Z2L

AMPD

3.5.4.6

2A3L

CDA
DAA
DHO

3.5.4.1
3.5.1.81
3.5.2.3

1K6W
1M7J
1J79

DHPase

3.5.2.2

1GKR

GAH
HYD
IAD
IPase
PTE
RDP
RSD
URE

3.5.4.3
3.5.2.2
3.4.19.5
3.5.2.7
3.1.8.1
3.4.13.11
4.1.1.44
3.5.1.5

1WKQ
1NFG
1ONW
2BB0
1HZY
1ITQ
2DVT
2UBP

MTAD

3.5.4.28

1J6P

OMAH

4.2.1.83

2GWG

PHD

3.1.1.57

4D8L

AGD

3.5.1.82

3GIP

IIA

3.5.99.4

2QT3

ENA
IDCase
HPP
ATZA

3.5.2.18
4.1.1.66
3.1.3.15
3.8.1.8

2UVN
4HK7
4GC3
3LS9

Although DHPase and HYD have the same E.C. number, they are different enzymes and have different substrate
specificities. DHPase enzymes (including L-hydantoinase) catalyze the reversible hydrolytic ring opening of six- or
five-membered cyclic diamides such as dihydropyrimidines and 5′-monosubstituted hydantoins to the corresponding
3-ureido acids and carbamoyl amino acids, respectively. HYD is an industrial enzyme that is widely used in the
production of D-amino acids which are precursors for synthesis of antibiotics, peptides and pesticides.
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Biochemical studies on the amidohydrolase superfamily have revealed that the metal cofactor
is catalytically essential for the majority members (19). The metal cofactor is located at the
opening of the barrel near the C-terminal ends of several β strands, coordinated by several
histidine, aspartic acid and in some occasions cysteine residues of the β strands and βα loops.
The metal-containing site is referred to as the catalytic face of the barrel, in contrast to the
stabilizing face of the opposite end of the barrel (20). To accommodate the metal center and
substrates, the catalytic face often has a wider width than the stabilizing face, consequently
making the other side of the barrel appear more compressed. Thus, the barrel sometimes looks
like a conoid.
The most common metal in this enzyme superfamily is a zinc ion or a dinuclear Zn2 pair.
However, transition metals, such as divalent iron, nickel and manganese ions, are also observed
in amidohydrolase enzymes. Cobalt ion can often be substituted for zinc in vitro, producing a
comparable or even higher level of enzyme activity (14). Non d-block metal ions, such as Mg2+
and Ca2+, are usually unable to perform the biochemical functions at the enzyme active site,
suggesting that the role of the d-block metal cofactor is beyond simply providing a cationic
charge for substrate binding.
The metal cofactor is tethered to the protein through a few protein residues. There are several
types of active site structural architecture known in this enzyme superfamily, and the origin of
the metal ligands is a valuable tool to divide the enzyme superfamily into seven subgroups (19).
A mononuclear cofactor requires four or five ligands, while a dinuclear cofactor demands five or
six protein ligands. One notable structural feature is that at least one water molecule or waterderived hydroxide is coordinated to the metal ion(s) in the enzyme structures. The solventderived ligand generally remains bound to the metal in the enzyme–substrate complex, but it is
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replaced by substrate on some occasions such as 2,6-dihydroxybenzoate (γ resorcylate)
decarboxylase (RSD) (21).
For a mononuclear metal cofactor of this enzyme superfamily, the fifth β strand invariably
provides a histidine ligand for the metal coordination. The sixth β strand contributes a histidine
residue either as a metal ligand or a nonligand but an important catalytic component at the
enzyme active site. These two histidine residues are the signature amino acids conserved across
the mononuclear and dinuclear metal cofactor containing amidohydrolase superfamily members.
It is common for the first and/or eighth β strands to add more protein ligands for metal
coordination. An aspartic acid residue from the eighth β strand in many amidohydrolase enzymes
plays a dual role, i.e. acid/base catalyst and metal ligand.
The two divalent metals are separated by 3.6 Å in the dinuclear metal cofactor. The more
buried metal cation is coordinated to two histidine residues from the end of β strand 1 and an
aspartate from β strand 8. The more solvent-exposed metal ion is ligated to protein through two
imidazole side chains of histidine from β strands 5 and 6 (19). The two divalent metal ions are
bridged by a hydroxide in addition to a carbamate functional group originating from the
posttranslational modification of a lysine residue from β strand 4 in the presence of bicarbonate.
In some cases, an unmodified glutamic acid from β strand 4 or a cysteine from β strand 2 is
employed as a bridge instead of the modified lysine. Until now, the characterized dinuclear
amidohydrolase enzymes have a homogeneous metal preference. However, some mixed metal
cofactors may exist. Enamidase, for instance, is a bifunctional enzyme belonging to the
amidohydrolase family that mediates hydrolysis of 1,4,5,6-tetrahydro-6-oxonicotinate to
ammonia and (S)-2-formylglutarate; it reportedly contains a Fe-Zn cofactor (22).
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A subfamily under the amidohydrolase superfamily, polymerase and histidinol phosphatase,
catalyzes the reaction of phosphoester hydrolysis. Members in this subfamily have a trinuclear
metal center buried in a distorted (β/α)7 barrel. The β-strand 3 is much longer than other strands
composed the barrel and overlays with the β-strand 3 and 4 of the (β/α)8 structures. All the metal
ligands for the mono- and di- nuclear metal center are conserved and coordinate the α and β
metals. In addition, the third metal is coordinated by an aspartate or histidine from the end of βstrand 1 and two histidine residues from the end of β-strand 2 and 8.
The identification of several metal independent members further expanded the structural
diversity of the amidohydroloase superfamily. The overall structure of metal independent
members still adopts a (β/α)8 TIM-barrel fold and the four conserved residues, three histidine
(two from the end of β-strand 1 and one from β-strand 6) and one aspartate (from the end of βstrand 8) ligand residues in the mononuclear metal center, are still present in the active site.
These conserved residues are now proposed to conduct new catalytic roles since they no longer
serve as metal ligand. Other than the histidine residues from the sixth β strands, which are
conserved throughout the entire family, the remaining metal ligands exhibit some variations. For
example, an HxH metal-binding motif is commonly seen in strand 1 of the β-barrel, but HxD and
ExH have been observed from the ACMSD protein subfamily of Amidohydrolase_2 (18). The
histidine from the fifth β-strand is absent in the cofactor free members. Moreover, the metalbinding motif from strand 1 does not always serve as metal ligands. For instance, in the
structures of AGD, the HxH motif is present in the active site but it is not ligated directly to the
divalent metal.
The overall sequence conservation among the amidohydrolase superfamily is rather low,
indicating that the TIM-like barrel fold is not dictated by details of sequences but rather by
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overall distribution of polar or charged and nonpolar or noncharged residues. Also, it is not
unusual that enzymes in this superfamily contain noncatalytic domains in addition to the
catalytic domain. Thus, conventional sequence alignments occasionally fail to reveal the general
characteristics of a potential new member of the amidohydrolase superfamily. When either the
metal-binding motif or the TIM-like barrel is not obvious, an advanced sequence alignment may
be required. If this is the case, a secondary structure pattern can be calculated by the PSIPRED
protein structure prediction server at http://bioinf.cs.ucl.ac.uk/psipred (23). Then a ‘secondary
structure-based’ sequence alignment with those members with known three-dimensional
structures may reveal clusters of similar residues at topologically equivalent positions. An
example using this strategy was described in a recent study of ACMSD, which successfully
predicted that this is a new member of the amidohydrolase superfamily. A site-directed
mutagenesis analysis was followed and the results revealed important information concerning the
enzyme such as metal ligand identities and active site residues as well as their possible roles in
the catalytic process (15).
However, one should be cautious in drawing conclusions solely based upon a sequence
study. Sequence, and even structural, similarities do not always translate into functional
similarities. One extreme example in the functionally diverse amidohydrolase superfamily is the
difference between melamine deaminase and atrazine chlorohydrolase. These two enzymes share
98% sequence identity, but catalyze completely different reactions (24).
1.3.3

Catalytic mechanism of members in the amidohydrolase superfamily

The best-characterized members of the amidohydrolase superfamily share a common
catalytic mechanism. Scheme 1.2 illustrates the proposed hydrolytic mechanism for the
mononuclear Zn-dependent enzyme ACMSD. The common feature of the mechanism is that a
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reaction catalyzed by the enzyme of this superfamily. From a chemical perspective, the enzyme
OMAH of the ACMSD protein family catalyzes a mechanistically insightful reaction; it adds a
water molecule to the substrate, as if it were the half-reaction in a decarboxylation mechanism
proposed for ACMSD (Scheme 1.2). Although there is no characterized member of the
Amidohydrolase_3 subfamily at the present stage, it is almost certain that some structural
variations and new functionalities will soon be described for members of this branch.
An arginine residue, Arg239 in ACMSD, is conserved across the characterized members
catalyze the decarboxylation reaction and proved to be catalytically essential. Arg239 has been
shown to play important role in substrate binding in solution for ACMSD. Crystal structure of
IDCase in complex with a substrate analogue further demonstrated that this arginine specifically
binds to the leaving carboxyl group. Unlike other active site residues, Arg239 is intruded from a
neighbouring subunit, indicating this subfamily of enzymes needs to function as dimers. This is
also verified by the gel filtration studies done for OMAH and RDC.
The dinuclear enzymes proceed similarly, with a second divalent metal ion providing
additional activation power towards the substrate. DHO is one of the best characterized dinuclear
amidohydrolase enzymes. It is believed that the original keto oxygen of the substrate interacts
with the more solvent exposure metal ion in DHO, while the more buried metal ion activates the
nucleophilic attack during catalysis. A proposed mechanism of DHO catalyzed reaction is shown
in Scheme 1.3.
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Scheme 1.3. The proposed catalyytic mechaniism of dihyddroorotase (D
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not require a divalent metal (30). Later on, BmulJ_04915 and GLI are found as the second and
third examples (31). Although this group of enzymes does not contain a metal cofactor, the
original metal binding residues, including three histidine and one aspartate, are still conserved in
the active site with new catalytic functions. For LigI and BmuIJ_04915, the three histidine
residues are proposed to bind and polarize the substrate. The Aspartate residue is proposed to
activate a water molecule for nucleophilic attack (Scheme 1.5).
The amidohydrolase superfamily has attracted substantial attention as a large structure-based
cluster of enzymes with thousands of members and divergent catalytic functions. In the past few
years there have been huge advances in the studies of the amidohydrolase superfamily. Large
volumes of sequence are now becoming functionally annotated, and many members that exhibit
distinct biological significances are now structurally defined. It is becoming clear that the metalcofactor elaborated by the sturdy and versatile TIM-like β barrel is enormously powerful. The
substrate specificity appears to be mostly dictated by the loops, insertions and conformational
restrictions of the catalytic face of the TIM-like β barrel. This insight has come from site-directed
mutagenesis, kinetics, structural and spectroscopic studies of many members of the superfamily.
Major advances have been made, but a structure-based functional annotation is still
challenging. Many principals and strategies related to the design of loops, insertions, subunit
interactions and the catalytic impact of protein dynamics remain to be elucidated. Nonetheless,
the rapid expansion of knowledge concerning the metal-dependent TIM-barrel enzymes is
making the amidohydrolase superfamily a well characterized large enzyme group that may
enable a reliable evolutionary analysis for the origin of the divergent members. The
amidohydrolase superfamily as a whole is emerging as a popular and valuable asset in the
enzymology field for studying structure–function relationships and evolution.
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1.4 ACMSD is a Transition Metal Dependent Decarboxylase
Decarboxylation is one of the most common processes in nature and one of the most
fundamentally important reactions in biological systems. Essentially all of the carbon dioxide
evolved in fermentation and respiration is generated by the decarboxylation of organic acids
(32). Decarboxylases are known for their roles in a wide variety of catabolic and anabolic
pathways including decarboxylation of α- and β-keto acids, amino acid conversions, and
carbohydrate synthesis (33). Within the IUPAC classification scheme, these are currently divided
into at least 90 different classes. Substantial effort has been applied to the study of the 60 origin
and the mechanisms of production of metabolic carbon dioxide, and considerable knowledge has
been accumulated regarding the decarboxylation mechanisms in biological systems. Enzymatic
decarboxylation usually utilizes either an organic cofactor such as pyridoxal 50-phosphate and
biotin, or an inorganic cofactor, such as an iron or zinc complex, in the catalytic reaction.
ACMSD is one of the decarboxylases whose activity is dependent of inorganic metals. Metal
ions are employed as cofactors in many decarboxylases, some of which do not function as
catalytic centers. For instance, the Zn2+ ion in the biotin-dependent decarboxylases helps to
properly orient the substrate while the Mg2+ ion in the ThDP-dependent decarboxylases assists in
binding the thiamine cofactor. In NAD(P)+-dependent decarboxylases, such as malic enzymes, a
divalent metal ion (Mn2+ or Mg2+) plays an important role in both catalysis and structure stability.
In some cases, metal cofactors play critical catalytic roles.
1.4.1 Mechanism of ferrous-dependent oxidative decarboxylases
α-Ketoglutarate (αKG)- and nonheme ferrous-dependent dioxygenases are classic ferrousdependent decarboxylases (34,35). The αKG-dependent dioxygenase reaction proceeds in two
half reactions. The first half of the reaction is a ferrous and O2-dependent oxidative
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decarboxylation reaction of αKG. The cleavage of the O-O bond results in one oxygen atom
inserting into αKG while the other oxygen remaining at the Fe center (Scheme 1.6). The αKGand Fe-dependent enzymes are widespread and versatile, catalyzing an exceptionally wide range
of energetically demanding biosynthetic and degradative reactions such as the stereo-selective
desaturation of inactivated C-C single bonds, ring expansion, oxidative ring closure, and
hydroxylation processes (35), which are important in the biosynthesis of collagen (36),
antibiotics biosynthesis (37,38), cellular response of hypoxia (39), repair of
alkylatedDNA(40,41), regulation of gene expression by demethylation of histones (42), and
many other biological processes.

Scheme 1.6. A proposed mechanism for ferrous-dependent oxidative decarboxylation of αKG.
The catalytic mechanism of αKG-dependent dioxygenases has been extensively studied. This
family of enzymes all require an iron(II) center, which is relatively weakly coordinated by three
amino acid side chains, typically in a 2-his-1-carboxylate facial triad (43). The mechanism for
this group of decarboxylases proceeds via a Fe(IV)=O intermediate (Scheme 1.6), which was
first proposed three decades ago and recently confirmed by Bollinger and Krebs using EPR and
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Mössbauer spectroscopy (44-49) and by Hausinger using continuous-flow resonance Raman
spectroscopy (50,51). In this model, the binding of the enzyme to αKG, theprimary substrate, and
the binding of molecular oxygen follows an ordered binding mechanism (49,52). The iron center
of the resting enzyme is coordinated with two histidines and one carboxylate (Asp or Glu)
residues together with three water molecules. The addition of the co-substrate, αKG, will replace
the two water ligands with its 1-carboxyl and 2-keto groups. The primary substrate will then
enter and expel the third water molecule, which leads to an empty coordination site ready for a
dioxygen molecule to come in and bind to the iron center (49,53). Addition of dioxygen to the
substrate/co-substrate/iron-bound enzyme complex leads to the oxidation and decarboxylation of
αKG to produce succinate and form a substrate-hydroxylating Fe(IV)=O species through two
non-accumulating complex species in which the Fe(IV)=O intermediate has been trapped and
characterized (44,48,50,54-56). Although the details of the decarboxylating mechanism remain
elusive, it has been demonstrated that decarboxylation of αKG occurs prior to or concomitantly
with the formation of this substrate-hydroxylating Fe(IV)=O intermediate (55). Carbon dioxide
may remain bound to the metal center in its hydrated or nonhydrated form as observed in the
self-hydroxylation reaction study in taurine/aKG dioxygenase (57) and the crystallographic study
in deacetoxycephalosporin C synthase (58). In the next step, the highly reactive Fe(IV)=O
intermediate abstracts a hydrogen atom from the primary substrate and generates a radical
species on the substrate. It also causes a reduction of the metal center. The radical abstracts the
hydroxyl group from the iron center, resulting in the hydroxylation of the substrate (47,48). The
rate-determining step in the catalytic cycle is the release of products (55). For some enzymes in
this family, the Fe(IV)=O intermediate is believed to perform an electrophilic attack on the
aromatic ring of the primary substrate rather than hydrogen abstraction (47,59,60).
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1.4.2

Mechanism of manganese-dependent decarboxylases

Enzymes that require Mn2+ and O2, but not any organic cofactors, to decarboxylate substrates
include oxalate decarboxylase (EC 4.1.1.2) and the closely related oxalate oxidase (EC 1.2.3.4).
Moreover, 4-oxalocrotonate decarboxylase (EC 4.1.1.77) forms a complex with vinylpyruvate
hydratase and utilizes either Mn2+ or Mg2+ as a cofactor to convert 2-oxo-3-hexenedioate to 2oxo-4-hydroxypentanoate (61,62). Oxalate decarboxylase catalyzes the conversion of oxalate to
formate and carbon dioxide. Oxalate decarboxylase utilizes both Mn2+ and dioxygen as its
cofactors, but the reaction does not involve a net redox change (63). Oxalate oxidase also
requires Mn2+ and dioxygen for its catalytic activity. Furthermore, it degrades oxalate to produce
carbon dioxide. However, the reaction uses dioxygen as a substrate involves a net redox reaction
(64,65). Both oxalate decarboxylase and oxalate oxidase catalyzing reactions utilize free radicals
to cleave a relatively stable carbon–carbon bond. Current proposed mechanisms for oxalate
degradation by oxalate decarboxylase and oxalate oxidase suggest several essentially identical
steps up to formation of the Mn-bound formyl radical (64,66). In fact, it has been demonstrated
that oxalate decarboxylase can be converted to an efficient oxalate oxidase by mutating amino
acids on a flexible active site lid (67). Scheme 1.7 illustrates a proposed mechanism for oxalate
decar boxylase based on a number of hypotheses (64-69).
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Scheme 1.7. Proposed mechanism for oxalate decarboxylase.
In 2007, the two metal centers in oxalate decarboxylase were individually characterized
using high field, multifrequency EPR spectroscopy (70). The carbon dioxide anion radical shown
in step five in Scheme 1.7 was trapped in oxalate decarboxylase by Angerhofer and co-workers
in 2011 using an EPR spin trapping technique. Through mutagenesis, the authors were able to
disrupt a hydrogen bond responsible for closing the flexible loop across the substrate binding
channel. This led to a buildup of a carbon dioxide anion radical. A closed conformation is
required for decarboxylation, which ensures that the harmful anion radical intermediate remains
bound at the active site during catalysis (71). At the resting state of the enzyme, Mn2+
coordinates to three conserved histidine residues, a conserved glutamate or aspartate residue, and
two water molecules (65,69). When malate comes into the active site, it binds to the metal ion
monodentately and replaces one of the water molecule ligands. Then dioxygen binds to Mn2+ and
replaces the other water molecule. One electron transferred from the metal to the binding
dioxygen results in a Mn3+-superoxo species, which functions as an electron sink to facilitate the

23
decarboxylation reaction. An electron is drawn from the bound substrate to the metal to generate
a radical on the bound oxalate. Cleavage of the C-C bond of this radical intermediate releases
CO2 and gives a manganese ion-bound formyl radical anion intermediate. At this point the
mechanisms of oxalate oxidase and oxalate decarboxylase purportedly divert. In the hypothetical
mechanism of oxalate decarboxylase, protonation occurs at the carbanionic carbon of the formyl
radical intermediate, which is followed by an electron transfer from the manganese ion to the
formyl radical forming a product bound Mn3+-superoxo species. Product dissociation from the
active site completes the reaction cycle and regenerates the enzyme.
1.4.3

Mechanism of magnesium-dependent decarboxylases

Divalent metal ions can catalyze a decarboxylation reaction at the β-carbon of α-keto
carboxylic acid, while decarboxylases can increase the rate of the reaction dramatically. One of
the most extensively studied cases is the decarboxylation of oxaloacetate. The reaction catalyzed
by oxaloacetate decarboxylase is dependent on divalent metal ions. This enzyme is active with
either Mn2+ or Mg2+. Besides the divalent ion, the decarboxylation catalyzed by this enzyme from
some organisms also requires biotin, while NAD(P)+ is essential for the enzyme from other
species. A proposed mechanism for oxaloacetate decarboxylase from Pseudomonas putida,
which requires only divalent metal cations, is shown in Scheme 1.8 upper (72). The
decarboxylation catalyzed by 4-oxalocrotonate decarboxylase is believed to proceed in a
mechanism similar to that of oxaloacetate decarboxylase (61). The metal divalent cation is
thought to form a complex with the α-keto acid moiety and one of the oxygen atoms from
thecarboxyl group of the substrate, functioning as an electron sink to stabilize the enolate
intermediate (73,74). The enzyme serves to provide substrate specificity and to lower the energy
of the ground state to a much more favorable value. Protonation at the Cb position yields the
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product pyruvate. The proton incorporated in the product can be in a retained or inverted
stereochemical configuration compared to the leaving carboxyl group of the substrate. A recent
study reported that the decarboxylation catalyzed by 3-keto-L-gulonate 6-phosphate
decarboxylase is also Mg2+ ion-dependent. The reaction mechanism of this enzyme has been
extensively studied (75-79). These studies have provided a hypothetical mechanism shown in
Scheme 1.8 lower). In the proposed mechanism, the departure of CO2 is facilitated by forming an
enediolate intermediate stabilized by the Mg2+ ion. However, the required Mg2+ ion does not
ligate to the oxygen of the carboxyl group. Instead it coordinates to the oxygen of the keto-group
at the C3 position and the oxygen of the hydroxyl-group at the C4 position of the substrate,
forming a cis-1,2-enediolate intermediate. Protonation of C1 of the intermediate is completed
through a proton relay system involving two alternative water molecules in the active site and the
side chains of a conserved histidine or a conserved arginine as the ultimate proton sources.
Protonation can lead to either R or S configurations depending on which of the two conserved
residues is used as the ultimate source of the proton.
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1.4.4

Transient metal-dependent, O2-independent decarboxylases

ACMSD was initially thought to be a cofactor-free enzyme (12,13). It has recently been
found to be a metalloenzyme belonging to the amidohydralase superfamily (14,15). This enzyme
is an illustrative example of the ACMSD protein family (also known as the Amidohydrolase_2
subfamily) (18,80), whose members are decarboxylases or hydrotases rather than hydrolases or
deaminases. Members of the ACMSD protein family catalyze a CAC bond cleavage reaction
instead of hydrolytic reaction (80,81). Understanding the mechanism of ACMSD will shed light
on the mechanisms of the continually emerging members of the ACMSD protein family.
However, it is unknown whether ACMSD adopts the mechanism from the amidohydrolase_1
subfamily or follows a model evolved by other decarboxylases (82). Scheme 1.9 is a mechanistic
model adopted from the well-characterized amidohydrolase_1 subfamily. In the first step, the
substrate binds to the enzyme with its C2 carboxylate close but not to themetal center at a rate of
2.4 * 106 s-1M-1 (10). An active site histidine, His228 as numbered in the Pseudomonas
fluorescens enzyme (80), assists in the deprotonation of a water ligand to form hydroxide, which
then nucleophilically attacks the double bond between C2 and C3 of the substrate, resulting in a
hydrated tetrahedral intermediate. The subsequent collapse of the tetrahedral intermediate is
assisted by the concerted deprotonation of His228 and the rebinding of the hydroxyl group to
themetal ion. The carboxylate attached to the C3 position becomes the leaving group. The
decarboxylation step is a rapid reaction (>500 s-1) but the release of the product aminomuconatee-semialdehyde is slow (9 s-1) (10).
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Scheme 1.9. A working hypothesis for mechanism of the ACMSD reaction.
The amidohydrolase-derived mechanism shown in Scheme 1.9 predicts that the metal-bound
hydroxide is the catalytic driving force of the decarboxylation reaction. The pKa value of the
water ligand is lowered from 15.7 of the unbound state to about 9.6 because of its coordination to
zinc (83). This value can be further reduced to nearly the physiological pH with the assistance of
an active site base catalyst, presumably His228 in PfACMSD, and therefore generates a
hydroxide anion, which performs a nucleophilic attack on the C2 and C3 double bond of the
substrate. As expected, mutation at His228 significantly reduces the enzyme activity and removal
of the metal bound water molecule completely deprives the enzyme activity. This hydroxide
attack mechanism is believed to be present in the enzyme 4-oxalomesaconate hydratase, which
was identified as a part of this family in a recent bioinformatics study (80). This enzyme
catalyzes the addition of a hydroxide ion and a proton across a C=C bond of its substrate. The
added hydroxide is preserved in the product so that the proposed hydroxide attack for the
ACMSD enzyme family is visualized in this specific member, as if it were an interruption of an
ACMS decarboxylation reaction. The metal-bound hydroxide attack of the substrate is also
proposed to occur in another zinc-dependent structurally characterized decarboxylase member of
the ACMSD family, c-resorcylate decarboxylase (21). Therefore, the metal-bound hydroxide
assisted C-C/C=C cleavage is likely to be a common mechanism for the ACMSD subfamily of
the amidohydrolase superfamily.
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1.5 AMSDH is a Member of the Aldehyde Dehydrogenase Superfamily
AMSDH is an NAD+ dependent aldehyde dehydrogenase that oxidizes the aldehyde group of
2-AMS to its corresponding acid, competing with the spontaneous decay of 2-AMS to picolinic
acid (Scheme 1.1). Sequence alignment indicates that AMSDH is a member of the
hydroxymuconate semialdehyde dehydrogenase subfamily under the aldehyde dehydrogenase
(ALDH) superfamily. AMSDH has not been studied at the molecular level, and no structure was
available before our work.
1.5.1

Aldehyde dehydrogenase superfamily

Due to the innate chemical reactivity of aldehyde molecules, many of them are toxic even at
low concentrations. Aldehydes are generated from both endogenous (formed during metabolism
of alcohols, amino acids, biogenic amines, vitamins, steroids, and lipids) and exogenous (formed
from the metabolism of a number of drugs and environmental agents) precursors. Members of
the ALDH superfamily catalyze the detoxification of endogenous and exogenous aldehydes and
are widely spread in both prokaryotic and eukaryotic organisms.
The first aldehyde dehydrogenase was identified and purified from beef liver in 1949 (84).
The first primary structure of an ALDH was obtained from human liver in 1984 (85). Since then,
43,773 ALDH sequences (listed as aldedh in the Pfam database) are identified and 607 structures
have been solved. Although ALDH are found in 5325 species with very diverse substrate
preferences, they all utilize NAD(P)+ as a cofactor to provide oxidation power during catalysis
and their overall tertiary structure is highly conserved. The primary sequence, however, has
relatively low conservation. Based on a primary sequence alignment of 145 ALDH proteins, only
four residues are strictly conserved across the superfamily, including two glycines, one
phenylalanine, and one glutamate (86). The catalytic thiol, a cysteine residue, is also conserved
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in all sequences except one. In cephalopod omega-crystallins, the otherwise conserved cysteine
is replaced by an arginine, and it has been reported to lack ALDH activity (87).
To date, nineteen human ALDH genes have been identified according to their divergent
evolution based on the ALDH nomenclature system established in 1998. Human ALDH genes
are closely related to human health and many diseases caused by defects in aldehyde metabolism
are caused by mutations in the genes which encode the respective enzymes. For example,
ALDH1a1 helps maintain the corneal transparency (88). A single nucleotide polymorphism in
encoded ALDH1b1 was found to be related with alcohol induced hypersensitivity symptoms
including asthma and flushing (89). Inactivation of ALDH2 will cause both heart disease (90)
and alcohol sensitivity problems (91). It has been shown that a much higher percentage of Asian
exhibit acute alcohol intoxication compared to Europeans. The underlying reason is a mutation
of a glutamate residue to lysine in the ALDH2 gene which leads to inactivation of the expressed
enzyme (92). Mutations in the ALDH7a1 gene were found to be related to pyridoxine-dependent
seizures in children. This is because the mutation abolishes the activity of antiquitin and leads to
the accumulation of δ 1-piperideine-6-carboxylate-α-aminoadipic semialdehyde (93). Recent
studies also indicate that increased activity of ALDH1a1 could serve as a hallmark of cancer
stem cells (94).
1.5.2

Structural features of members in the ALDH superfamily

The first X-ray crystal structure of an ALDH was solved in 1997 as a homo-dimer (95).
Quaternary structures of most ALDH solved later are either homodimers or homotetramers,
which consists of a dimer of dimers. All members of the ALDH superfamily have very similar
three-dimensional structures, even those with low sequence identities. These similarities arise
from several conserved glycine and proline residues which are responsible for constructing the
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Rossmann folds with six β-strands and four α-helices. The majority of ALDH enzymes have a
strong preference for either NAD+ or NADP+. Studies have shown that residues close to the
adenosine ribose are responsible for co-substrate selectivity in NAD(P)+ dependent
dehydrogenases. Presence of an acidic residue near the adenosine 2’-position is a major
characteristic for NAD+ binding proteins because the anion side chain can interact with both 2’and 3’-hydroxyl group of the NAD+ adenosine ribose. Also, the carboxyl group of the acidic
residue could prevent NADP+ from binding by repelling its 2’-phosphate (98-101). On the other
hand, placing a positively charged lysine or arginine at the same position will tune the cosubstrate selectivity towards NADP+ (102-104).
Multiple hydrogen bonds and salt bridges are involved in stabilizing the co-substrate.
However, the nicotinamide head of NAD(P) remains flexible and stays in different
conformations dependent upon the oxidation state (105,106). In the oxidized state, NAD(P)+ lies
in the Rossmann fold in an extended conformation, allowing the hydride to transfer from the
substrate to reduce the co-substrate during the first half of the reaction. Reduced NAD(P)H
adopts a bent conformation, in which the nicotinamide head moves back towards protein surface
and leaves space for the second half of the reaction, acyl-enzyme hydrolysis, to take place.
The catalytic domain has a topologically related βαβ-type polypeptide fold. The catalytic driving
force, a cysteine residue, sits in the active site in close proximity to the NAD(P)+ nicotinamide
group and is connected to the protein surface by a channel, presumed to be the substrate binding
channel. As an active-site catalytic thiol, this cysteine is easier to be oxidized than regular
cysteine residues. Hence, purified ALDH enzymes easily lose their catalytic activity if they are
not protected by reducing agents. It was suggested that the cysteine residue can be protected by
forming a covalent bond with the NAD(P)+ co-substrate (107,108). In some ALDH enzymes, a
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After the glutamate residue rotates into an active position, it will work as a general base to
deprotonate an ordered water molecule. The activated water will then attack the thioester carbon
(previously the aldehydic carbon), leading to the formation of the second tetrahedral intermediate
(Scheme 1.10, intermediate 3). This glutamate is another strictly conserved residue in the ALDH
superfamily and its function as a general base has been well studied in the past decades
(108,117,119,120). Finally, collapse of the second tetrahedral intermediate and scission of the CS bond leads to product release.
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CHAPTER 2

EVIDENCE FOR A DUAL ROLE OF AN ACTIVE SITE HISTIDINE IN

α-AMINO-β-CARBOXYMUCONATE-ε-SEMIALDEHYDE DECARBOXYLASE
The section of chapter 2 is our published work on ACMSD: Evidence for a Dual Role of an
Active Site Histidine in α-Amino-β-Carboxymuconate-ε-Semialdehyde Decarboxylase. Lu Huo,
Andrew J. Fielding, Yan Chen, Tingfeng Li, Hiroaki Iwaki, Jonathan P. Hosler, Lirong Chen,
Yoshie Hasegawa, Lawrence Que, Jr., and Aimin Liu. (2012) Biochemistry, 51(29), 5811-5821.
This work is supported in part by grants from NSF Grant MCB-0843537 (AL), NIH grants GM
038767 (LQ) and GM 056824 (JPH), the Japanese strategic projects to support the formation of
research bases at private universities: matching fund subsidy from MEXT, 2008-2012 and the
University of Minnesota Chemical Biology Initiative in conjunction with the NIH-supported
Chemistry Biology Interface Training Grant GM 08700 (AJF).
2.1 Abstract
The previously reported crystal structures of α-amino-β-carboxymuconate-ε-semialdehyde
decarboxylase (ACMSD) show a five-coordinate Zn(II)(His)3(Asp)(OH2) active site. The water
ligand is H-bonded to a conserved His228 residue adjacent to the metal center in ACMSD from
Pseudomonas fluorescences (PfACMSD). Site directed mutagenesis of His228 to tyrosine and
glycine in the present study results in complete or significant loss of activity. Metal analysis
shows that H228Y and H228G contain iron rather than zinc, indicating that this residue plays a
role in metal selectivity of the protein. As-isolated H228Y displays a blue color, which is not
seen in wild-type ACMSD. Quinone staining and resonance Raman analyses indicate that the
blue color originates from Fe(III)-tyrosinate ligand-to-metal-charge-transfer (LMCT). Co(II)substituted H228Y ACMSD is brown in color and exhibits an EPR spectrum showing a highspin Co(II) center with a well-resolved 59Co (I = 7/2) eight-line hyperfine splitting pattern. The
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X-ray crystal structures of the as-isolated Fe-H228Y (2.8 Å), Co- (2.4 Å) and Zn-substituted
H228Y (2.0 Å resolution) support the spectroscopic assignment of metal ligation of the Tyr228
residue. The crystal structure of Zn-H228G (2.6 Å) was also solved. These four structures show
that the water ligand present in WT Zn-ACMSD is either missing (Fe-H228Y, Co-H228Y, and
Zn-H228G) or disrupted (Zn-H228Y) in response to His228 mutation. Together, these results
highlight the importance of His228 for PfACMSD’s metal specificity as well as maintaining a
water molecule as ligand of the metal center. His228 is thus proposed to play a role in activating
the metal-bound water ligand for subsequent nucleophilic attack on the substrate.
2.2 Introduction
Histidine, an essential amino acid, is found at the active site of a myriad of enzymes. The
imidazole side chain of histidine can serve as a coordinating ligand in metalloproteins and in
many cases is a catalytically important component in the active sites of enzymes. The pKa of the
imidazolium ion (~ 7) permits significant concentrations of both acidic and basic forms near
neutral pH, making it a commonly found general acid-base catalyst in enzymes (121). The
participation of histidine in catalysis has also been illustrated in the well-studied mechanisms
proposed for members of the amidohydrolase superfamily (19,81). The best-characterized
members of the amidohydrolase superfamily share a common catalytic mechanism by which a
metal-bound water is proposed to be activated by an active site base to yield a metal-hydroxo
species. Subsequently, the hydroxide attacks the substrate bearing the amide or other functional
groups at the carbon or phosphorus center to form a tetrahedral carbon or pentacoordinate
phosphorus intermediate on the substrate (19,81). The collapse of the substrate-based
intermediate leads to the hydrolytic products.
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The enzyme α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD)
catalyzes the decarboxylation of its substrate ACMS to form 2-aminomuconate semialdehyde
product (AMS). It is the first enzyme known to perform an O2-independent nonoxidative
decarboxylation with d-block divalent metal cofactors such as zinc, cobalt, or iron (14). ACMSD
is proposed to be a prototypical member of a new protein subfamily in the amidohydrolase
superfamily representing a novel nonhydrolytic C-C bond breaking activity (15,18). Scheme 2.1
outlines a working mechanism of ACMSD action.
ACMSD plays an important role in two distinct metabolic pathways, the mammalian
kynurenine pathway for tryptophan degradation (122) and the bacterial 2-nitrobenzoic acid
pathway for biodegradation of nitroaromatic compounds (12,123,124). In both pathways,
ACMSD controls the final fate of the metabolites by competing with a slow spontaneous reaction
that produces the excitotoxin quinolinic acid (QA) and directs the metabolic flux away from QA
to energy production (125), QA is an endogenous selective agonist of N-methyl-D-aspartate
receptors (2). It modulates neurotransmission and mediates immune tolerance. Reduced activity
of ACMSD can lead to abnormal QA concentration in body fluids, which has been linked to
numerous diseases, including diabetes (125), neuropsychiatric diseases (126), neurodegenerative
disorders such as Alzheimer’s and Huntington’s diseases (127,128), stroke, and epilepsy (2,129).
Therefore, the results of mechanistic study on ACMSD have significant medical implications.
Although ACMSD was discovered more than 55 years ago (130), little was known about the
catalytic mechanism until our recent collaborative studies of Pseudomonas fluorescences
ACMSD (PfACMSD) (14) unmasked its metal cofactor and determined its three dimensional
structure (80). The as-isolated enzyme contains a zinc ion (80) and it works equally well when
substituted with a cobalt(II) ion (14,15). The decarboxylation is rapid (> 500 s-1); the product
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release from the active site is the rate-limiting step (10). Recently, the crystal structure of human
ACMSD was reported with a bound inhibitor 1,3-dihydroxyacetonephosphate (131). The human
ACMSD and PfACMSD present a nearly identical overall structure consisting of an (α/β)8-barrel
core and a five-coordinate protein-bound zinc ion (80,131). The metal ion is bound to the
enzyme by three histidines (His9, His11, and His177), one aspartic acid residue (Asp294), and
one water ligand. A nearby histidine from β-strand 6, i.e. His228 in PfACMSD residue
numbering, is located in the secondary sphere and is part of a hydrogen-bonded system that
appears to facilitate deprotonation of the water ligated to the catalytic zinc (Figure 2.1). A
comprehensive biochemical, spectroscopic and structural study presented in this work suggests
that His228 is a major determinant of metal preference in PfACMSD and that it plays an
important role in maintaining the hydrolytic water ligand necessary for the decarboxylase
chemistry in this enzyme.

Figure 2.1. The active site histidine (His228 or hHis224) is in H-bond distance with the metalbound water ligand (Wat) in crystal structures of ACMSD. (A) as-isolated Zn-PfACMSD (PDB:
2HBV), (B) Co(II)-substituted PfACMSD (2HBX), and (C) an inhibitor-bound structure of
hACMSD (2WM1).

2.3 Experimental Procedures
Site-Directed Mutagenesis. The plasmid containing His-tagged ACMSD from Pseudomonas
fluorescens was used as a template for construction of all of the mutants (15). The forward

37
primers used in the site-directed mutagenesis are 5’CAAGATCTGTTTCGGGggTGGTGGGGGAAGTTTCG-3’ for H228G and 5’CAAGATCTGTTTCGGGtATGGTGGGGGAAGTTTCG-3’ for H228Y. ACMSD mutants were
constructed by the PCR overlap extension mutagenesis technique (132). The insertion of each
construct was verified by DNA sequencing to ensure that base alterations were introduced
correctly as expected and with no undesired changes. After sequencing, the positive clone was
used for overexpression of these mutants in E. coli BL21(DE3).
Bacterial Growth and Protein Preparation. The expression and purification of WT
PfACMSD and its mutants were the same as described previously (15). Apo H228G was
prepared by EDTA treatment; Zn(II) and Co(II) containing H228G proteins were prepared by
metal reconstitution reaction as previously described (14). Because iron cannot be removed from
as-isolated H228Y by high concentration EDTA, Zn(II)- and Co(II)-H228Y proteins were
obtained by substituting 0.1 mM CoCl2 or ZnCl2 to M9 medium prior to the addition of IPTG for
induction during cell culture. The protein was purified in the presence of 0.1 mM CoCl2 or ZnCl2
during affinity chromatographic step by using Co(II)- and Zn(II)-charged IMAC columns,
respectively.
Metal Analysis. The metal content of the as-isolated ACMSD from LB was determined by
inductively coupled plasma optical emission spectroscopy (ICP-OES) using a Spectro Genesis
spectrometer (Spectro Analytical Instruments). Assays were performed in triplicate for the
mutants the same day as the assay samples of the wild-type (WT) enzyme. Standard curves were
prepared using a transition element standard mixture (CCS-6) from Inorganic Ventures. Error
(standard deviation) within three measurements of each sample was less than 1%, while error
between different ACMSD preparations was within 4%. Metal content is reported per ACMSD
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monomer. Protein concentration was measured using Coomassie Plus protein assay reagent
(Pierce) according to the manufacturer's instruction. Molar concentration of PfACMSD
monomer was determined by using 39 kDa as the molecular weight (14).
Circular Dichroism Spectroscopy. The CD spectra (190 - 250 nm) of ACMSD and mutant
proteins were acquired on a JASCO J-810 spectropolarimeter (JASCO, Easton, MD, USA) at
ambient temperature. In each measurement, a protein sample (10 μM) was placed in a 1-mm path
length quartz cell in 0.05 M potassium phosphate, pH 7.5. All spectra were the average of ten
scans with a scan rate of 50 nm min−1.
Preparation of ACMS and Enzyme Activity Assay. ACMS was generated from 3-hydroxyanthranilic acid using 3-hydroxyanthranilate 3,4-dioxygenase containing no free transient metal
ion as reported previously (15). Specific activities of ACMSD proteins were measured in
triplicate at room temperature on an Agilent 8453 diode-array spectrophotometer by monitoring
the absorbance of ACMS at 360 nm as described previously (15).
Electronic Spectroscopy. UV-Vis absorption spectra were obtained in 25 mM HEPES-NaOH
buffer, pH 7.0, and 5% glycerol at room temperature on a Cary 50 spectrophotometer. Reduced
Fe(II)-H228Y for UV-Vis and resonance Raman experiments was prepared by adding 13 μL 30
mM sodium dithionite or L-ascorbate (~ 2 equivalents per Fe) to 150 μL 1.4 mM Fe(III)-H228Y
in an 1-mm path length cuvette.
Quinone-based NBT Staining. Purified proteins were first electrophoresized on a 12% SDS–
PAGE gel and then transferred onto a nitrocellulose membrane using the Mini Trans-Blot Cell
Assembly (Bio-Rad). The transblotting was conducted in the transfer buffer (25 mM Tris-HCl,
192 mM glycine, and 20% methanol) at 100 V for 1 h. The proteins were temporarily visualized
by 0.1% ponceau S in 5% acetic acid (133). After the temporary stains were removed by washing
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with water, the protein-containing nitrocellulose membrane was immersed in a solution of 0.24
mM NBT and 2 M potassium glycinate, pH 10, in the dark for 45 min to visualize the quinonecontaining protein band (134). This method was designed to identify quinonoid compounds, such
as DOPA, and is a convenient assay for quinone-containing proteins (135). Purified methylamine
dehydrogenase (MADH) from Paracoccus denitricans (a generous gift from Dr. Victor L.
Davidson), a protein consisting of two large α-subunits and two small β-subunits with a
tryptophan tryptophyquinone prosthetic group in each of its small subunit (136), was used as
both of a positive and a negative control in Ponceau S staining and NBT staining experiments.
Electronic Paramagnetic Resonance (EPR) Spectroscopy. HEPES buffer (25 mM, pH 7.0)
containing 10% glycerol was used in the EPR sample preparations. X-band EPR spectra were
obtained in perpendicular mode on a Bruker (Billerica, MA) EMX spectrometer at 100-kHz
modulation frequency using a 4119HS high-sensitivity resonator. Low temperature was
maintained with an ITC503S temperature controller, an ESR910 liquid helium cryostat, and a
LLT650/13 liquid helium transfer tube (Oxford Instruments, Concord, MA). Measurements were
conducted by keeping the frequency of the electromagnetic radiation constant while the magnetic
field was swept.
Raman Spectroscopy. Resonance Raman spectra were collected on an Acton AM-506
spectrophotometer (1200 groove rating) using Kaiser Optical Systems holographic supernotch
filters and a Princeton Instruments liquid N2-cooled CCD detector (LN-1100PB) with 4 cm-1
spectral resolution. HEPES buffer (25 mM, pH 7.0) containing 5% glycerol was used in the
sample preparations. Spectra were collected at 100 mW laser power using a Spectra Physics
1060-KR-V krypton ion laser (568.2 and 647.1 nm) or a 2030-15 argon ion laser (488.0 and
514.5 nm). Raman frequencies were referenced to indene standard with an accuracy of ± 1 cm-1.
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Raman spectra were collected at 4 °C by 90° scattering from a flat bottomed NMR tube with 3060 minutes to collect each window of spectra. The full spectra were collected in two overlapping
windows; the florescent background was subtracted before normalizing spectra at nonresonance
enhanced protein phenylalanine ring vibration at 1004 cm-1 and splicing normalized spectra
together. Baseline corrections (polynomial fits) were applied using Gram/32 Spectral Notebook
(ThermoGalactic). Excitation profiles were constructed by comparing peak intensities of
resonance enhanced bands of normalized spectra to nonresonance enhanced vibration at 1004
cm-1. Difference resonance Raman spectra of Fe(III)-H228Y were obtained by subtracting the
spectrum of WT Zn-ACMSD both normalized at 1004 cm-1 vibration followed by a base line
correction.
X-ray Data Collection and Crystallographic Refinement. Co(II)-H228Y, Zn(II)-H228Y and
Zn(II)-H228G ACMSD were crystallized following the condition previously established for WT
ACMSD by hanging drop vapor diffusion in VDX plates (Hampton Research). Single crystals
suitable for X-ray data collection were obtained from drops assembled with 1 μL protein solution
layered with 1 μL reservoir solution containing 0.1 M Tris-Hcl (pH 8.75), 0.2 M MgCl2, and
15% PEG 5000. Reservoir solution for Fe(III)-H228Y was modified and contained 0.1 M Tris
(pH 7.0), 0.2 M MgCl2, and 17% PEG 5000. Crystals were frozen in liquid nitrogen after being
dipped into the cryoprotectant solution that contained 30% of glycerol or ethylene glycol in the
mother liquid. X-ray diffraction data were collected at SER-CAT beamline 22-ID or 22-BM of
the Advanced Photon Source (APS), Argonne National Laboratory, Argonne, IL. Data were
collected at 100 K using a beam size matching the dimensions of the largest crystal face. The
data were processed with HKL-2000 (137). Structure solutions were obtained by molecular
replacement using MolRep (138) from the CCP4i program suite (139) with the entire WT Co(II)-
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ACMSD structure (PDB entry 2HBX) for Co(II)/Fe(III)-H228Y ACMSD and WT Zn(II)ACMSD structure (PDB entry 2HBV) for Zn(II)-H228Y/Zn(II)-H228G ACMSD as the search
models. Refinement was carried out using REFMAC (140) in the CCP4i program suite (139) for
Fe(III)- and Co(II)-H228Y and PHENIX software for Zn(II)-H228Y and Zn(II)-H228G, and
model-building was carried out in COOT (141). Restrained refinement was carried out using no
distance restraints between the metal center and its ligands. Residue Tyr228 and Gly228 were
well-ordered and added to the model based on the 2Fo-Fc and Fo-Fc electron density maps.
Refinement was assessed as complete when the Fo-Fc electron density contained only noise.
2.4 Results
Biochemical properties of the His228 mutants—To probe its role in the enzyme mechanism,
His228 was mutated to tyrosine, which also has a ring structure and is capable of hydrogen
bonding, and glycine, which effectively deletes the side chain and thus eliminates hydrogen
bonding. Both variants were expressed as soluble proteins. Surprisingly, the H228Y mutant
purified from cells grown in LB medium exhibits a blue chromophore while wild-type (WT) ZnACMSD is colorless (Figure 2.2). Metal analysis of the blue H228Y-ACMSD by ICP-OES
spectroscopy showed the enzyme contained 0.51 ± 0.013% Fe, 0.08 ± 0.003 Zn and 0.001 ±
0.0004 Cu ions per polypeptide chain, whereas the wild-type enzyme prepared under the same
experimental conditions contained only zinc (80). Likewise, the as-isolated H228G mutant
contained mainly Fe ion (0.32 ± 0.001 per polypeptide chain) and trace amount of zinc. A sharp
ferric EPR signal is seen at g = 4.27 from the two as-isolated His228 mutants (not shown). These
results suggest His228 is an important determinant of metal selectivity in this enzyme.
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The as-isolated H228G and H228Y were catalytically inactive regardless of whether the Fe
ion is in the ferrous or ferric oxidation state. Zinc- and cobalt-substituted variants were also
tested. H228Y was inactive in both Zn(II) and Co(II) forms, as was Zn(II)-H228G. These results
suggest that His228 is essential for the enzyme catalytic activity.

Figure 2.2. UV-Vis spectra of Fe-H228Y. The as-isolated Fe(III)-H228Y protein(dark blue
trace), its reduced form (black) and the different spectrum (red) showing two absorption at
370 nm and 595 nm. Photographs of the as-isolated Fe(III)-H228Y (right) and reduced Fe(II)H228Y (left) are shown in the inset.
The blue color in H228Y is not due to formation of a metal-bound dihydroxyphenylalanine—
Two possibilities were considered for the origin of the blue chromophore of the as-isolated Fecontaining H228Y. The first option is an oxygenated Tyr may be produced by post-translational
modification resulting from oxygen activation by the redox active iron. Examples can be found
for a number of non-heme iron enzymes (135,142,143). However, this option is not supported by
A quinone-based staining assay (135) using reversible ponceau S staining of a nitrocellulose
membrane (See Supporting information Figure S2.1). Alternatively, it could be due to the
coordination of Tyr228 to the active site metal, as tyrosinate-metal interactions have been
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observed in many other enzymes, such as purple acid phosphatases (144). phospholipase D
(145), and catalases (146).
Resonance Raman characterization suggests an Fe(III)-tyrosinate chromophore in asisolated Fe-H228Y—The blue Fe-H228Y mutant exhibits two UV-Vis absorption bands at 370
and 595 nm, with respective extinction coefficients of 3000 and 1300 M-1 cm-1 (Figure 2.2).
While the 370 nm feature is a common spectral characteristic of the Fe(III)-bound nonheme Fe
proteins, the blue chromophore at 595 nm is within the range of the Fe(III)-tyrosinate LMCT
band with an absorption maximum that is typically between 410 – 600 nm (1000 – 2500 M-1cm-1
per phenolate ligand) (147). In contrast, an iron(III)-catecholate LMCT chromophore typically
exhibits two lower energy bands between 400 – 580 nm and 550 – 900 nm (2000 – 2500 M-1cm1

), these are not present in Figure 2.2. The blue chromophore vanished upon the addition of

sodium dithionite or L-ascorbate to the protein, suggesting that reduction of the Fe(III) metal
center to Fe(II) is linked with the loss of the intense ligand-to-metal charge-transfer (LMCT)
transition.
Figure 2.3A shows resonance Raman spectra of the as-isolated blue Fe-H228Y acquired with
568.2 nm laser excitation using 90° scattering geometry compared to the spectra of reduced FeH228Y, WT Zn-ACMSD and the buffer (25 mM HEPES pH 7.0 with 5% glycerol by volume)
collected under the same conditions. Vibrations associated with the buffer solution and protein
were subtracted by taking the difference spectra of the as-isolated blue Fe-H228Y and WT ZnACMSD after normalizing both spectra by scaling to non-resonance-enhanced protein
phenylalanine ring vibration at 1004 cm-1 (Figure 2.3B). The difference spectrum shows
resonance-enhanced vibrations at 573, 792, 873, 1164, 1290, 1503, and 1604 cm-1. The
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Figure 2.3. Resonance Raman spectra of H228Y-ACMSD. (A) Resonance Raman spectrum with
568.2 nm laser excitation of (a) as-isolated blue Fe(III)-H228Y, (b) native Zn-ACMSD, (c)
Fe(II)-H228Y ACMSD, and (d) Fe(III)-H228Y ACMSD. (B) Difference resonance Raman
spectra of Fe(III)-H228. (C) Excitation profiles for resonance enhanced bands.
excitation profile of the 1164, 1290, 1503, and 1604 cm-1 features shown in Figure 2.3C
illustrates maximum enhancement of these vibrations near the absorption maximum of the blue
chromophore at 595 nm, while the 573, 792, and 873 cm-1 vibrations are more enhanced at 647.1
nm. The spectrum of the reduced form of the colorless Fe(II)-H228Y does not exhibit any
resonance-enhanced vibrations but closely resembles the WT Zn-ACMSD (Figure 2.3A).
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The resonance enhanced vibrations of Fe(III)-H228Y at 573, 1164, 1290, 1503, and 1604
cm-1 are collectively regarded as the Raman signature for a Fe(III)-tyrosinate chromophore
(Table 2.1) (147-159). These vibrations are distinct from those expected for a Fe(III)-catecholate
chromophore, which has characteristic vibrations observed at 1270, 1320, 1425, and 1475 cm-1
(Table 2.1) (160-164). By analogy to previous work on nonheme Fe proteins the 573 cm-1 can be
assigned to the Fe-(O)Tyr vibration, while the higher frequency vibrations are associated with
aromatic ring modes. The 792 and 873 cm-1 vibrations may originate from a Fermi doublet
formed by the mixing of the fundamental υ1 symmetric ring-breathing vibrational mode and first
overtone υ16a non-planar ring vibration (165-168). Solid L-tyrosine exhibits a Fermi doublet with
peaks at 803 and 845 cm-1 as well as the υ16a fundamental at 419 cm-1 (166). The two peaks
observed for the blue Fe-H228Y have a much larger splitting of 81 cm-1. An even larger splitting
has been observed for porcine uteroferrin (803 and 873 cm-1), while the υ16a fundamental was not
detected (165,168). The large splitting of tyrosine Fermi doublet was rationalized as a result of
strong covalence of the Fe(III)-tyrosinate metal ligand bond based on the fact that it was
resonance enhanced and that its center of gravity (~ 838 cm-1) is similar to that of L-tyrosine (~
824 cm-1) (165). Upon 647.1 nm laser excitation of the blue Fe-H288Y, a weak peak is observed
at 418 cm-1 that may be assigned to the fundamental υ16a vibration.
Table 2.1. Resonance Raman vibrations and LMCT bands of nonheme iron protein and model
complexes with Fe(III)-phenolate and Fe(III)-catecholate chromophores.
λmax (nm)
(ε, M-1cm-1)
Fe(III)-phenolate complexes
Complexa

H228Y-Fe(III)ACMSD

370(3000),
595(1255)

Fe(II)-HPPD + O2
Porcine uteroferrin
[Fe(salhis)2]ClO4

595(2600)
545(1000)
530(4100)

Resonance Raman Vibrations (cm-1)

Reference

573

792

873

1164

1290

1503

1604

this work

583
575

751
803

881
873

1171
1173
1159
1132

1290
1293
1337
1310

1502
1504
1476
1452

1600
1607
1625
1605

(148,169)
(165,168)
(153)
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Fe(III)serotransferrin
Fe(III)-lactoferrin
Fe(III)ovotransferrin
Catechol 1,2dioxygenase
Protocatechuate
3,4-dioxygenase

470(2500)

759

828

465(2070)
465(2000)
450(3000–
4000)
435(3000),
525

[Fe(salen)(OC6H410
4-CH3)]
Fe(III)-catecholate complexes
Fe(III)TyrH415(1700),
dopamine
695(2000)
420(1500),
Blue PMI
680(2100)
Fe(III)-MndD675(750)
DOPA

592

530

1288

1508

1613

(156,159)

1170

1272

1500

1604

(157,158)

759

860

1173

1264

1501

1603

(151)

757

872

1175

1289

1506

1604

(153,154)

756

826

1172

1254

1506

1604

(149,152)

854

1180

1266

1168

1272

1501

1603

(147,155)

568

528

1174

592

631

1275

1320

1425

1475

(163)

591

631

1266

1330

1428

1482

(161)

569

646

1273

1318

1423

1464

(170)

666

586
Fe(II)TauD-αKG
550(700)
544 580 623 644 1261 1314 1425 1475
(162,171)
+O2
a
Abbreviations used in this table: ACMSD, α-Amino-β-carboxymuconate-ε-semialdehyde decarboxylase from
Pseudomonas fluorescens; salhis, N-[2-(4-imidazolyl)ethyl]salicylaldimine; salen, N,N'-ethylenebis
(salicy1idenamine) dianion; MndD, homoprotocatechuase 2,3-dioxygenase from Arthrobacter globiformis; DOPA,
dihydroxyphenylalanine; PMI, phosphomannose isomerase from Candida albicans expressed in Escherichia coli;
TauD taurine/α-ketoglutarate dioxygenase from Escherichia coli; HPPD, (4-hydroxyphenyl) pyruvate dioxygenase
from Pseudomonas fluorescens; α-KG, α-ketoglutarate.

Fe(III)-tyrosinate LMCT bands in the visible region typically range from 410–600 nm where
the energy of the LMCT transition can be correlated with the Lewis acidity and the Fe(III/II)
redox potential of the iron center and can give additional information about the nature of the
other coordinating ligands (147). The low energy of the Fe(III)-tyrosinate LMCT band of FeH228Y at 595 nm and the observation that Fe-H228Y is easily reduced by mild reducing agents
are consistent with a Lewis acidic metal center with weak field ligands (148). Post-translationally
modified blue (4-hydroxyphenyl) pyruvate dioxygenase (HPPD) has a similarly low-energy Fetyrosinate LMCT band at 595 nm (148,169). From its crystal structure (172), unmodified HPPD
has an iron center coordinated by two histidines and one glutamate, but no tyrosinate ligand.
However it does have several phenylalanine amino acid residues in the second sphere, one of
which has been proposed to be self-hydroxylated to form the tyrosinate ligand in blue-HPPD
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(164,172). Based on the similar energies of their LMCT bands, blue Fe(III)-H228Y and the selfhydroxylated HPPD are likely to have comparable ligand environments with two or three
histidine residues and a carboxylate group from either an aspartate or glutamate. Along with the
fact that H228Y no longer picks up Zn(II), the Fe(III) is likely to be coordinated by His9, His11,
His177, Asp294 and Tyr228 residues in the ACMSD active site.
Spectroscopic characterization of Co(II)-substituted H228Y— Co(II)-H228Y was obtained
by adding supplemental CoCl2 to the M9 minimum growth medium and purification buffer (see
experimental procedures). ICP-OES spectroscopic analysis confirmed that H228Y isolated with
supplemented cobalt contains 0.98 ± 0.02 cobalt and 0.05 ± 0.03 iron per protein monomer. The
cobalt-substituted H228Y displays a brown chromophore that is darker than the color of the WT
Co(II)-substituted ACMSD (Figure 2.4, top), The brown chromophore originates from forbidden
metal d-d transitions, the intensities of which can be correlated to the metal coordination number.
Decreasing the coordination number increases the intensity of the d-d bands due to greater p-d
orbital mixing. Typically, six-coordinate high-spin Co(II) complexes have extinction coefficients
of less than 50 M-1cm-1 above 500 nm, while five- and four-coordinate complexes have values
between 50 – 250 M-1 cm-1 and greater than 300 M-1cm-1, respectively (173-175). The visible
spectrum of the brown Co(II)-substituted H228Y is similar to that of WT Co(II)-ACMSD above
500 nm (Figure 2.4, top), consistent with a 5-coordinate Co(II) center (176). However, the
spectrum below 500 nm is distinct from that of the wild-type protein (Figure 2.4, top). The
absorption peaks at 355 (680 ± 20 cm-1M-1) and 420 nm (430 ± 10 cm-1M-1) in WT ACMSD are
respectively red shifted to 380 (590 ± 30 cm-1M-1) and 458 (490 ± 20 cm-1M-1) in the Co(II)substituted H228Y. These differences indicate that the Co(II) center in the H228Y mutant is in a
weaker ligand field environment than in WT Co(II)-substituted ACMSD. This observation is
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consistent with the substitution of a water ligand by a stronger π-donating ligand in Co(II)substituted H228Y due to Tyr228 ligation to the metal as suggested by resonance Raman study
for Fe-H228Y in as-isolated H228Y protein.
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Figure 2.4. UV-Vis and EPR spectra of Co(II)-H228Y-ACMSD. Top panel: UV-Vis spectra of
Co(II)-H228Y ACMSD (black) and Co(II)-substituted WT ACMSD (red). Photographs of the
as-isolated Co-WT (left) and Co-H228Y (right) are shown in the inset. Bottom panel: EPR
spectra of Co(II)-H228Y ACMSD obtained at 3G modulation, 0.25 mW microwave power, and
10K. The asterisk indicates a g=4.27 signal from a small amount of Fe ion present in the sample
due to a change in the metals preference of H228Y.
Electron paramagnetic resonance (EPR) spectroscopy was employed to characterize the
electronic structure of the metal center in Co(II)-substituted H228Y. The EPR spectrum of Co-
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H228Y exhibits
e
an S = 3/2 spectrrum with a well-resolved
w
d eight-line 59
Co hyperfiine interactioon

pattern asssociated wiith the low-ffield feature (Figure 2.4, bottom), consistent withh a high-spinn
Co(II) ion bound speecifically to the
t protein. An
A Fe(III) EPR
E signal iss also presennt at g = 4.277,
showing that a minorr fraction of protein still binds iron even
e
under thhe cobalt-ricch conditionss.
The well-resolved 59Co
C hyperfinee structure of
o Co-H228Y
Y is observabble even at 10
1 – 20 K, buut
only a featureless cob
balt signal can be observved in WT Co-ACMSD
C
at this tempeerature (14).. The
g value of
o the high-fiield feature of
o the Co-H2228Y mutannt is also diffferent from that
t of the WT
W
protein, i.e.,
i 2.343 veersus 2.613, indicating thhat the ligand geometry around the metal
m
ion in
H228Y iss different frrom that of the
t WT enzyyme (14). Thhe optical and EPR data suggest that the
high-spinn cobalt centter in the broown H228Y is distinct frrom the cobaalt center in the
t wild-typpe
enzyme. The spectrall features aree most reminniscent of hiigh-spin fivee-coordinate cobalt centeers
with squaare pyramidaal geometry,, such as thaat found in innhibitor derivvatives of coobalt carboniic
anhydrasse (177).

Figure 2..5. Superimp
posed overalll structures of
o ACMSD containing different
d
mettals. WT Zn((II)ACMSD in blue, WT
T Co(II)-ACMSD in maggenta, Fe(IIII)-H228Y ACMSD in orrange, Co(II))n(II)-H228Y
Y in green, annd Zn(II)-H2228G in red.
H228Y inn yellow, Zn
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X-ray crystal structure—While the spectroscopic data strongly suggest a tyrosinate ligation
to Fe in the as-isolated H228Y protein, it remains unclear that if Tyr228 is a metal ligand in
Co(II)-substituted H228Y. The zinc-containing mutants do not have chromophore or EPR
features. In order to observe directly what changes at the enzyme active site arise from the point
mutation and metal substitution, we obtained single crystals from the as-isolated Fe(III)-H228Y,
Co(II)-substituted H228Y, Zn(II)-substituted H228Y, and Zn(II)-reconstituted H228G proteins.
The X-ray crystal structures of Fe(III)-H228Y (2.8 Å, PDB entry: 4ERG), Co(II)-H228Y (2.4 Å
resolution, PDB entry: 4ERA), and Zn(II)-H228G (2.6 Å, PDB entry: 4EPK) were solved in the
P42212 space group, while Zn(II)-H228Y (2.0 Å, PDB entry: 4ERI) was determined in the C2
space group. Data collection and refinement statistics are presented in Table 2.2. Figure 2.5
shows the superimposition of the four structures we determined against the previously reported
WT Zn(II)-ACMSD and Co(II)-substituted ACMSD data. As previously seen in the wild-type
enzyme, the mutants of PfACMSD exhibits a homodimeric quaternary structure. The substitution
of His228 with either Tyr or Gly has little impact on the folding of the overall TIM-barrel
scaffold, regardless of the metal identity. The circular dichroism spectra of these variants were
nearly identical to that of the WT enzyme (not shown), consistent with the structural data. In
Figure 2.5, structural variations relative to WT ACMSD are highlighted in different colors.
These structural differences are mainly observed in the previously defined mobile insertion
domain, which is more flexible compared with other parts of the structure (80). Limited
structural differences in a few loop regions are observed due to changes of metal ligation in the
metal-substituted mutants. Therefore, we conclude that no significant change in secondary
structure was introduced due to the mutation and metal substitution. The organization of amino
acids residues surrounding the metal center is very similar in all four structures with one

51
exception of one of the metal ligands, Asp294, which tilts towards the imidazole ring of His9 to
various degrees (Figure 2.6).

Figure 2.6. The active site structures of ACMSD containing different metals. (A) As-isolated
Fe(III)-H228Y, (B) Co(II)-substituted H228Y, (C) Zn(II)-H228Y, and (D) Zn(II)-substituted
H228G. The 2Fo − Fc electron densities are taken from chain A and contoured at 1.5σ. The larger
spheres represent metal ions. The smaller gray sphere in panel C represents a water molecule,
which is weakly bound to the zinc ion (2.44 Å) as compared to the zinc−water ligand distance of
2.04 Å in the wild-type enzyme (PDB entry 2HBV). Such a water ligand is missing from the metal
center in all other H228G and H228Y structures.
Table 2.2. X-ray crystallography data collection and refinement statistics
Data collection
Detector type
Source

Fe-H228Y
MAR300 CCD
APS, Sector 22-ID

Co-H228Y
MAR225 CCD
APS, Sector 22-BM

Zn-H228Y
MAR300 CCD
APS, Sector 22-ID

Zn-H228G
MAR300 CCD
APS, Sector 22-ID

Space group

P42212
a=b=90.03,
c=167.31

C2

P42212

Unit cell lengths (Å)

P42212
a=b=90.43,
c=167.53

a=153.84, b=48.56,
c=110.20

a=b=91.50,
c=170.12

Unit cell angles (˚)

α=β=γ=90º

α=β=γ=90º

α=γ=90º, β=126.89º

α=β=γ=90º
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Wavelength (Å)
Temperature (K)
Resolution (Å) a
Completeness (%)a
Rmerge (%)a, b
I/σI a
Multiplicity a

1.00
100
2.80 (2.85)
99.8 (99.8)
10.1 (69.7)
60.8 (2.5)
24.2 (9.8)

1.00
100
2.00 (2.03)
92.7 (54.7)
6.1 (22.8)
51.1 (6.0)
6.3 (3.4)

1.00
100
2.60 (2.64)
98.4 (68.7)
7.7 (65.6)
63.1 (1.9)
18.6 (7.2)

2.8

1.00
100
2.40 (2.44)
99.2 (94.1)
10.1 (61.0)
40.5 (2.9)
13.9 (9.6)
Refinement
2.4

Resolution (Å)
No. reflections;
working/test
Rwork (%)c
Rfree (%)d
Protein atoms
Ligand atoms
Solvent sites

2.0

2.6

17041/915

26155/1382

19.9
27.3
5194
2
9

21.5
29.5
5194
2
88
Ramachandran statisticse
92.73
5.61
Root mean square deviation
0.011
1.464

41014/2073
20.5
25.6
5194
3
209

22859/1173
20.8
28.1
5153
3
32

94.52
4.72

91.78
7.61

0.008
1.098

0.009
1.204

Preferred
Allowed (%)

93.48
5.61

Bond lengths (Å)
Bond angles (˚)

0.011
1.299

PDB access code
4ERG
4ERA
4ERI
4EPK
Values in parentheses are for the highest resolution shell.
b
Rmerge = Σi |Ihkl,i - ‹Ihkl›|/Σhkl Σi Ihkl,i, where I is the observed intensity and ‹Ihkl› is the average intensity of multiple
measurements.
c
Rwork = Σ||Fo|-|Fc||/Σ|Fo|, where |Fo| is the observed structure factor amplitude, and |Fc| is the calculated structure
factor amplitude.
d
Rfree is the R factor based on 5% of the data excluded from refinement.
e
Based on values attained from refinement validation options in COOT.
a

Inspection of the metal center shows that Tyr228 is a metal ligand in all three H228Y mutant
proteins (Figure 2.6), with Tyr-to-metal bond lengths of 2.13, 2.12, and 2.41 Å in chain A, and
2.26, 2.16, 2.44 Å in chain B in the Co-, Fe-, and Zn-H228Y structures, respectively. It would
appear that the interaction between the Zn ion and the Tyr228 residue weaker than corresponding
interactions with Fe and Co. Nonetheless, the angles of the Tyr228 plane, phenolic oxygen and
the metal, including zinc, are well within the range of typical metal-ligand angular orientations
(110 – 140°) reported in biological systems (130.2°, 137.3°, and 128.7° in chain A, and 129.7°,
132.5°, and 122.6° in chain B in the Co-, Fe-, and Zn-H228Y structures, respectively) (178).
Hence, the prediction of Tyr228 ligation by our spectroscopic work is confirmed by these asisolated and metal-substituted H228Y structures. It should be noted that the metal center in chain
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B in the mutant structures shows a noticeable degree of disorder. This was the same as
previously observed in the as-isolated and cobalt-substituted wild-type ACMSD structures
(2HBV & 2HBX) (80).
The most significant structural difference with respect to the WT structure is that the water
ligand is missing from the metal center in Fe(III)-H228Y, Co(II)-substituted H228Y, and Zn(II)reconstituted H228G proteins. Modeling of the omit maps (Figure S2.2) show the electron
density can only be fitted by the metal ion in these structures. However, the resolution is not
sufficiently high to assign the solvent content in the Fe(III)-H228Y and Zn(II)-H228G data sets,
the missing water ligand cannot be reliably concluded based on these structures. In contrast,
Zn(II)-H228Y and Co(II)-substituted H228Y structures contain reasonable amount of water
molecules. The water ligand is missing from the cobalt structure, whereas, the water ligand is
still present in the Zn(II)-substituted H228Y structure but at a much longer distance from the
metal, 2.44 Å in chain A and 2.38 Å in chain B from the zinc ion as compared to 2.05 and 2.07 Å
in WT Zn-ACMSD structure. Our EPR, resonance Raman and optical data suggest a low
coordination number in the Co(II)- and Fe(III)-H2228Y metal center. Taken together, it is likely
that the water ligand is missing, or dissociated, from the metal center in Co(II)- and Fe(III)H228Y mutants. Moreover, the hydrogen bonding network that potentially activates the water
ligand is significantly altered. In the WT Zn-ACMSD crystal structure the water ligand hydrogen
bonds to both His228 and Asp294, while in the H228Y mutant the distance between Asp294 and
the water ligand is elongated to 3.60 Å in chain A and 3.67 Å in chain B, ,compared to 2.88 and
3.33 Å in the WT Zn-ACMSD. In the H228G structure, the metal center is still five-coordinate
even though the water ligand is absent. Asp294 becomes a bidentate ligand to the metal ion.
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From the H228G structure and the three H228Y structures, we conclude that His228 plays an
important role in metal ion recruitment and maintaining the position of the water ligand.
2.5 Discussion
His228 is a major determinant of metal ion selectivity in PfACMSD—ACMSD was thought
to be a cofactor-free enzyme for about 50 years until we found many divalent transition metal
ions can effectively activate it (14). In the subsequent study, we found that the as-isolated protein
contains only zinc ion (80). However, the molecular basis of metal selectivity in proteins is
generally poorly understood and the preference for zinc within the active site of ACMSD has
remained a mystery prior to this work. In the present study, a point mutation of a second
coordination sphere His228 residue to Gly or Tyr is described to change PfACMSD’s metal ion
selectivity from Zn to Fe ion. In general, the primary control of metal selectivity in proteins
should be the metal-binding ligand set. A single site mutation on a non-metal ligand residue
changes metal selectivity in a protein is a surprising result. To our knowledge, the finding
described in this work for metal selection role of a second coordination sphere residue is only the
second example in literature. Previously, mutation of a conserved glutamate in Escherichia coli
manganese superoxide dismutase has been shown to change metal preference to Fe ion (179). In
all other documented cases the residue identified for affecting metal selectivity is a metal ligand.
The lesson learned from PfACMSD His228 is anticipated to improve our understanding of metal
ion selectivity in proteins and expand the scope of roles histidine plays in the enzyme active site.
The origin of blue color in H228Y—To understand the underlying reason for the loss of
enzyme activity due to mutation of His228, a spectroscopic study was performed to interrogate
the metal center’s chemical and electronic structure in H228Y. The optical and NBT-staining
data suggest the ligation of Tyr228 to the Fe ion in the as-isolated Fe(III)-H228Y, and this notion
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is further supported by our resonance Raman results. These data also eliminate the possibility of
post-translational modification of Tyr228 to a DOPA.
The role of His228 in maintaining the hydrolytic water ligand forcatalysis—His228 attracted
our attention because it is a strictly conserved active site residue. It lies on the opposite side of
the presumed substrate binding pocket (80,131). A previous structural study has revealed the
conformational diversity of this active site residue (80). In the present work, His228 was mutated
to tyrosine and glycine. In line with our expectations, neither of the protein variants had a
measureable catalytic activity; regardless of which metal was incorporated into the active site.
The biochemical and spectroscopic data suggest that the loss of catalytic activity is, in large part,
due to the missing histidine that acts as an acid/base catalyst and, the loss of the water ligand.
Thus, a dual role of His228 is revealed, i.e., it stabilizes the water ligand while plays an
important role in metal selectivity of the enzyme.
Tyrosinate ligation to the metal center was identified by resonance Raman spectroscopy and
further supported by the EPR data. The UV-Vis absorption spectra of both WT and Co(II)substituted H228Y suggest five-coordinate metal centers. Therefore, the water ligand in the wildtype enzyme is likely replaced by the Tyr228 residue in the mutant. In the crystal structures of
H228Y proteins loaded with three different metal ions, Tyr228 is a metal ligand. The
spectroscopic data and the crystallographic results are consistent to each other.
A water ligand is observed in all published structures of ACMSD, including Co(II)- and Zn(II)PfACMSD, as well as Zn(II)-hACMSD proteins. Such a water ligand is also present in other
members of the ACMSD subfamily, including 4-oxalomesaconate hydratase, and γ-resorcylate
decarboxylase (21,80,180). The structures of Fe(III)-H228Y, Co(II)-H228Y and H228G are the
first structures determined that do not show a water ligand, while Zn(II)-H228Y shows a weakly
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bound water ligand with a longer distance to the metal center compared to the WT protein.
Because of its weak binding to the Zn center, the pKa of the water ligand in Zn(II)-H228Y may
not be decreased as effectively as in the WT proteins by coordination to the zinc ion. Cobalt and
zinc ions are particularly strong Lewis acids and can dramatically reduce the pKa of bound water
ligands. In a well-established example of carbonic anhydrase, the bound Zn(II) ion decreases the
pKa of its water ligand from 15.7 to 7 (181-183). Catalysis ensues from this zinc activation of its
bound water. His228 is strictly conserved within all known ACMSD amino acid sequences, and
in all available structures of the enzyme this residue is in hydrogen bonding distance to the water
ligand. The primary role of this His228 is proposed as deprotonation of the metal-bound water so
that a hydroxide ion can be generated as an active site nucleophile at ca. pH 6 – 7, the optimum
pH range for ACMSD. Although the hydroxide attack mechanism model shown in Scheme 2.1
for ACMSD is distinct from other metal-dependent decarboxylases, it shares common features
with the established mechanisms in the amidohydrolase superfamily (19).
The results described in this work are consistent with our working model of the ACMSD
reaction (Scheme 2.1). In the working mechanistic model shown in Scheme 2.1, the metal-bound
water molecule is deprotonated to hydroxide anion (OH-) with the assistance of His228, which is
acting as a general acid/base catalyst to deprotonate the zinc-bound water molecule for attack on
the substrate. The hydroxide ion performs a nucleophilic attack on the C2=C3 double bond of
ACMS with concomitant protonation at C3. Essentially, a water molecule is added across the
double bond with the hydroxyl group at C2 and the new proton at C3, generating a substratebased tetrahedral intermediate. Collapse of the tetrahedral intermediate initiates the
decarboxylation and produces α-aminomuconate-ε-semialdehyde and regenerate the metal
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center. This decarboxylation model follows a hydrolytic mechanism consistent with the
mechanistic paradigm of the amidohydrolase superfamily.

Scheme 2.1. The proposed catalytic role of His228 in ACMSD reaction.
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2.6 Supporting Information

Figure S 2.1. Ponceau S (left) and nitroblue tetrazolium (NBT) quinone (right) staining of
purified MADH and blue H228Y ACMSD from Pseudomonas fluorescences. Lane 1: MADH;
lane 2: blue H228Y ACMSD; lane 3: pre-stained protein molecular weight ladder. The quinonebased staining assay was carried out to test the potential presence of the quinonoid compounds,
including L-3,4-dihydroxyphenylalanine (DOPA). Methylamine dehydrogenase (MADH) from
Paracoccus denitrificans was used as a control. Reversible ponceau S staining of the
nitrocellulose membrane reveals three bands on the MADH lane corresponding to the β-subunit,
α−subunit, and a small amount of αβ heterodimer, while there is only one single band on the
H228Y lane under the SDS-PAGE conditions (left panel), demonstrating that MADH and blue
Fe-H228Y were both purified to near homogeneity. After thoroughly rinsing away the ponceau S
red dye, the same membrane was subjected to the quinone-based NBT staining. Only the small
β-subunit and the partially dissociated αβ fraction of MADH were visualized by the NBT
staining, while Fe-H228Y and the large α-subunit of MADH were both unstained (right panel).
Blue Fe-H228Y was insensitive to specific staining. Hence, the NBT staining data led us to
eliminate the possibility of a quinonoid compound in blue Fe-H228Y.
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Figure S 2.2. Omit maps (green) generated from the 2Fo-Fc maps (blue) after removing metal ion
and any assigned water ligand(if any). The electron density is contoured at 1.5 σ. (A) as-isolated
Fe(III)-H228Y (PDB entry: 4ERG), (B) Co(II)-substituted H228Y (4ERA), (C) Zn(II)-H228Y
(4ERI), and (D) Zn(II)-substituted H228G (4EPK).
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CHAPTER 3 THE POWER OF TWO: ARGININE 51 AND ARGININE 239* FROM A
NEIGHBORING SUBUNIT ARE ESSENTIAL FOR CATALYSIS IN α-AMINO-βCARBOXYMUCONATE-ε-SEMIALDEHYDE DECARBOXYLASE
The section of chapter 3 is a published work on ACMSD: The Power of two: arginine 51 and
arginine 239* from a neighboring subunit are essential for catalysis in α-amino-βcarboxymuconate-ε-semialdehyde decarboxylase. Lu Huo, Ian Davis, Lirong Chen, and Aimin
Liu. (2013) J. Biol. Chem., 288(43), 30862-30871. This work was supported in part or whole by
NSF grant MCB-0843537 and Georgia Research Alliance Distinguished Scholar Program (AL).
X-ray data was collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-ID
and 22-BM beamlines at the Advanced Photon Source, Argonne National Laboratory. Use of the
Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science,
Office of Basic Energy Sciences, under Contract No. W-31-109-Eng. We thank Dr. B.-C. Wang
and the SER-CAT staff scientists of the Section 22 of Argonne National Laboratory for
assistance in beamline preparation and X-ray data collection.
3.1 Abstract
While the crystal structure of α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase
(ACMSD) from Pseudomonas fluorescens was solved as a dimer, this enzyme is a mixture of
monomer, dimer, and higher order structures in solution. In this work we found that the dimeric
state, not the monomeric state, is the functionally active form. Two conserved arginine residues
are present in the active site: Arg51 and an intruding Arg239* from the neighboring subunit. In
this study, they were each mutated to alanine and lysine, and all four mutants were catalytically
inactive. The mutants were also incapable of accommodating pyridine-2, 6-dicarboxylic acid, a
competitive inhibitor of the native enzyme, suggesting that the two Arg residues are involved in
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substrate binding. It was also observed that the decarboxylase activity was partially recovered in
a heterodimer hybridization experiment when inactive R51A/K and R239A/K mutants were
mixed together. Of the 20 crystal structures obtained from mixing inactive R51A and R239A
homodimers which diffracted to a resolution lower than 3.00 Å, two structures are clearly
R51A/R239A heterodimers and belong to the C2 space group. They were refined to 1.80 and
2.00 Å resolutions, respectively. Four of the remaining crystals are apparently single mutants and
belong to the P42212 space group. In the heterodimer structures, one active site is shown to
contain dual mutation of Ala51 and Ala239* while the other contains the native Arg51 and
Arg239* residues, identical to the wild-type structure. Thus, these observations provide the
foundation for a molecular mechanism by which the oligmerization state of ACMSD could
regulate the enzyme activity.
3.2 Introduction
Arginine residues perform diverse functions in proteins due to their charge distribution,
capability of forming multiple hydrogen bonds and their long flexible side chains. One popular
function is the formation of salt bridges in which the positively charged guanidine head pairs
with a negatively charged carboxylate group (184,185). In enzymes, arginine residues are often
proposed to participate in recognizing, binding and maintaining the orientation of substrates and
reaction intermediates (186-188). Arginine is also involved in RNA recognition because its
guanidium group is able to form five hydrogen bonds with RNA acceptor groups (189).
Although not widespread, arginine residues have also recently been proposed to act as a general
base in several enzymes (190-192).
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Two arginine residues in α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase
(ACMSD) caught our attention because they appear to be in an optimal position to bind the
substrate α-amino-β-carboxymuconate-ε-semialdehyde (ACMS) by interacting with its two
carboxyl groups. ACMSD is a metal-dependent enzyme in the amidohydrolase superfamily
(14,15), and its substrate, ACMS, is an unstable tryptophan catabolic intermediate in the
kynurenine pathway (2,14,129). The conversion of ACMS to α-amino-muconate-ε-semialdehyde
(AMS) is catalyzed by ACMSD, however ACMS spontaneously forms quinolinic acid (QA) in a
non-enzymatic dehydration process in the absence of ACMSD (125,193) (Scheme 3.1). Thus,
ACMSD is a key enzyme that determines the QA levels. QA is maintained only at the basal level
for the de novo synthesis of a small fraction of NAD+ in mammals. Reduced activity of ACMSD
leads to accumulation of QA in body fluids, a condition which is known to be related to several
neurodegenerative diseases including Alzheimer’s disease (127), Huntington’s disease (128),
stroke (2), and epilepsy (2,126,129). However, the instability of ACMS and the compounds with
similar structures makes studying the mechanism of ACMSD substrate binding technically
challenging.

Scheme 3.1. ACMSD in metabolic pathway
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The first crystal structure of ACMSD was solved as a homodimer from Pseudomonas
fluorescens (80). Two strictly conserved arginine residues are present at the active site: Arg51
and Arg239* (Figure 3.1). Arg51 is located in the mobile insertion domain, which is proposed to
undergo conformational changes upon substrate binding because of its unique position and high
flexibility (80). Arg239* is an intruding residue which is inserted from the sixth α-helix of the
other subunit and it is labeled with a * hereafter to distinguish its origin from the chain of a
neighboring subunit. Because of its high flexibility, this residue is shown to be present in
alternative conformations in chain B of the crystal structure.

Figure 3.1. The active site metal center of PfACMSD and the putative substrate-binding pocket
(illustrated with an ellipse).
The second ACMSD crystal structure is the human enzyme in complex with 1,3dihydroxyacetone-phosphate. This inactive complex was assigned as a monomer by Rizzi and
coworkers (131). The equivalent residue of Arg51 is shown in the active site, but the counterpart
of Arg239 is far removed from the catalytic center. The same group previously reported that
functional human ACMSD is a monomer because gel-filtration chromatography showed the
asisolated enzyme with a molecular mass around 50 kDa (194), which is between monomer (38
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kDa) and dimer (76 kDa) mass. In fact, it is still unclear whether the catalytically active form of
human ACMSD in solution is a monomeric or dimeric enzyme at the present time. All of the
PfACMSD structures determined thus far, including wild type and mutants charged with
different transition metals, are dimeric (25,80). If the monomeric form is catalytically active,
then only one conserved arginine residue, Arg51, is present in the active site of the enzyme in
both human ACMSD and PfACMSD structures. Arg239 of the same subunit is not located near
the enzyme active site in the monomeric state and would therefore be less likely to be an
essential component of catalysis. Thus, point mutation at residue 239 provides a sensible means
for probing the effects of protein oligmerization on the catalytic activity.
The present work represents the first attempt to investigate the molecular mechanism by which
the oligmerization state of ACMSD could determine the enzyme activity. The quaternary state
required for catalytic activity is reported, and the catalytic role of the two conserved arginine
residues, Arg51 and the intruding Arg239* from the neighboring subunit, are proposed.
Interestingly, we found that the inactive Arg51 and Arg239 mutants could form a
crystallographically accessible, catalytically-active heterodimer through protein hybridization.
3.3 Experimental Procedures
Site-Directed Mutagenesis. R51A, R51K, R239A, and R239K single mutation mutants were
constructed by using the PCR overlap extension mutagenesis technique (132) described
previously (15) and by using the plasmid containing ACMSD from Pseudomonas fluorescens as
a template (14). The mutants were verified by DNA sequencing to ensure that base changes were
introduced correctly and that no random changes had occurred. After sequencing, the positive
clone was used for protein expression in Escherichia coli BL21(DE3).
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Protein Preparation, SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Size
Exclusion Chromatography. Expression and purification of ACMSD proteins followed the
protocol established previously (10,14,15,25) with a few minor changes. Rather than using pH
8.0 buffer during affinity chromatography purification, pH 7.4 was used to increase protein
stability of the mutants. Metal-free apo-enzyme was obtained by treating purified protein with 5
mM EDTA for 12 h followed by running a G50 desalting column. Zn(II) and Co(II) containing
ACMSD were reconstituted as previously described (14). Purified protein samples were mixed
with SDS loading buffer and heated for 10 min or with no heating prior to loading to 10% SDSPAGE. ACMSD was loaded onto a Superdex 75 column pre-equilibrated with buffer containing
25 mM HEPES (pH 7.0) and 5% glycerol (v/v). Protein was eluted with the same buffer.
Enzyme Activity Assay. The substrate ACMS was generated enzymatically by catalyzing the
dioxygenation of 3-hydroxyanthranilic acid in oxygen saturated buffer with ferrous 3hydroxyanthranilate 3,4-dioxygenase containing no free transient metal ion as reported
previously (14,15,25). Briefly, the ACMSD enzyme assay mixture contained 5 – 120 μM ACMS
and an appropriate amount of ACMSD protein in 25 mM HEPES buffer with 5% glycerol, pH
7.0. Specific activities of ACMSD proteins were measured in triplicate at room temperature on
an Agilent 8453 spectrophotometer by monitoring the decrease of ACMS absorbance at 360 nm
using a molar extinction coefficient of 47,500 M-1cm-1 (195) when the substrate concentration
was equal to or lower than 20 μM, or at 320 nm using a molar extinction coefficient of 9600 M1

cm-1 when the substrate concentration was higher than 20 μM (15).
Derivation of Equations for Analysis of the Correlation of Monomer/Dimer Ratio and

Catalytic Activity. In order to show that dimerization is required for catalytic activity, a series of
activity assays were performed in which the stock concentration of ACMSD is varied while
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keeping the final assay concentration constant. If the rate of dissociation of the ACMSD dimers
is sufficiently slow on the time scale of the assay, then the measured activity should conform to
eq 1 where kobs is the observed decarboxylation rate, kmax is the maximum rate, and %D is the
mole ratio of dimer present in the assay.
·%

(1)

In order to solve for the percent dimer, mass balance was invoked to define M0 as the total
protomer concentration, M as the monomer concentration, and D as the dimer concentration.
2 ,
2

(2)

The dimer percentage can then be written in terms of dimer concentration and total protomer
concentration (a quantity which is known in an activity assay) alone.
%

(2')

The association constant for this equilibrium, can then be written in terms of dimer concentration
and total protomer concentration by substitution of eq 2, as seen in eq 3.
(3)
Distribution and collection of like terms then gives eq 4, and eq 4 can be multiplied by M0-2 to
give eq 5.
4

4

1
2

0
0

(4)
(5)

The quadratic equation can now be invoked on eq 5 to solve directly for the dimer percentage
and is shown in eq 6. Multiplying the right side of eq 6 by a disguised 1, (2M0/ 2M0), the
expression for the dimer percentage can be simplified to eq 7.
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(6)
%

1

(7)

Substitution of eq 7 back into eq 1 gives kobs as a function of kmax, Ka, and M0 (i.e., eq 8). Nonlinear least squares fitting can then be used to obtain both Ka and kmax (though both positive and
negative square roots should be considered; only the negative roots gave convergent fits of the
measured data).
· 1

(8)

Protein Hybridization. Arg51 and Arg239 mutants were mixed in a 1:1 ratio in 25 mM
HEPES buffer, pH 7.0, containing 5% glycerol. The final protein concentration for each mutant
was 12 μM. Specific activity of the mixtures was examined frequently after mixing by a
spectrophotometric assay on an Agilent 8453 diode-array spectrophotometer as described above.
Identification of a Competitive Inhibitor. Pyridine-2,6-dicarboxylic acid (PDC) inhibition pattern
and constant were determined by measuring kcat and Km in the presence of varying inhibitor
concentrations (0, 20, 40, and 80 μM). Apparent Km values for each inhibitor concentration were
plotted as a function of inhibitor concentration and inhibition is expressed as Ki values in
micromolar (Ki = intercept/slope).
Analysis of PDC Inhibitor Interaction with the Arginine Mutants. PDC in HEPES buffer
displays UV absorbance at 270 nm with extinction coefficient of 4,100 M-1cm-1. ACMSD
proteins (1.5 ml, 40 μM in each sample type), including wild type, R51A, R239A, H228G, and
premixed R51A and R239A for 48 h, were incubated with one equivalent of PDC for 5 min in
separate experiments, followed by filtration in an Amicon ultra centrifugal filter tube with
cellulose membrane of 10,000-dalton cut-off. PDC (40 µM) with no protein was used in the
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control experiment. Samples were centrifuged in 3,000 × g for 8 min. The flow-through solution
containing unbound DPA was quantified by Agilent 8453 spectrophotometer.
X-ray Data Collection and Crystallographic Refinement. Zinc-reconstituted mutant proteins
were used for crystallization. All single crystals were obtained following the crystallization
conditions described in the previous studies (25,80). For the heterodimer crystal, R51A and
R239A were mixed for more than 48 h at 4 °C before being used for crystallization by hanging
drop vapor diffusion in VDX plates (Hampton Research). Mother liquid containing 20%
ethylene glycol was used for crystal mounting. X-ray diffraction data were collected at SERCAT beamline 22-ID/BM of the Advanced Photon Source (APS), Argonne National Laboratory,
Argonne, IL. Data were processed with HKL-2000 (137). Structure solutions were obtained by
molecular replacement with MolRep (138) from the CCP4 suite (139) with wild-type ACMSD
(PDB code 2HBV) as the search model (80). Refinement was carried out using PHENIX
software (196), and the model-building was carried out in COOT (141). Ala51 and Ala239 were
modeled based on the 2Fo-Fc and Fo-Fc electron density maps. Refinement was assessed as
complete when the Fo-Fc electron density contained only noise.
3.4 Results
ACMSD Does not Exist as a Single Species in Solution. As shown in Figure 3.2A, ACMSD
presents several bands by SDS-PAGE that correspond to monomer, dimer, and higher order
oligmerization states if the sample is not heated before loading onto the gel (Figure 3.2A lane 1).
However, if the sample is heated before loading, the bands corresponding to the higher order
states and most of the dimer are not observed (Figure 3.2A lane 2). The size-exclusion
chromatography profile, on the other hand, presents two major peaks. The molecular weight of
the protein eluted in the first peak is larger than 100 kDa, and the second peak exhibits a
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molecular weight of ca. 51 kDa. The molecular weight of a PfACMSD monomer, however, is 38
kDa. Also, there is no difference in the specific activity of the two fractions as they elute from
the column. The second peak shows two major bands corresponding to ACMSD monomer and
dimer molecular weights on SDS-PAGE when not heated before loading (Figure 3.2A lane 3).
The band which arises from the dimer is not observed upon heating of the sample before loading
(Figure 3.2A lane 4). Hence, we assign the second peak as a combination of ACMSD monomer
and dimer and the first peak as a mixture of higher order complexes which are not able to be
resolved further.

Figure 3.2. ACMSD is a mixture of monomer and higher oligormers in solution and is not active
as monomer. (A) The UV absorbance at 280 nm of ACMSD as a function of the elution volume
from size exclusion chromatography column: Superdex 75. The inset is an SDS-PAGE. Lane 1:
As-isolated ACMSD with no heating, 2: as-isolated ACMSD heated for 10 min, M: molecular
marker, 3: fraction 2 with no heating, 4: fraction 2 heated for 10 min. (B) The specific activity of
ACMSD as a function of different enzyme stock concentration.
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In order to estimate the dimer dissociation constant, ACMSD was prepared in stock
concentrations ranging from 0.1 to 50 μM (protomer concentration) and allowed to equilibrate at
4 °C for 24 h. Specific activity of the different stock concentrations was determined by keeping
the final enzyme and substrate concentrations constant. The specific activity increased with
increasing stock concentration. Decarboxylation rates as a function of enzyme stock
concentration were plotted in Figure 3.2B and data were fit to eq 8, which represents the
equilibrium of ACMSD between inactive monomer and active dimer forms as described in the
Experimental Procedures. Fitting of the data to eq 8 gives a Ka of 3.3×106 M-1, and a maximum
specific activity of 9.4 μmol•min-1•mg-1.
Mutational Analysis and Catalytic Activity Rescue Through Protein Hybridization. Arg51
andArg239 were each mutated to alanine and lysine. All of the four mutants were found to be
completely inactive with either zinc or cobalt as the cofactor, the two metals which were
previously found to be optimal for catalytic activity in the wild-type enzyme. Chemical rescue
performed on R51A and R239A by guanidine derivatives was unsuccessful in restoring
enzymatic activity. However, when the two mutants, R51A and R239A, were mixed together,
enzyme activity was slowly restored (Figure 3.3A). Reaction rates were determined at several
time points after mixing. Samples incubated for 1, 7, and 24 h on ice were analyzed by following
decay of the substrate ACMS at 360 nm for 1 min. Reaction with no enzyme and the two
inactive arginine mutants were used as negative controls. The rate of activity rescue was
temperature dependent, and the rate of recovery was faster when the mixing reaction was carried
out at room temperature rather than on ice. Specific activity was calculated and plotted as a
function of incubation time as shown in Figure 3.3B and fit to a single exponential association,
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Figure 3.3. Activity rescue by mixing R51A and R239A. (A) Catalytic activity rescue of mixed
R51A and R239A mutants. Decay of substrate ACMS in the first 1 min was monitored by UVVis at 360 nm. Autodecay of substrate (black trace), in the presence of R51A (red), and in the
presence of R239A (blue), are three overlapped lines. R51A and R239A were pre-mixed on ice
for 1 hour (green), 7 hour (pink), and 24 hours (tan), respectively. (B) The rescued activity
increased as a function of incubation time of the two mutants. Data were fitted to a single
exponential equation. The incubation and kinetic reaction are done in room temperature. (C)
Michaelis-Menten kinetics of the 1:1 mixed R51A and R239A after 48 hours of equilibration.
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eq 9, where A is the measured specific activity, Amax is the maximum activity, k is the
associative rate constant, and t is time in minutes. According to the fitting, the maximum rate is
152 ± 5 nmol•min-1•mg-1, and the rate constant is 7.2 ± 0.5 × 10-3 min-1. We also determined
kinetic parameters for the mixed zinc-reconstituted mutants after 48h of equilibration on ice.
Figure 3.3C shows the Michaelis-Menten plot. The Km, 9.3 ± 1 μM, of the mixed mutants is
similar to that of the wild-type Zn-ACMSD, 9.6 μM. The kcat, 0.15 ± 0.01 s-1, of the mixed
mutants, on the other hand, is dramatically decreased compared to the 6.5 s-1 of the WT ZnACMSD (80).
· 1

9

Structural Determination of R51A, R239A and the Hybridized Mixtures of the Two Mutants.
All crystals of R51A and R239A ACMSD belong to the P42212 space group. They diffracted
poorly and only at relatively low resolutions. The best structures obtained were 2.50 Å resolution
forR51A (Protein Data Bank entry: 4IFO) and 2.40 Å for R239A (4IFR). Interestingly, crystals
from the mixture of these two mutants were crystallized in both the P42212 and C2 space groups.
A total of twenty data sets were collected from individual single crystals obtained from
crystallization trays with equal molar ratio mixing of R51A and R239A mutant proteins. Among
the twenty crystal structures that we have solved, three of them are R239A homodimer, and one
of them is an R51A homodimer. All of these four structures are determined in the P42212 space
group. Two single crystals were found to belong to the C2 space group, and they were refined to
1.8 Å (Protein Data Bank entry: 4IG2) and 2.0 Å (4IFK) resolutions, respectively. The structures
determined from these two crystals clearly differ from R51A or R239A, and they fit the proposed
heterodimer as illustrated in Figure 3.4. Fourteen of the data sets in the P42212 space group
cannot be assigned to any homodimer or heterodimer due to incomplete electron density which
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might be caused by the flexibility of the arginine side chain or low arginine occupancy. The data
collection and refinement statistics for both the homodimer single mutants and the heterodimers
are listed in Table 3.1.

Figure 3.4. Molecular mechanism for catalytic activity rescue through protein hybridization of
the two completely inactive mutants.
Both DNA sequencing and electron density map of the mutant crystal structures demonstrate
the successful substitution of arginine residues with alanine in both R51A and R239A variants
Figure 3.5A (top and middle panels). The alignment of R51A (4IFO) and R239A (4IFR)
structures with the wild-type structure (2HBV) are shown in Figure 3.5B (top and middle
panels), respectively. Both mutants exhibit homodimeric quaternary structures as previously seen
in wild-type ACMSD. Secondary structure changes caused by mutation (colored in blue and
cyan) can be observed in both subunits of the two structures and they are mainly observed in the
loop regions. No significant structural deviations, however, were observed for the folding of the
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Table 3.1. X-ray crystallography data collection and refinement statistics.
Data collection

R51A-R239A
Heterodimer #1

R51A-R239A
Heterodimer #2

R51A Homodimer

R239A Homodimer

Detector type

MAR225 CCD

MAR300 CCD

MAR300 CCD

MAR300 CCD

Source

APS, Sector 22-BM

APS, Sector 22-ID

APS, Sector 22-ID

APS, Sector 22-ID

Space group
Unit cell lengths
(Å)
Unit cell angles (°)
Wavelength (Å)
Temperature (K)

C2
a=153.10,
b=48.52,c=109.83
α=γ=90, β=126.80
1.00
100
35.00-1.80
(1.86-1.80)
86.1(42.7)
5.0(60.0)
37.2(1.5)
6.8(3.7)

C2
a=153.85,
b=49.06,c=110.55
α=γ=90, β=127.10
0.80
100
35.00-2.00
(2.03-2.00)
97.6 (87.6)
10.7(47.8)
28.4(1.9)
5.9(2.9)
Refinement
2.00

P42212
a=b=91.21,
c=170.47
α=β=γ=90
0.80
100
35.00-2.50
(2.54-2.50)
99.9(100.0)
7.8(64.0)
34.9(2.9)
15.8(11.4)

P42212
a=b=91.16,
c=167.99
α=β=γ=90
0.80
100
35.00-2.40
(2.44-2.40)
99.6(95.7)
9.9(79.3)
50.0(1.9)
22.0(7.5)

2.50

2.40

Resolution (Å) a
Completeness (%)a
Rmerge (%)a, b
I/σI a
multiplicity a
Resolution (Å)
No.reflections;
working/test
Rwork (%)c
Rfree (%)d
No. of protein
atoms
No. of ligand
atoms
No. of solvent sites

1.80
51829/2590

42682/2143

25616/1304

28612/1452

23.2
28.2

20.9
26.3

19.7
24.4

21.0
29.5

5174

5184

5162

5144

2

3

2

2

141

229
100
26
Average B factor (Å2)
Protein
49.0
39.7
54.0
73.5
Zn(II)
36.9
31.3
55.2
64.8
Mg(II)
N/A
60.4
N/A
N/A
Solvent
40.8
38.7
42.5
59.1
Ramachandran statisticse
preferred (%)
93.01
94.07
93.76
91.32
allowed (%)
4.56
4.10
4.11
5.18
Root mean square deviation
Bond lengths (Å)
0.009
0.008
0.010
0.009
Bond angles (°)
1.249
1.149
1.175
1.236
PDB entry
4IG2
4IFK
4IFO
4IFR
a
Values in parentheses are for the highest resolution shell.
b
Rmerge = Σi |Ihkl,i - ‹Ihkl›|/Σhkl Σi Ihkl,i, where Ihkl,i is the observed intensity and ‹Ihkl› is the average intensity of multiple
measurements.
c
Rwork = Σ||Fo|-|Fc||/Σ|Fo|, where |Fo| is the observed structure factor amplitude, and |Fc| is the calculated structure
factor amplitude.
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d
e

Rfree is the R factor based on 5% of the data excluded from refinement.
Based on values attained from refinement validation options in COOT.

overall TIM-barrel scaffold, indicating that the impact due to mutation is limited to specific
flexible regions. We further analyzed the dimerization interface using the ACMSD wild-type and
mutant structures at an online server: Protein Data Bank Europe Protein Interfaces, Surfaces and
Assemblies (PDBePISA) (197). The results indicate the interface contains a total of 13 H-bonds
and 13 salt bridges. Nevertheless, these analyses would not be sufficient to draw a definitive
conclusion if there were no intruding residue Arg239 catalytically important which allowed us to
generate an active heterodimer from mixing two inactive dimers. In the wild-type structure,
Arg239 contributes two Hbonds by interacting with the main chain molecules of the neighboring
monomers to help to stabilize the dimer. In the R239A structure, the dimerization is not
interrupted because these two hydrogen bonds are substituted by the following two new Hbonding interactions: Glu252 of chain A interacts with Lys189 of chain B and Arg247 of chain A
interacts with Met191 of chain B.
Figure 3.5B (bottom panel) shows the superimposition of the heterodimer structure (4IFK)
and the wild-type Zn-ACMSD structure (2HBV). The structural deviations of the mutant relative
to the wild-type are highlighted in red. The comparison clearly shows that major changes can
only be observed in chain B. This observation is expected because in subunit A of the
heterodimer, Arg51 and Arg239* are both in place with electron density similar to that in the
wild-type structure (Figure 3.5A bottom). The electron density for both arginine residues’ side
chains in subunit B is missing, indicating that both residues 51 and 239* are alanines (Figure
3.5A bottom). Hence, subunit A represents a complete native-like ACMSD subunit, but subunit
B is a “double mutant” containing two alanine residues. It is noted in the structure of the native
enzyme that Arg239* adopts two conformations because of its high flexibility (80). Likewise,
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this residue in subunit A has alternative conformations which are only partially covered by the
electron density map.

Figure 3.5. Active site and overall structures of R51A, R239A, and heterodimer. (A) Electron
density of position 51 and 239 in the R51A homodimer (top panel), R239A homodimer (middle),
and R51A-R239A heterodimer (bottom). (B) Superimposed overall structures of WT Zn-ACMSD
with Zn-R51A (top) and Zn-R239A (middle), and heterodimer (bottom). The well-aligned
structural components are shown in gray color, while structural changes for R51A and R239A are
highlighted in blue and cyan colors, respectively.
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Arg51 and Arg239 are Essential for Substrate Binding. Based on the current and previous
studies, we propose that the two arginines are critical for proper substrate binding at the enzyme
active site and for preventing its autocyclization to QA. Since the substrate, ACMS, is unstable
and all arginine mutants are catalytically inactive, studying the postulated role of the two
arginines in substrate binding is challenging. Therefore, an efficient competitive inhibitor needs
to be found. Unfortunately, the inhibitors reported from previous in vivo studies, phthalate esters
for instance (198,199), were not effective on the pure enzyme in our experiments. Acyclic
ACMS analogue compounds tend to be unstable in solution, however, 2,6-pyridine-dicarboxylic
acid (PDC), a cyclic compound, is structurally similar to ACMS (Figure 3.6A). Both compounds
contain conjugate repeating single-bond double-bond structures and two carboxylate groups. The
difference is that PDC is a stable compound due to its cyclic, aromatic structure, while ACMS
tends to dehydratively autocyclize. Figure 3.6B shows that PDC behaves kinetically as a
competitive inhibitor for the ACMS decarboxylation. The Ki value was determined to be 22.7 ±
1.8 μM. This allows for use of PDC as an analog of ACMS to study substrate binding.
The catalytic activity-based kinetic approach, unfortunately, cannot be employed to assess
the binding of substrate or substrate analog compounds to the inactive mutant proteins. We took
advantage of the fact that PDC has an electronic absorption band at 270 nm (ε270 nm =
4100 M-1cm-1, determined in 25 mM HEPES buffer, pH 7.0) and designed an experiment to test
PDC’s binding to the wild-type and mutant proteins of ACMSD utilizing separation by
centrifuge filters. The threshold for membranes in centrifuge filters with a 10,000 Da cut-off is
smaller than ACMSD but much larger than PDC. If the PDC is bound to ACMSD it will not be
able to pass the filter membrane while unbound PDC molecules can pass freely. The amount of
PDC in the flow-through was quantitated by UV absorbance. Wild-type ACMSD was employed
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as a positive control while the same buffer containing no protein was used as one negative
control. A previously well-characterized mutant H228G (25), was also employed as a secondary
positive control. His228 is a strictly conserved residue sitting in the interior side of the metal
center which is previously shown to function as a general base to deprotonate the water ligand
during catalysis and is not related with substrate binding. The properties and crystal structure of
H228G have been reported previously (25). Figure 3.6C shows that WT and H228G ACMSD
proteins exhibit similar binding of PDC. In contrast, R51A and R239A are unable to effectively
bind PDC as exhibited by the similar absorbance of their flowthroughs to the negative control.
This experiment suggests that the two arginine residues play an important role in binding of the
substrate analogue, which implies that they play a role in substrate binding in the native enzyme.

Figure 3.6. Arginine mutants cannot bind the competitive inhibitor PDC. (A) Chemical structure of
ACMS and PDC. (B) Competitive inhibition of wild-type ACMSD by 0, 20, 40, and 80 μM of PDC. (C)
PDC in flow through of centrifuge detected by UV-Vis spectroscopy.
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3.5 Discussion
It is often a challenging task to determine whether or not an experimentally determined
structure represents the biologically-relevant assembly. It is also often difficult to pin down the
role of a critical residue in catalysis when its mutants are completely inactive. An additional
complexity in the present case is that the two conserved arginine residues which are being
studied are proposed to bind the substrate, ACMS, which is unstable, so no binding constant can
be easily measured. We have crafted a series of biochemical tests to show that P. fluorescens
ACMSD must function as a dimer, and the two conserved arginine residues, including one
intruded into the catalytic center from a neighboring subunit, are required for substrate binding in
catalysis.
The molecular mechanism by which the catalytic activity is rescued through hybridization is
illustrated in Figure 3.4. During dimer–monomer equilibrium, three kinds of dimers form in
solution when the two inactive homodimers of R51A and R239A are mixed: R51A homodimer,
R239A homodimer, and R51A-R239A half-active heterodimer, in which one of the monomers
has both Arg51 and Arg239 to constitute a complete active site identical to that of the native
enzyme. If it is assumed that all homodimers are completely dissociated and rearranged, the
percentage of formation of R51A homodimer and R239A homodimer will be both 1/4.
Consequently, the rest 1/2 will be the half-active heterodimer. As a result, the maximum activity
that can be rescued theoretically will be 25% of the wild-type ACMSD assuming there is no
cooperative interaction and that each of the dimers has the same association constant. By
comparing the kcat values of the equilibrated mixed mutant ACMSD with WT ACMSD, 9.2% of
the theoretical maximum activity is recovered. The inability to recover more activity can likely
be attributed to unequal equilibrium constants for each of the species (inactive homodimer
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formation may be thermodynamically preferred to half-active heterodimer formation), or some
protein dynamics and cooperativity may have been lost due to the mutations of important active
site residues.
To our knowledge, this X-ray crystallographic study provides the first unambiguous
experimental evidence for the formation of hybridized active heterodimer by mixing of two
inactive homodimers. These structures allow for a molecular level understanding of the
correlation of enzymatic activity with the protein quaternary structure and the mechanism of
activity rescue from two completely inactive mutants. Together with our previous work, we now
can describe the functionally-active assembly of the enzyme and the role of the two arginines in
a more definitive manner as discussed below.
The homodimer structures contain a ~2,500 Å2 dimer interface area. Prior to this work, the
question of whether dimerization is an artificial aggregation or required for enzyme activity was
not known. We showed here two major bands corresponding to monomer and dimer on the
polyacrylamide gel, indicating the existence of both dimer and monomer forms in aqueous
solution. Enzyme specific activities were measured under identical assay conditions using
protein at different stock concentrations. The finding, i.e. increasing specific activity with
increasing protein stock concentrations, indicates that ACMSD is active when in the dimeric
form and loses activity as it dissociates to the monomeric form.
Dimer formation as a mechanism for enzyme activation is common in nature. Cytochrome c
peroxidases (200), cell death protease caspases (201,202), diaminopimelate epimerase (203), and
histidine kinase CheA (204) are just a few examples similar to ACMSD. The reason behind this
dimerization-induced activation is usually the generation or extension of binding faces at the
dimer interface (205). Hence, protein activation is triggered by an increase in the local protein
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concentration. As calculated by the dependence of specific activity on stock enzyme
concentration, the dissociation constant of ACMSD is 0.3 μM. This is within the Kd range for
“weak” transient complexes that show a dynamic mixture of both monomer and dimer states in
vivo which could be tuned by physiological environmental factors such as pH and local protein
or ligand concentrations (206).
The mutagenesis and reaction rescue experiments described in this study show that both
Arg51 and Arg239 are required for enzyme activity. However, their role in catalysis was
unknown due to the silent nature of their activity in all the point mutants, including the
conservative Lys mutants, until the identification of an effective competitive inhibitor of the
enzyme, PDC. By using this competitive inhibitor, the problems which arise from use of an
unstable substrate can be mitigated. The inability of PDC to bind to the arginine mutants is
demonstrated by the filtration experiment. With proper positive and negative controls, the
designed experiment provides a straightforward and reliable conclusion. Hence, we propose both
arginine residues R51 and R239* are involved in substrate binding during catalysis (Figure 3.7).
It is noteworthy that this scenario resembles a well-documented example in a highaffinity nitrate
transporter where two perfectly conserved arginine residues are required for substrate binding
(207). Likewise, arginines play crucial roles in the active sites and subunit interfaces of the
ATPase domains of AAA and AAA+ proteins (208).
Heterodimer-induced activity restoration has also been previously observed, although not
structurally characterized, in histidine protein kinase CheA, a protein essential for bacterial
chemotaxis’ stimulus-response coupling by phosphorylating another two chemotaxis proteins:
CheY and CheB (209). CheA must be autophosphorylated at its own His48 residue before this
phosphoryl group can be transferred to CheY and CheB (210,211). Escherichia coli expresses
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two kinds of CheA proteins: the full length CheAL and the N terminally truncated CheAS, which
lacks His48, the site of autophosphorylation (210). But in the presence of both CheAS and kinase
defective CheAL mutant, CheA470GK, the mutant can still be phosphorylated. Thus, the
autophosphorylation is accomplished within the CheAS-CheA470GK heterodimer is suggested
even in the absence of structural proof as shown in the present study (204).
The results described in this work helped us further refine our working model for the
ACMSD catalytic cycle. Previously, the roles of His228 and the metal bound water were
proposed and demonstrated (25). The two catalytically essential arginine residues Arg51 and
Arg239* are now added to the model (Figure 3.7). They are proposed to work as a team to
recognize the substrate and stabilize both the substrate and possibly catalytic intermediates.
Because the two residues at each metal center belong to two different subunits, the requirement
of protein dimerization for enzyme activity becomes evident.
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Among cellular metabolic proteins, monomers are a small fraction compared to multimeric
proteins. Homodimers and homotetramers are two major forms of oligomerized proteins (205).
Compared to monomeric proteins, oligomerized proteins have some apparent advantages. Firstly,
oligomerization enables higher-order protein regulation, such as allosteric and concentration
sensing regulations. Secondly, protein oligomerization can help to increase protein stability and
the flexibility of activity by subunitcooperation. Lastly, homo-oligomers are more economic
because they allow for a smaller genome while still building large proteins. Hence, the
oligmerization of ACMSD may function as a mechanism of protein concentration sensing and
enzyme activity adjustment in vivo.

84
CHAPTER 4 HUMAN α-AMINO-β-CARBOXYMUCONATE-ε-SEMIALDEHYDE
DECARBOXYLASE (ACMSD): A STRUCTURAL AND MECHANISTIC UNVEILING
The section of chapter 4 is our manuscript under preparation: Human α-amino-βcarboxymuconate-ε-semialdehyde decarboxylase (ACMSD): A structural and mechanistic
unveiling. Lu Huo, Fange Liu, Hiroaki Iwaki, Tingfeng Li, Yoshie Hasegawa, and Aimin Liu.
We thank Dr. Shin-Ichi Fukuoka for providing cDNA clone of human ACMSD, Dr. Lirong Chen
for stimulating discussions in the analyses of the structural data.
4.1 Abstract
Human α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase determines the fate of
tryptophan metabolites in the kynurenine pathway by controlling the quinolinate levels for de
novo NAD biosynthesis. The unstable nature of its substrate has made gaining insight into its
reaction mechanism difficult. Our electron paramagnetic resonance (EPR) spectroscopic study
on the catalytically active, Cu-substituted enzyme suggests that the native substrate does not
directly ligate to the metal ion. Substrate binding did not result in a change of either the
hyperfine structure or the super-hyperfine structure of the EPR spectrum. We also determined the
crystal structure of the enzyme in its native state (at 1.99 Å resolution), a substrate analoguebound form (2.50 Å resolution), and a selected active site mutant form with one of the putative
substrate binding residues altered (2.32 Å resolution). These structures illustrate that each
asymmetric unit contains 3 pairs of dimers. Consistent with the EPR findings, the ligand-bound
complex structure shows that the substrate analogue does not directly coordinate to the metal ion
but is bound the active site and stabilized by positively charges residues through non-covalent
interactions.
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4.2 Introduction
α-Amino-β-carboxymuconate-ε-semialdehyde (ACMS) is a metabolic intermediate found in
two catabolic pathways: the kynurenine pathway (Scheme 4.1), which is responsible for
tryptophan catabolism, and the 2-nitrobenzoic acid biodegradation pathway (14). ACMS is
unstable and non-enzymatically dehydrates to quinolinic acid (QUIN) with a t1/2 of 33 min at 20
°C, pH 7.0 (10). QUIN is the universal precursor for the de novo biosynthesis of NAD, providing
the pyridine ring (193,212). In humans, QUIN levels must be tightly regulated (< 100 nM)
because it is also an agonist of N-methyl-D-aspartate receptors, and its overproduction can cause
overexcitement of neurons and cell death in the central nervous system (2,5,8,9,213). Elevated
QUIN concentrations in bodily fluids have been observed in an exceptionally wide range of
neuropsychiatric diseases including anxiety, depression, epilepsy, and neurodegenerative
conditions such as Alzheimer’s and Huntington’s diseases (3-7,127,128). A 300-fold elevation of
QUIN has also been detected in the brain of patients with HIV infection (214). Moreover, over
the past two decades, an increasingly accumulating volume of evidence unanimously suggest
that abnormal activity of the kynurenine pathway participates in the initial phases of
neuropathological processes (7,129), the pathogenesis of AIDS-dementia complex (215,216),
and Alzheimer’s disease (2-4,217). When QUIN was injected into healthy rats, the characteristic
neuropathological features of Huntington’s disease started to develop (5). Thus, the connection
between QUIN and related diseases flows both ways, i.e. in symptomatic patients QUIN levels
are elevated, and in healthy mammals QUIN injection induces symptoms of disease. Notably,
ACMS decarboxylase (ACMSD) directs the vast majority of metabolites to further catabolic
steps controlled by enzymes and, by doing so, avoids the overproduction of QUIN (Scheme 4.1)
(14,193). Thus, the decarboxylase ACMSD is of significant biomedical importance.
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Scheme 4.1. ACMSD in the Kynurenine pathway
Prior to this work, the structure of human ACMSD (hACMSD) in its catalytically active
form was unavailable. The elucidation of this structural information is crucial for the design of
small molecule regulators and for the interpretation of biochemical and spectroscopic studies.
We are also interested in the structural and mechanistic divergence between hACMSD from the
tryptophan kynurenine pathway and Pseudomonas fluorescens (PfACMSD) from the 2nitrobenzoic acid metabolic pathway. However, hACMSD has proven to be a considerable
challenge to express in prokaryotic systems. Although expression of hACMSD as a weakly
active enzyme has been achieved in mammalian cell lines (13) and the eukaryote, Pichia pastoris
(194), prior attempts to express hACMSD in bacterial systems were all unsuccessful
(13,131,194).
In the present work, we successfully expressed hACMSD in E. coli and obtained catalytically
active form of the enzyme. By using substrate analogue and metal-substituted hACMSD, we
employed a combined structural and spectroscopic approach to tackle the question of how the
unstable substrate interacts with the enzyme’s active site.
4.3 Experimental Procedures
Expression of Human ACMSD. To construct an Nterminally His10-tagged hACMSD
expression plasmid, the hACMSD cDNA (13), a generous gift from Dr. Fukuoka, was amplified
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by the polymerase chain reaction with the forward primer 5’GGAATTCCATATGAAAATTGACATCCATAG-3’ and the reverse primer 5’CCGCTCGAGTCATTCAAATTGTTTTCTCTC-3’ (built-in NdeI and XhoI sites are
underlined). The PCR product was purified from a 0.8% agarose gel, digested with NdeI and
XhoI, and ligated in the equivalent sites of pET16b (Novagen). After sequencing, the positive
clone was used for transformation into E. coli BL21 (DE3) containing the GroEL/ES
overexpression plasmid pGro7, pColdII-pGro7, pColdII-pG-Tf2, and pET16b-pG-Tf2,
respectively (Takara Corp., Japan).
Cell Culture. Single colonies of E. coli containing the appropriate pET-hACMSD plasmid
were used to inoculate 50 mL of M9 growth medium (1×M9 medium supplement with 1 mM
MgSO4, 0.1 mM CaCl2, 2 μg/mL vitamin B1, 0.04% casamino acids, 0.4% D-glucose, and a
divalent metal ion described below). To obtain hACMSD with desired metal at the active site, a
divalent metal ion of either CoCl2, CuSO4, Fe(NH4)2(SO4)2, or ZnCl2 was added to a final
concentration of 0.05 to 0.5 mM prior to induce expression. The cell culture medium also
contained 100 μg/mL ampicillin, 40 μg/mL chloramphenicol and 500 μg/mL L-arabinose, the
latter of which induces the expression of the protein chaperone GroES-GroEL. The cells were
grown at 37 °C with shaking until the OD600 reached 0.4, at which time the temperature was
lowered to 25 °C. hACMSD expression was induced by 0.1 mM isopropyl β
Dthiogalactopyranoside at an OD600 of 0.6. The cultures were allowed to further grow at 25 °C
for 16 h before being harvested by centrifugation at 8000 × g for 15 min at 4 °C. The wet cells
were washed with 50 mM potassium phosphate buffer, pH 8.0, twice before storage at -80 °C.
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Protein Isolation. Human ACMSD was purified using a modified procedure described for the
bacterial analogue (25,26). Frozen cells were resuspended in 50 mM potassium phosphate, pH
8.0, containing 300 mM NaCl and 0.1 mM protease inhibitor phenylmethylsulfonyl fluoride.
The cell slurry was passed through an M-110P Microfluidics cell disruptor and the debris was
removed by centrifugation at 27,000 × g for 30 min at 4 °C. The supernatant was loaded onto a
HiPrep immobilized metal ion affinity chromatography (Ni-NTA) 26/20 column (80 mL resin)
for isolation of the native enzyme or FF 16/10 columns charged with either Co2+, Cu2+ or
Zn2+ depending on the corresponding metalspecific hACMSD preparations in order to minimize
possible metal cross-contamination in purified protein. The proteins were eluted in a two-step
gradient with increased concentration of imidazole in the buffer. The major fractions with
ACMSD decarboxylase activity were pooled, concentrated, and further purified on a Superdex
75 column (26/60) using an ÄKTA FPLC protein purification system with a 25 mM HEPES
buffer, pH 7.0, containing 5% glycerol. Protein concentrations were determined using Coomassie
Plus protein assay reagent (Pierce). The expression level and enzyme purity were determined by
SDS-PAGE on 12% polyacrylamide gels.
Metal Analysis. The metal content of ACMSD was assayed in triplicate by inductively
coupled plasma optical emission spectrometry (ICP-OES) using a Spectro Genesis spectrometer
(Spectro Analytical Instruments GmbH & Co. KG, Germany) as previously described (25).
Metal ions loosely or nonspecifically bound to the enzyme were removed by an overnight
incubation of 0.5 mM EDTA with the protein solution at 4 °C followed by desalting on a 5-mL
HiTrap column with 10 mM Tris-HCl (pH 7.4) and buffer wash with the ICP buffer and
ultrafiltration.
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EPR Spectroscopy. The interaction between ACMS and the enzyme-bound metal center was
measured by EPR spectroscopy using Cucontaining ACMSD in the absence or presence of 3
equivalents of ACMS in the assay buffer. The EPR samples were obtained by mixing the protein
solution with the substrate solution at 25 °C using a rapid-freeze-quenching apparatus, Update
Instruments, system 1000. The reaction mixture was shot directly to an EPR tube and frozen in
liquid nitrogen. The entire mixing and freezing process was completed in less than 5 seconds. In
a parallel EPR experiment, the response of the addition of 3 equivalents of ACMS to copper
sulfate was determined with the same buffer system. The same X-band EPR instrumentation is
used as those previously described (14,15).
Steady State Kinetics. The enzyme activity of the recombinant hACMSD was determined
according to the procedures described in detail in earlier reports (14,15,25). Briefly, ACMS was
generated from 3-hydroxyanthranilate by an enzymatic method (14). The ACMSD enzyme assay
mixture contained 0 – 120 μM ACMS and an appropriate amount of ACMSD protein in 25 mM
HEPES buffer, pH 7.0 with 5% glycerol. Specific activities were calculated from the initial
velocities of ACMS decay monitored by the loss of absorption at 360 nm using an absorbance
coefficient constant of 47,500 M-1cm-1 when the substrate concentration was equal to or lower
than 20 μM, or at 320 nm using an absorbance coefficient constant of 9,600 M-1cm-1 when the
substrate concentration was between 20 – 120 μM. In the enzyme concentration dependence
assay, 800 μM Zn-hACMSD was diluted to 200 nM by the reaction buffer. The initial rate of the
reaction was monitored from 1 to 240 min frequently in triplet after dilution: a saturated
substrate concentration of 15 μM was used. The inhibition pattern of pyridine-2,6-dicarboxylic
acid (PDC) acting on hACMSD was obtained by determining the kcat and Km in the presence of
varying concentrations of PDC (0, 20, 40, and 80 μM) in both buffer and substrate solution.

90
Apparent Km values for each inhibitor concentration were plotted as a function of inhibitor
concentration and inhibition is expressed as Ki values in micromolar (Ki = y-intercept/slope).
X-ray Protein Crystallography. Catalytically active form of Zn-hACMSD was used to screen
crystallization conditions in Art Robbins 96-well Intelli-Plates using an ARI Gryphon
crystallization robot. The initial hit was obtained from the Index Screening Kit (Hampton
Research). After optimization, crystals were obtained from drops assembled with 1.5 μL of 28
mg/mL hACMSD mixed with 1.5 μL of a reservoir solution containing 0.2 M lithium sulfate
monohydrate, 0.1 M Tris-HCl pH 6.5 - 7.5, and 20 - 25% polyethylene glycol 3,350, by hanging
drop diffusion in VDX plates (Hampton Research). PDC-hACMSD co-crystals were obtained by
preincubating hACMSD with 10 equivalents of PDC for 30 min prior to crystallization. Crystals
suitable for X-ray diffraction were obtained ca. 10 days after crystal growth at 18 °C.
Crystallization mother liquor containing 20% glycerol was used as a cryoprotectant. All crystals
obtained under these conditions belong to the P212121 space group and data were processed with
HKL-2000 (137). The three dimensional structures of hACMSD were solved by molecular
replacement using our previously published Pseudomonas fluorescens (PfACMSD) structure as a
search model (PDB code: 2HBV) using PHENIX (196). Electron density analysis and model
building were carried out in Coot (141). The unit cell images were generated with PyMol (218)
with the aid of the SuperSym plugin available at http://supersym.sourceforge.net.
4.4 Results
Overexpression of the Human Enzyme in E. coli. hACMSD expressed from the constructed
vectors, pColdII-pGro7, pColdII-pG-Tf2, and pET16bpG-Tf2 was only found in inclusion
bodies.Fortunately, the constructed pET16b-pGro7 plasmid expressed hACMSD as a soluble and
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enzymatically active protein. The enzyme expressed from this system was purified to near
homogeneity as described under “Experimental Procedures”. Five to ten mg of pure enzyme was
obtained from each liter of cell culture when gown in the LB medium; however the yield was
significantly reduced when a minimal medium was used. Purified hACMSD is stable at 4 °C for
weeks and can endure freeze/thaw cycles with liquid nitrogen multiple times without a
significant loss of activity.
Metal Content and Catalytic Activity. Metal analysis of hACMSD purified from cells grown
in the LB medium contained several metals. Iron, zinc and copper were present and the total
metal content was substoichiometric. Metal analysis of hACMSD purified from the cells cultured
in the M9 minimal media supplemented with 100 μM of varying metal ions is presented in Table
4.1. Activity assays demonstrated that hACMSD expressed in the presence of Zn2+ exhibited
activity comparable to what was found for the most active forms of PfACMSD bound with a
Zn2+ or Co2+ ion (14). Co2+-containing hACMSD, on the other hand, exhibited very little specific
enzymatic activity relative to Co-PfACMSD. It should be noted that the contribution of Zn ion to
the activity of Co-, Cu-, and Fe-hACMSD was subtracted based on Table 4.1 metal analysis data
with regard to the Zn-hACMSD activity.
Table 4.1. Percentage of metal occupation and corresponding activity of hACMSD from different
medium cultures.

LB

M9

M9 +
Co2+

M9 +
Cu2+

M9 +
Fe2+

M9 +
Zn2+

Co

0

0

96.8

0.4

0.8

0

Cu

2.2

2.9

0.7

47.9

3.6

9.7

Fe

28.7

9.8

1.0

10.0

55.1

7.5

Zn

13.8

9.8

0.8

0.6

7.7

64.4

Specific activity
(nmol/min/mg)

910

800

190

90

400

3540
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Unlike PfACMSD (14), the metal ions in hACMSD could not be removed by the metal
chelators EDTA, 1,10-phenanthroline or 8-hydroxy-quinoline-5-sulfonic acid, and the enzyme
activity was not affected by the addition of these metal chelators. Moreover, the addition of one
to ten equivalents of Co2+, Cu2+, Fe2+, or Zn2+ to purified hACMSD did not increase enzyme
activity, indicating that the purified human enzyme cannot be reconstituted in vitro. Since in
vitro metal reconstitution was not successful for the human enzyme, we attempted to add zinc
ions to the M9 medium at various concentrations prior to induction of the cells, so that a variety
of zinc/hACMSD ratios could be obtained. Although we had no control over the final zinc
content in the purified protein using this method, we did successfully purify the human enzyme
with different amounts of zinc ion. Figure 4.1 shows that the specific activity of hACMSD is
proportional to the zinc content of the enzyme.
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Figure 4.1. The specific catalytic activity of hACMSD as a function of Zn content in the protein
reveals that hACMSD is a zinc-dependent enzyme.
Kinetic Properties. Zn-hACMSD yielded steady-state kinetic parameters similar to those of
Zn2+-containing PfACMSD (31). A kcat value of 4.8 s-1 was measured for hACMSD with 64.4%
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zinc ion occupancy. According to Figure 4.1, this value is anticipated to be 7.5 s-1 with a
fullyloaded zinc ion. The Km (5.8 μM) and the kcat (7.5 s-1) values of hACMSD are comparable to
the Km (9.6 μM) and the kcat (6.5 s-1) reported for Zn-PfACMSD with ca. 80% zinc occupancy
(80). When hACMSD was diluted from 800 μM to 200 nM, it lost 90% of activity after 4 h
(Figure 4.2). Since proteins prefer to form higher oligomer state at higher concentration, the
hACMSD dimer will start to dissociate once its concentration drops. Loosing catalytic activity
after dilution implies that hACMSD is unlikely to be active in the monomeric state. Similar
observations have been reported for the bacterial ACMSD (26).
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Figure 4.2. The catalytic activity of hACMSD decays after dilution, indicating that hACMSD
has better activity at higher oligomerization sate. The relative activity of concentrated and
diluted samples was measured under the same conditions as described in the text. The
experimental data was fitted with first exponential decay (red line).
Probing the Nature of the Enzyme-Substrate Interactions. Although ACMS is an unstable
molecule, we find that it tends to form stable complexes with various metal ions. Figure 4.3A
shows that ACMS binds to a cupric ion in solution. The EPR signal intensity of CuSO4 solution
is weak due to the coupling of copper ions. Addition of unstable ACMS to CuSO4 led to the
formation of stable Cu2+-ACMS complex which gives rise to well-resolved type II copper EPR
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spectrum (219). Since this technique is highly sensitive to the changes of the electronic/chemical
structure of a Cu2+ ion, especially when the superhyperfine structure is resolved, we analyzed
ACMS perturbation to the enzyme-bound copper center by EPR spectroscopy.
To probe whether the substrate ACMS is ligated directly to the metal, we obtained Cusubstituted hACMSD. Since the metal ion cannot be extracted and reconstituted, we
circumvented this problem by isolating the human enzyme from cell culture of a metal-depleted
minimal medium supplemented with cupric ion. The Cu-substituted protein is catalytically active
although it is a relatively poor catalyst. Its kcat value was 0.1 ± 0.02 s-1 and Km value was 3.3 ±
0.2 μM.
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Figure 4.3. Low-temperature X-band EPR spectroscopic study confirms that the substrate binds to the free
metal ion but does not directly coordinate to the catalytic metal ion in ACMSD. (A) Free CuSO4 and
CuSO4-ACMS, (B) as-isolated Cu-hACMSD and Cu-hACMSD-ACMS, and (C) a magnified view of
superhyperfine structure of Cu-hACMSD in the absence/presence of ACMS. The spectrometer
conditions: temperature, 20 K; modulation amplitude, 0.3 mT; microwave power, 0.5 mW; time constant,
40.96 ms; and sweep time 1.79 mT/s for the field from 225 to 375 mT.
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Both hyperfine splitting due to the nuclear spin of copper (I = 3/2) and nitrogen (I = 1)induced superhyperfine interactions are present in the EPR spectrum of Cu-hACMSD (Figure
4.3B). The EPR parameters obtained from a simulation of the spectrum of wild-type CuhACMSD have an A// value of 18.7 mT and a g// value of 2.218, both typical for a type II Cu2+
center. In the perpendicular region, a multiple-line superhyperfine structure with a splitting of
about 1.5 mT is well resolved in the spectrum (Figure 4.3C). The superhyperfine structure
originates from the spin-spin interaction between the nuclear spin of the nitrogen atoms (nuclear
spin I = 1) and the electron spin of the Cu2+ ion. When 3 molar equivalents of ACMS were added
to Cu-hACMSD, frozen in less than 5 s, and subsequently measured by EPR at 20 K, no spectral
change was observed. In sharp contrast to the free copper ion in solution, the presence of
ACMS is unable to induce any disturbance in the hyperfine and superhypefine structures of the
Cu center in hACMSD. Thus, there is no direct ligation between ACMS and the Cu center.
Crystal Structure. The structure of hACMSD was obtained from native, catalytically competent
form of the enzyme and was refined to 1.99 Å resolution (Table 1, PDB entry: 4OFC). Each unit
cell contains four asymmetric units in which six protomers are found as a trimer of dimers,
Figure 4.4A. The dimer interface contains a surface area of about 2,400–2,460 Å2 and is
primarily formed by three helical regions which are composed of residues 191 to 201, 230 to
244, and 271 to 281 of each subunit. The central area of the dimer interface is strictly
hydrophobic. Analysis of the dimer interface reveals a total of 24-33 direct hydrogen bonding
interactions and 18-21 salt bridges for each dimer. The detailed interactions are listed in Table
4.3.
Due to the instability of ACMS, the substratebound ACMSD structure is not yet available.
However, pyridine-2,6-dicarboxylic acid is a heterocyclic, stable ACMS analogue that
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competitively inhibits the bacteria ACMSD (26). We found that it is also an effective
competitive inhibitor of hACMSD (Figure 4.5A) with a Ki value of 15.2 ± 0.5 μM. We
successfully co-crystallized this compound with hACMSD (Table 1, PDB entry: 4IH3) and the
overall structure is nearly identical to the ligand-free enzyme. PDC is bound at the active site and
forms ionic interactions with Arg47 and Arg235*, where the asterisk indicates this residue is
from a neighboring subunit (Figure 4.5B). The PDC-bound structure shows that the inhibitor is
fairly close to the zinc ion with the C4 ca. 2.6 Å from the zinc ion. However, the closest oxygen
is 5.6 Å away from the metal ion. Thus, the substrate analogue does not directly coordinate to the
metal ion.

Figure 4.4. The crystal structure of hACMSD is solved as a homodimer. (A) Each unit cell contains 4
asymmetric units of 3 pairs of dimers. (B) The catalytic center contains two arginine residues, Arg47
and Arg235* from a neighboring subunit.
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Table 4.2. X-ray crystallography data collection and refinement statistics.
Data collection

hACMSD

PDC-hACMSD

R47A hACMSD

Space group

P212121

P212121

P212121

Unit cell lengths (Å)

a=88.704, b=101.082,
c=232.820

a=88.368, b=101.655,
c=233.117

a = 89.142, b=101.686,
c = 232.613

Unit cell angles (˚)

α=γ= β=90

α=γ= β=90

α = β = γ = 90

Wavelength (Å)

1.0

1.0

0.8

Temperature (K)

100

100

100

45.00-1.99 (2.03-1.99)

45.00-2.50 (2.50-2.54)

50.00-2.33 (2.37-2.33)

87.6 (81.3)

75.4 (65.7)

98.4 (82.8)

15.3 (78.2)

9.9 (29.3)

13.2 (48.6)

20.6 (2.3)

10.3 (1.5)

17.9 (2.0)

10.1 (8.0)

9.7 (8.5)

25.3 (13.7)

a

Resolution (Å)

a

Completeness (%)
a, b

Rmerge (%)
I/σI a

Multiplicity

a

Refinement
Resolution (Å)

1.99

2.50

2.32

No. reflections;
working/test

130135/6497

55192/2809

85220/4492

Rwork (%)c

19.88

20.20

20.8

d

Rfree (%)
No. of protein atoms
No. of ligand atoms
No. of solvent sites

24.07
15984
6
994

Protein
Zn(II) or PDC
Solvent

29.7
26.3
31.3

28.28
15810
78
286
Average B factor (Å2)
33.3
39.4
28.4

30.0
23.6
32.2

Ramachandran statisticse
96.15
91.82
2.60
5.86
Root mean square deviation
0.008
0.029

0.015

Bond angles (˚)

1.155

1.262

1.785

PDB entry

4OFC

4IH3

4IGN

Preferred (%)
Allowed (%)
Bond lengths (Å)

a

27.6
15774
6
821

97.7
2.3

Values in parentheses are for the highest resolution shell.
Rmerge = Σi |Ihkl,i - ‹Ihkl›|/Σhkl Σi Ihkl,i, where Ihkl,i is the observed intensity and ‹Ihkl› is the average intensity of multiple
measurements.
c
Rwork = Σ||Fo|-|Fc||/Σ|Fo|, where |Fo| is the observed structure factor amplitude, and |Fc| is the calculated structure
factor amplitude.
d
Rfree is the R factor based on 5% of the data excluded from refinement.
e
Based on values attained from refinement validation options in COOT.
b
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Table 4.3. Hydrogen bonds stabilizing the dimeric surface in the 2.0 Å resolution crystal
structure of human ACMSD (4OFC.pdb) calculated from PDBePISA.
H-Bond #

Subunit B

Distance (Å)

Subunit C

1

ASP 151[ OD1]

3.01

ARG 183[ NE ]

2

ASP 151[ OD1]

2.89

ARG 183[ NH2]

3

ASP 151[ OD2]

2.45

LYS 186[ NZ ]

4

ASP 151[ OD2]

3.06

ARG 183[ NE ]

5

TYR 187[ O ]

3.64

CYS 247[ SG ]

6

TYR 187[ OH ]

3.12

ASN 153[ ND2]

7

TRP 191[ O ]

2.8

ARG 235[ NE ]

8

TRP 191[ O ]

3.02

ARG 235[ NH2]

9

MET 195[ SD ]

3.29

ARG 235[ NH2]

10

GLU 198[ OE2]

2.88

ARG 183[ NH1]

11

GLU 198[ OE2]

2.95

ARG 183[ NH2]

12

MET 208[ O ]

3.52

TYR 187[ OH ]

13

PHE 231[ O ]

2.62

SER 273[ OG ]

14

ASP 250[ OD2]

2.5

TYR 187[ OH ]

15

ASP 270[ OD2]

2.64

LYS 256[ NZ ]

16

PRO 295[ O ]

2.94

HIS 238[ NE2]

17

GLY 297[ O ]

2.96

HIS 238[ NE2]

18

ASN 153[ ND2]

3.34

TYR 187[ OH ]

19

ARG 183[ N ]

3.9

GLU 149[ OE1]

20

ARG 183[ NE ]

2.99

ASP 151[ OD2]

21

ARG 183[ NH1]

2.83

GLU 198[ OE2]

22

ARG 183[ NH2]

3.36

GLU 198[ OE1]

23

ARG 183[ NH2]

2.78

ASP 151[ OD1]

24

LYS 186[ NZ ]

2.75

ASP 151[ OD2]

25

TYR 187[ OH ]

2.67

ASP 250[ OD2]

26

ARG 235[ NE ]

2.83

TRP 191[ O ]

27

ARG 235[ NH2]

2.96

TRP 191[ O ]

28

ARG 235[ NH2]

3.51

MET 195[ SD ]

29

HIS 238[ NE2]

2.94

PRO 295[ O ]

30

HIS 238[ NE2]

3.01

GLY 297[ O ]

31

CYS 247[ SG ]

3.68

TYR 187[ O ]

32

LYS 256[ NZ ]

2.82

ASP 270[ OD1]

33

SER 273[ OG ]

2.71

PHE 231[ O ]
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Figure 4.5. The crystal structure of hACMSD in complex with a substrate analogue sheds light on the
enzyme-substrate interaction mode. (A) Competitive inhibition of hACMSD by 0, 20, 40, and 80 μM
of PDC. (B) The co-crystalized structure shows that the competitive inhibitor PDC is bound by Arg47
and Arg235* near the zinc ion.

To further prove that the unstable substrate binds to the enzyme by the active site arginines,
we mutated Arg47 and Arg235* to alanine. Both R47A and R235A variants showed no
detectable catalytic activity, proving that they are important residues for catalysis. The result of
this analysis is consistent with our structural findings shown in Figure 4.4B. While R235A
eludes crystallization, the crystal structure of the R47A mutant was solved at 2.32 Å resolution
(Table 4.2). Similar to the wild-type enzyme structure, six protomers in three dimers are present
in each asymmetric unit (Figure 4.6). The same interface region is observed between the
protomers as observed in the wild-type enzyme. The RMSD value is only 0.254 Å from 14,034
out of 14,040 atoms for the structures of R47A and wild type.
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Figure 4.6. Crystal structure of R47A hACMSD. A symmetric unit of the structure (shown in
color) contains three pairs of dimers.
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4.5 Discussion
Our work on human ACMSD solved several longstanding mysteries. The first pertains to the
cofactor identity. Our previous work on the analogous bacterial system indicates that PfACMSD
is a metal-dependent enzyme (14,15,80). Thus, one would expect hACMSD is a metalloprotein.
However, all prior studies on hACMSD suggest that the catalytic activity of human enzyme is
independent of metal ions (13,194). This is likely due to the observation that neither a metal
chelator, nor external metal affects the activity of purified hACMSD. The first crystal structure
of hACMSD was later determined with a zinc ion bound at the enzyme active site, but how the
zinc ion is associated with catalytic activity was not discussed (131), leaving a questionable
cofactor-free conclusion for hACMSD in literature. Here, by showing protein expressed in a
minimal medium supplemented with increasing concentrations of zinc ions, giving higher
decarboxylase activity together with the data present in Table 4.1, we found that hACMSD has
the best affinity for zinc ion and the zinc enzyme gives rise to the highest catalytic activity. The
catalytic efficiency of Zn-hACMSD is significantly higher than that previously reported for the
same enzyme expressed in Pichia pastoris, which has a similar Km but a lower kcat value of 1.0
s-1 (194). Thus, it becomes evident that the hACMSD is a zinc-dependent enzyme.
Since chelators are demonstrably to be able to extract the metal ion from PfACMSD but not
the human enzyme, hACMSD apparently binds its metal more tightly. The crystal structures
solved provide a molecular understanding for this nonconformity. An aspartate and three
histidine residues in hACMSD coordinate the zinc ion. Notably, His174 is a metal ligand in all
six protomers of each asymmetric unit of the structure, with a bond distance of 2.2-2.3 Å. In
contrast, the equivalent histidine in PfACMSD, His177, presents significant flexibility in the
structure we have solved (PDB entry: 2HBV). In subunit A, His177 coordinate to the zinc ion
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with distance of 2.2 Å. In subunit B, His177 is no longer a metal ligand and is 4.2 Å away from
the zinc ion. Thus, His177 is a weaker ligand in PfACMSD. The observed metal affinity
deviation therefore becomes understood.
It is challenging to predict the cofactor dependency of a protein base on the primary structure
if the cofactor is a single atomic metal. Although characteristic sequences can be used to identify
some metal binding motifs, including zinc finger, calcium hand, and iron-sulfur cluster, drawing
conclusions based solely on sequence can be misleading. For example, LigI is a member of the
amidohydrolase superfamily, whose members were all previously demonstrated to be divalent
metal dependent including ACMSD. Based on sequence alignment, LigI has all four conserved
residues, three histidines and one aspartate, for metal coordination. However, later mechanistic
and structural studies revealed that LigI is actually metal independent and the four metal ligand
residues are with new catalytic roles (30). Sometimes, even with the assistance of biochemical
study, prediction of metal cofactor can still be misjudged. The enzyme urinate isomerase
catalyzes the isomerization reaction of D-glucuronate and D-fructuronate was initially thought to
be metal independent because metal chelators do not affect the enzyme activity (212). Later on,
an improved study suggested that uronate isomerase is actually a mononuclear zinccontaining
enzyme (220). Hence, a combined knowledge of sequence, biochemical assay, and structure are
needed to correctly identify a metal cofactor. In the present case, it is fortunate that hACMSD
holds its metal tightly, so its preference for zinc ion is visible in isolated protein in our hand
although this property also caused misjudgment in some of the earlier studies for the metal
cofactor-dependency (13,194).
Since its initial identification from rat liver, ACMSD has been known for 58 years (130) and
this enzyme has arisen significant biomedical interest. Following our success in obtaining the
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bacterial enzyme structure in 2006 (80), a structure of the enzyme in its inactive form,
complexed with 1,3-dihydroxyacetone-phosphate (DHAP), was obtained through molecular
replacement in 2009 by Garavaglia et al. (PDB entry 2WM1) (131). It should be noted that the
DHAP-bound structure is monomeric with only one subunit in each asymmetry unit, whereas the
three hACMSD structures present in this study, including a substrate-free and ligand-bound
structure, and all of the PfACMSD structures determined thus far (25,26,80), are homodimers.
Although all these coordinates are highly valuable data for future structure-based design of
bioactive small molecule targeting of hACMSD, a quaternary structure variety is apparently
present. We think that the diversity brings up the following questions: (1) is the quaternary
structure of ACMSD linked to the catalytic activity, and (2) is a ligand-induced structural change
a potential mechanism of catalytic activity regulation? While the latter question will be a subject
for future study, the results presented in this work and the comparison with our previous studies
on the bacterial enzyme shed insightful clues, as discussed below.
We have recently shown that PfACMSD is a mixture of monomer and dimer in solution, and
that the former is catalytically inactive while the latter is functionally competent (26). The
decarboxylase activity is dependent on the presence of two arginine residues (Arg51 and
Arg239*, star indicates that Arg239 is from the neighboring subunit), which play a key role in
substrate binding (26). Likewise, when hACMSD is in the dimeric form, the corresponding
arginine residues (Arg47 and Arg235*) are both present in the active site in a manner resembling
what has been described for PfACMSD (Figure 4.7). When hACMSD is in the monomeric form
bound with the DHAP, Arg235 is 25 Å from the catalytic metal and cannot be a residue involved
in substrate binding (131). Thus, these conserved arginine residues are effective probes for
determining the functional assembly of ACMSD.
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Figure 4.7. A side-by-side comparison of the active site architecture of (A) PfACMSD and (B)
hACMSD shows similar substrate binding environment.
It is evident that alteration of the decarboxylase quaternary structure, between monomer and
homodimer, is a possible avenue to regulate the catalytic activity. 5-Carboxyl-uracil
decarboxylase (IDCase) is a member of the ACMSD subfamily under the amidohydrolase
superfamily and has very high sequence similarity to ACMSD (18,81). This enzyme is the most
closely related neighbor of ACMSD in the reconstructed evolution tree. Recently, the crystal
structures of IDCase from both Cordyceps militaris and Metarhizium anisopliae were solved as
homodimers (221). The overall structure and the active site of IDCase mostly resemble ACMSD.
Interestingly, in both of the substrate 5-carboxyl-uracil and inhibitor 5-nitro-uracil bound binary
complex structures; the catalytic metal ion does not directly interact with the substrate and
inhibitor. The two conserved arginine residues, Arg68 (equivalent to Arg47 of hACMSD) and
Arg262* (equivalent to Arg235* of hACMSD) from the neighboring subunit play major roles in
substrate/inhibitor binding. Specifically, Arg68 forms two hydrogen bonds with the N1 and O2
of the substrate pyrimidine ring and Arg262* binds to the leaving carboxyl group in the substrate
bound structure (PDB entry: 4LAM). This observation further suggests that Arg47 and Arg235*
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are responsible for substrate binding not only in ACMSD but also in proteins from the same
subfamily. As a result, a dimeric quaternary structure is most likely required for enzyme activity
through the ACMSD subfamily.
Since mammals have no mechanism to store free amino acids not used for protein synthesis,
tryptophan is primarily directed towards catabolism. During starvation, when tryptophan levels
are low, the priority of catabolism is to preserve the kynurenine pathway intermediates for NAD
biosynthesis and thus, the activity of ACMSD must be lessened. Using a glycolic intermediate,
DHAP, to force ACMSD to change its structure to the catalytically inactive monomeric form is a
possibly unprecedented metabolic interrelation between the tryptophan kynurenine catabolic
pathway and glycolysis.
4.6 Conclusion
The biochemical, spectroscopic, and structural results led us to conclude that hACMSD is a
zinc dependent dimeric enzyme that harnesses its unstable, negatively charged substrate by its
two positive charged residues rather than by the metal ion during substrate positioning at the
early stage of the catalytic cycle. The quaternary structure variety, previously demonstrated in
the bacterial analogous enzyme (80) and now implicated in the human enzyme, is directly linked
to the enzyme catalytic activity. Thus, the structural arrangement of the catalytic center offers a
potential regulatory mechanism at a critical junction of the downstream tryptophan kynurenine
pathway.
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CHAPTER 5 EVIDENCE FOR A CATALYTIC ROLE OF THE WATER LIGAND IN αAMINO β-CARBOXYMUCONATE ε-SEMIALDEHYDE DECARBOXYLASE
REVEALED BY KINETICS AND CRYSTAL STRUCTURES IN COMPLEX WITH
AZIDE AND BROMIDE
The section of chapter 5 is our manuscript under preparation: Evidence for a catalytic role of the
water ligand in α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase revealed by kinetics
and crystal structures in complex with azide and bromide. Lu Huo, Vesna de Serrano, Lirong
Chen, and Aimin Liu.
5.1 Abstract
We found that the catalytic activity of Pseudomonas fluorescens α-amino-βcarboxymuconate-ε-semialdehyde decarboxylase (PfACMSD) is inhibited by common anions.
Bromide and azide were used to study the anion inhibition mechanism. Inhibition assay suggests
a competitive inhibition by azide and a mixed-type inhibition by bromide. Co-crystallized
structures of the enzyme with these two anions were determined at 2.15 and 2.50 Å resolutions,
respectively, and each with two ligand molecules in the active site of the enzyme. Both of the
azide molecules are shown to bind in the putative substrate-binding pocket, consistent with its
competitive inhibition. In contrast, the bromide-bound ACMSD structure reveals that one
bromide is bound at the site where azide molecules bind, and the other substitutes the metal
bound water ligand. These results help establish that the metal-bound water ligand plays a major
catalytic role and that the Arg51 residue is an important component in the second metal
coordination sphere involved in substrate binding.
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5.2 Introduction
Metal-bound water molecules have been long thought to be critical for playing a catalytic
role in several enzyme families, including amidohydrolase superfamily (19,81), carbonic
anhydrase family (181), metallo β-lactamases (222), and restriction endonucleases (223).
However, it is very difficult to experimentally prove the catalytic role of a specific water
molecule in enzymes. Until now, the only widely accepted and well-documented example for a
definitive catalytic role of metal-bound water is found in carbonic anhydrase, in which
biochemical, modeling and crystal structural studies all come together to demonstrate that the
catalytic driving force is indeed derived from the water ligand (181-183,224). In the past 50
years, hydrolytic water as a catalytic main power in enzymes, especially in many of those zincdependent hydrolytic enzymes, has increasingly been appreciated. Thus, it is imperative to
explicitly establish a second example from an enzyme other than the members of the carbonic
anhydrase family the catalytic role of metal bound water. It has become a textbook knowledge
that the metal coordination significantly reduces the pKa value of water from 15.7 to nearly
neutral, making it possible to become a hydroxide anion for subsequent nucleophilic attacks on
the substrate. However, this type of mechanism has never been proposed for a decarboxylase
prior to our study on an enzyme from the amidohydrolase superfamily. Here we present
biochemical and structural evidence for a catalytic role of the water ligand in a decarboxylase.
α-Amino-β-carboxymuconate-ε-semialdehyde (ACMSD) is an important enzyme that controls
the biosynthesis of quinolinic acid in kyneurine pathway in mammals (125) and also directs the
metabolic flux to energy production in 2-nitobenzoic acid degradation pathway in bacteria (12).
ACMSD is a metal-dependent enzyme (14) belonging to the amidohydrolase superfamily (15).
The members of this superfamily are believed to initiate catalysis by a water molecule (19,81). In
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all but one characterized members the water is a metal ligand. The catalytic role of the water
molecule was initially suggested by a pH-dependence study on phosphotriesterase (225) and the
crystal structure of adenosine deaminase in complex with a transition state analogue (226), both
of which are the well-studied members in the amidohydrolase superfamily. In a most recent
study, the enzyme Ligl is shown to be a very unique member of the superfamily. It does not
contain a metal ion in its active site (30). However, a water molecule is found in the active site
where substrate binds and a nucleophilic attack of the substrate by the water molecule is still
believed to be the critical step in catalytic cycle of Ligl.
5.3 Results and Discussion
We found in this work that ACMSD from Pseudomonas fluorescens is inhibited by
ammonium sulfate during protein purification, following the procedures previously established
for substrate generation and kinetic assays (15). We further carried out inhibition assays in the
presence of 25 mM following salts in 25 mM HEPES buffer (pH 7.0), NH4Cl, KCl, NaCl, NaBr,
NaI, NaNO2, NaN3, NaHCO3, CH3COONa, Na2SO4, NaH2PO4, and KH2PO4. The enzyme assay
results showed that NaI, NaN3, NaBr, and NaNO2 had the strongest inhibition power, whereas
CH3COONa, NaH2PO4, and KH2PO4 had no inhibition effect. NH4Cl, KCl, NaCl, NaHCO3 and
Na2SO4 had mild inhibition effects. Furthermore, NH4Cl, KCl and NaCl had the same inhibitory
effect while NaH2PO4 and KH2PO4 did not inhibit ACMSD, and therefore we conclude that the
cations we have tested are not potential inhibitors for the decarboxylation activity of ACMSD.
Hence, our subsequent study was placed on the anion inhibition mechanisms.
Two inhibition patterns were observed among different anioins, i.e. competitive inhibition
and a mixed-type inhibition. We focused on sodium bromide and sodium azide, the
representatives of the two observed inhibitory patterns. Figure 5.1A shows that in the presence of
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0, 1.25 mM, 2.5 mM, and 5 mM sodium azide, it inhibits the decarboxylation activity follows a
nearly pure competitive inhibition pattern with an inhibition constant of 0.76 ± 0.23 mM. In
contrast, in the presence of 0, 2.5, 5 mM and 7.5 mM sodium bromide, the ACMSD kcat values
decrease, whereas the corresponding Km values increase, suggesting a mixed-type, i.e.,
competitive and noncompetitive, inhibition (Figure 5.1B) with the competitive inhibition
constant of 1.30 ± 0.02 mM, and noncompetitive inhibition constant of 10.67 ± 2.66 mM.
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Figure 5.1. ACMSD activity inhibition by azide and bromide salts. Lineweaver-Burk plots of
ACMSD inhibited by azide ion competitively (A). Symbols of black, red, blue, and green
indicate sodium azide at 0, 1.25, 2.5, and 5 mM. And bromide ion (B), the axis crossing is
shown in the inset, indicating a mixed-type inhibition. Symbols of black, red, blue, and green
indicate inhibitors at 0, 2.5, 5 and 7.5 mM concentrations, respectively.
The ligand-bound crystal complexes were obtained by co–crystallizing ACMSD with 25 mM
NaN3 or NaBr. Crystals were grown by hanging drop vapor diffusion method at 18 °C. A total
drop volume of 3 µL was set up at 1:1 protein to crystallization solution ratio and equilibrated
against 500 μL of crystallization solution containing 0.2 M MgCl2, 0.1 M Tris, pH 8.75 and 15%
PEG 5000. X-ray diffraction data for N3–ACMSD were collected at the SER-CAT beamline 22–
ID of the Advanced Photon Source (APS), Argonne National Laboratory, Argonne, IL. Data for
the NbaD-Br complex were collected using a Rigaku MicroMax–007 HF copper rotating anode
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generator operated at 40 kV and 30 mA with Saturn944+ CCD detector at the Emory University
X–ray Crystallography Core Facility (Atlanta, GA). All data were indexed, integrated, and scaled
using the HKL-2000 suite (137). Structure solutions were obtained by molecular replacement
using MolRep (138) from the CCP4i program suite (139) with the published ACMSD structure
(PDB entry 2HBV) as a search model. Structures were then refined by iterative cycles of model
building in COOT (141) and positional and isotropic B factor refinement using Refmac5 (140) in
the CCP4i suite of programs (139) and PHENIX software. The X–ray data collection and
refinement statistics are summarized in Table 5.1.
Table 5.1. Data Collection and Refinement Statistics
ACMSD-Br- Complex
ACMSD-N3- Complex
+
Saturn944 CCD
MAR300 CCD
C2
C2
a=152.89, b=48.40, c=109.93 a=152.19, b=44.77, c=110.21
α=γ=90, β=126.74
α=γ=90, β=127.76
100
100
1.54
1.00
35.00-2.15(2.19-2.15)
50.00-2.50(2.54-2.50)
95.3(92.9)
94.8(62.8)
12.7(67.3)
7.0(28.7)
21.9(2.5)
21.2(2.9)
7.1(7.0)
3.4(1.7)
Refinement
resolution (Å)
2.15
2.50
no. reflections; working/test
32085/2216
19234/1923
Rwork (%) c
22.6
19.8
Rfree (%) d
30.9
27.9
no. of protein atoms
5298
5190
no. of ligand atoms
4
8
no. of solvent sites
99
60
Average B factor (Å 2)
protein
50.3
50.7
Zn(II)
45.0
43.0
Br- or N356.1
47.4
solvent
41.3
35.8
Ramachandran statistics e
preferred (%)
88.6
91.6
allowed (%)
10.5
6.7
Root mean square deviation
bond lengths (Å)
0.014
0.009
bond angles (°)
1.668
1.250
a
Values in parentheses are for the highest resolution shell.
Data collection
detector type
space group
unit cell lengths (Å)
unit cell (°)
temperature (K)
wavelength (Å)
Resolution (Å) a
Completeness (%) a
Rmerge (%) a, b
I/σI a
multiplicity a
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b

Rmerge = Σi |Ihkl,i - ‹Ihkl›|/Σhkl Σi Ihkl,i, where Ihkl,i is the observed intensity and ‹Ihkl› is the average intensity
of multiple measurements.
c
Rwork = Σ||Fo|-|Fc||/Σ|Fo|, where |Fo| is the observed structure factor amplitude, and |Fc| is the calculated structure
factor amplitude.
d
Rfree is the R factor based on 5% of the data excluded from refinement.
e
Based on values attained from refinement validation options in COOT.

The overall structures of ACMSD bound anions remain unchanged except some loop
movements compared to the ligand-free ACMSD structure (PDB code: 2HBV). Amino acids
arrangement in the active site, including metal ligands and second sphere residues, are not
interrupted, with the exception of Arg51, which moved away 1.1 Å from its original position for
accommodating azide ions and 0.9 Å for accommodating bromide ions. In the N3–bound
ACMSD structure, extra electron density in the substrate binding pocket of chain A revealed the
presence of two azide molecules (Figure 5.2A). The two azide molecules are in close proximity
to each other (2.8 Å), and both of them are at a distance of forming weak interaction with Arg51
residue (3.3 and 3.4 Å). The position of metal bound water is not disrupted by the azide anions
compared to the ligand-free ACMSD structure. The water ligand interacts with one of the azide
molecules that is localized just 2.6 Å away from the water ligand (Figure 5.2B). The substrate
ACMS is an unstable molecule, autocyclizing to quinolinic acid, and its binding site in ACMSD
has not been previously established. Azide inhibits ACMSD following a pure competitive
pattern, and accordingly we believe that the binding pocket for azide anions represents the
putative substrate binding site. Binding at this pocket is favored partly because that the positively
charged Arg 51 provides strong ionic interactions with the compounds with negative charges
including ACMS, which possess two carboxylate groups. The maximum rate was also slowed
down when higher concentration sodium azide was involved (above 5 mM in this work). It may
due to hydrogen bonding interaction between the metal bound water and one of the azide ions is
becoming stronger when higher concentration sodium azide salt is used (Figure 5.2B).
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other broomide ion waas found at the salt bridgge distance too the conservved R51 residue (4.0 Å))
(Figure 5.3B).
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CHAPTER 6 CAPTURE OF TETRAHEDRAL THIOHEMIACETAL AND THIOACYL
INTERMEDIATES IN AN AMINOMUCONATE SEMIALDEHYDE
DEHYDROGENASE
The section of chapter 6 is our manuscript under preparation: Capture of tetrahedral
thiohemiacetal and thioacyl intermediates in an aminomuconate semialdehyde dehydrogenase.
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6.1 Abstract
Aldehydes are ubiquitous intermediates in metabolic pathways, and their innate reactivity can
often make them quite unstable. There are several aldehydic intermediates in the metabolic

115
pathway for tryptophan degradation which can decay into neuroactive compounds that have been
associated with numerous neurological diseases. An enzyme of this pathway, 2-aminomuconate6-semialdehyde dehydrogenase, which is responsible for ‘disarming’ the final aldehydic
intermediate, has yet to be studied at the molecular level. Its activity steers the vast majority of
metabolic flux to further catabolism and prevents overproduction of a metabolic dead-end,
picolinic acid. Here we show crystal structures of a bacterial analogue enzyme in five
catalytically relevant forms: resting state, one binary and two ternary complexes, and a thioacyl
intermediate. We also report the structures of a tetrahedral thiohemiacetal intermediate and a
thioacyl intermediate from an active site mutant. These intermediates were characterized by
single-crystal, solution electronic absorption spectroscopy, and the mutant intermediate was
confirmed by mass spectrometry. The crystal structures also reveal that the substrate must
undergo an E/Z isomerization prior to oxidation. This study provides an in-depth mechanistic
understanding of this dehydrogenase.
6.2 Introduction
The dominant route of tryptophan catabolism, the kynurenine pathway, has recently garnered
increased attention given its apparent association with numerous inflammatory and neurological
conditions, e.g. gastrointestinal disorders, depression, Parkinson’s disease, Alzheimer’s disease,
Huntington’s disease, and AIDS dementia complex (127,128,228-231). Though the precise
mechanism by which the kynurenine pathway influences these diseases has not yet been fully
elucidated, it has been determined that several metabolites of this pathway are neuroactive.
Notably, the concentration of quinolinic acid, a non-enzymatically derived decay product of an
intermediate of the kynurenine pathway used for NAD+ biosynthesis, is elevated over 20-fold in
patients’ cerebrospinal fluid with AIDS dementia complex, aseptic meningitis, opportunistic
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infections, or neoplasms (232), and more than 300-fold in the brain of HIV-infected patients
(214). This NAD+ precursor has also been shown to be an agonist of N-methyl-D-aspartate
receptors, and an increase of its concentration may lead to over-excitation and death of neuronal
cells (2,129).
The apparent medical potential of the kynurenine pathway warrants detailed study and
characterization of its component enzymes and their regulation. One enzyme in particular, 2aminomuconate-6-semialdehyde dehydrogenase (AMSDH), is responsible for oxidizing the
unstable metabolic intermediate 2-aminomuconate-6-semialdehyde (2-AMS) to 2aminomuconate (2-AM). Based on sequence alignment, AMSDH is a member of the
hydroxymuconic semialdehyde dehydrogenase (HMSDH) family under the aldehyde
dehydrogenase (ALDH) superfamily (86). Aldehyde dehydrogenases are prevalent in both
prokaryotic and eukaryotic organisms and are responsible for oxidizing aldehydes to their
corresponding carboxylic acids. They use NAD(P)+ as a hydride acceptor to harvest energy from
the primary substrate and generate NAD(P)H, which provides the major reducing power to
maintain cellular redox balance (233,234). In addition to being commonly occurring metabolic
intermediates, aldehydes are reactive electrophiles, making many of them toxic. Enzymes of the
ALDH superfamily are typically promiscuous with regards to their substrates, however in recent
years, this superfamily has had several new members identified with greater substrate fidelity,
especially when the substrate is identified as a semialdehyde (235).
The putative native substrate of AMSDH, 2-AMS, is a proposed metabolic intermediate in
both the 2-nitrobenzoic acid degradation pathway of Pseudomonas fluorescens KU-7 (11) and
the kynurenine pathway for L-tryptophan catabolism in mammals (2,14,129). In the presence of
NAD+ and AMSDH, 2-AMS is oxidized to 2-AM (Fig. 6.1A), however it can also spontaneously
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decay to picolinic acid and water with a half-life of 35 s at neutral pH (10). Due to its instability,
2-AMS has not yet been isolated, leaving its identity as the substrate of AMSDH an inference
based on decay products and further metabolic reactions. There are several reasons for the poor
understanding of this pathway: it is complex with many branches, some of the intermediates are
unstable and difficult to characterize, and several enzymes of the pathway, including AMSDH,
are not well understood. Hence, the structure of AMSDH will help to address questions such as
what contributes to substrate specificity for the semialdehyde dehydrogenase, how 2-AMS is
bound and activated during catalysis, and to help identify its counterpart in the human genome.

Figure 6.1. Activity of AMSDH. (A) Reaction scheme showing the enzymatic generation of 2AMS. (B) Representative assay showing the ACMSD catalyzed consumption of ACMS. (C)
Coupled-enzyme assay in which AMSDH oxidizes 2-AMS to 2-AM. (D) Reaction scheme
showing 2-HMS oxidation by AMSDH. (E) Representative assay showing the activity of
AMSDH on 2-HMS. The inset is a Michaelis-Menten plot.
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6.3 Methods
Expression and Purification of PfAMSDH and PfACMSD. To construct a His10-tagged
AMSDH expression plasmid, nbaE gene from P. fluorescens (accession: AB088043.2) encoding
AMSDH was amplified by the polymerase chain reaction (PCR) using genomic DNA of P.
fluorescens strain KU-7 as a template and primers 5’GGAATTCCATATGAATACCTTACCAAGTCAAG-3’ and 5’CCCTCGAGTTAAATTTTTATGCAGATGTTGG-3’ (built-in NdeI and XhoI sites are
underlined). The PCR product was purified from a 0.8% agarose gel, digested with NdeI and
XhoI, and ligated in the equivalent sites of pET-16b (Novagen). Ligation product was
transformed to Escherichia coli BL21(DE3) for protein expression. A single colony was
introduced to 10 mL of autoclaved LB medium containing 100 µg/mL ampicillin and cultured at
37 °C. When cells reached ca. 0.6 OD at 600 nm, 1.5 mL of cells were diluted into 500 mL
autoclaved LB medium containing ampicillin. The cells were cultured in 37 °C until the optical
density reached ca. 0.8 at 600 nm. Isopropyl β-D-1-thiogalactopyranoside was then added to a
final concentration of 0.6 mM, and the temperature was lowered to 28 °C for 12 hours to induce
AMSDH expression before the cells were harvested by centrifugation at 8,000 g. The harvested
cells were then resuspended in 50 mM potassium phosphate buffer, pH 8.0, containing 300 mM
NaCl and 5% glycerol. The cell slurry was passed through an M-110P Microfluidics cell
disruptor and the debris was removed by centrifugation at 27,000 g for 30 min at 4°C. The
supernatant containing AMSDH was purified using a Ni-NTA affinity column on an ÄKTA
FPLC system (GE Healthcare). The major fraction with AMSDH activity was eluted by
increased imidazole concentration. Purified protein was concentrated and desalted on a prepacked HiTrap desalting column (GE Healthcare) using buffer containing 50 mM HEPES (pH
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7.5), 150 mM NaCl, and 1 mM DTT. Expression, purification and protein re-constitution of
ACMSD were performed as described previously (26).
Site-directed Mutagenesis. C302S, E268A, R120A, and R464A single mutation variants were
constructed by the PCR overlap extension mutagenesis technique (132). Plasmid containing
AMSDH from P. fluorescens was used as a template. The forward primers used in the sitedirected mutagenesis are 5'-CAACTCGGGGCAGGTCagcCTGTGTTCCGAACG-3' for C302S,
5'-GAAAGAAGTGTCTTTCgcgTTGGGGGGCAAGAACG-3' for E268A, 5'GGACCCTCGATATTCCTgcgGCCATTGCCAACTTTC-3' for R120A, and 5'GAACACCTGGTACTTGgcgGATCTGCGTACGCC-3' for R464A. The insert of each mutant
was verified by DNA sequencing and the positive clone was transformed to E. coli BL21(DE3).
The expression and purification of the mutants are the same as wild-type AMSDH.
Preparation of ACMS and 2-HMS. ACMS was generated by catalyzing the insertion of
molecular oxygen to 3-hydroxyanthranilic acid by purified, Fe2+ reconstituted 3hydroxyanthranilate 3,4-dioxygenase as described previously (14,26). 2-HMS is generated nonenzymatically from ACMS following a previously established method (236). The pH of
solutions containing ACMS was adjusted to ~2 by the addition of hydrochloric acid. 2-HMS
formation was monitored on an Agilent 8453 diode-array spectrophotometer at 315 nm. The
solutions were then neutralized with sodium hydroxide once the absorbance at 315 nm stopped
increasing. 2-HMS at neutral pH has a maximum UV absorbance at 375 nm (236).
Enzyme Activity Assay Using 2-HMS as Substrate. Steady-state kinetics analyses were
carried out at room temperature on an Agilent 8453 diode-array spectrophotometer. Reaction
buffer contains 25 mM HEPES and 1 mM NAD+, pH 7.5. Consumption of the substrate 2-HMS
by 200 nM AMSDH was detected by monitoring the decrease of its absorbance at 375 nm with a
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molar extinction coefficient of 43,000 M-1cm-1 for 15 s with a 0.5 s integration time. For mutants,
700 nM protein and a wavelength of 420 nm, ε420 11,180 M-1cm-1, was used. UV absorbance at
375 nm decreased and blue shifted to 295 nm, the maximum UV absorbance for the product, 2hydroxymuconic acid. This is consistent with previously reported data in which the ending
compound was purified and verified as the correct product (236). The pre-steady state spectra
were obtained by using Applied Photophysics Stopped-Flow Spectrometer SX20 (UK) with the
mixing unit hosted inside an anaerobic chamber made by Coy Laboratory Products (MI, USA).
Pre-steady state activity used the same reaction buffer but with 23 μM AMSDH or E268A and
25 μM 2-HMS and were carried out at 10 °C. The change in absorbance was monitored for 1.0 s.
Crystallization, Data Collection, and Refinement. Purified AMSDH samples at a final
concentration of 10 mg/mL containing no NAD+ or 10 equivalents of NAD+ were used to set up
sitting-drop vapor diffusion crystal screening trays in Art Robbins 96-well Intelli-Plates using an
ARI Gryphon crystallization robot. The initial crystallization conditions were obtained from
PEG-Ion 1/2 (Hampton Research) screening kits at room temperature. The screened conditions
were optimized by increasing protein concentration to 40 mg/mL and lowering crystallization
temperature to 18 °C. NAD+-bound AMSDH crystals were obtained from drops assembled with
1.5 μL of protein (pre-incubated for 10 minutes with 10 equivalents of NAD+) mixed with 1.5 μL
of a reservoir solution containing 20% polyethylene glycol 3350 and 0.2 M sodium phosphate
dibasic monohydrate, pH 9.1, by hanging drop diffusion in VDX plates (Hampton Research).
Pyramid shaped crystals which diffract up to ~1.9 Å appeared overnight. The reservoir solution
for crystallizing the cofactor-free AMSDH crystals contains 12% polyethylene glycol 3350,
0.1M sodium formate, pH 7.0. Crystals belonging to the same space group formed within 2-3
days with an irregular plate shape and diffracted up to ~2.2 Å. NAD+-AMSDH crystals were
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used for substrate-soaking experiments. Crystals were transferred to mother liquor solution
containing ~1 mM 2-HMS and incubated for 10 – 180 minutes before flash-cooling in liquid
nitrogen. Soaking 2-AMS as substrate is more complicated because of its instability.
Crystallization solution containing ~1.5 mM ACMS were used for soaking. After transferring
several crystals to the soaking solution (8 μL), 2 μL of 1 mM purified ACMSD was included to
catalyze the conversion of ACMS to 2-AMS. Crystals were flash-frozen after a 5 minincubation. Crystallization solution containing 20% glycerol or ethylene glycol was used as
cryoprotectant. X-ray diffraction data were collected on SER-CAT beamline 22-ID or 22-BM of
the Advanced Photon Source, Argonne National Laboratory.
Ligand Refinement and Molecular Modeling. The first AMSDH structure, the cofactor NAD+
bound structure, was solved by the molecular replacement method with the Advanced Molecular
Replacement coupled with Auto Model Building programs from the PHENIX software using 5carboxymethyl-2-hydroxymuconate semialdehyde dehydrogenase (PDB: 2D4E) as a search
model, which shares 39% of amino acids sequence identity with P. fluorescens AMSDH. The
ligand-free, mutant and ternary complex structures were solved by molecular replacement using
the refined NAD+-AMSDH as the search model. Refinement was conducted using PHENIX
software (196). The program Coot was used for electron density map analysis and model
building (141). NAD+/NADH, substrates 2-AMS and 2-HMS, and Cys-substrate covalent adduct
intermediate were well-defined and added to the model based on the 2Fo - Fc and Fo - Fc electron
density maps. Refinement was assessed as complete when the Fo - Fc electron density contained
only noise. The structural figures were generated using PyMOL software
(http://www.pymol.org/).
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Single-Crystal Spectroscopy. Electronic absorption spectra from single crystals held at 100 K
were collected at beamline X26-C of the National Synchrotron Light Source (NSLS) (237). The
electronic absorption data were typically obtained between 200 – 1000 nm with a Hamamatsu
(Bridgewater, N.J.) L10290 high power UV-Vis light source. The lamp was connected to one of
several 3-meter long solarization-resistant optical fibers with an internal diameter of 115, 230,
400, or 600 µm (Ocean Optics, Dunedin, FL). The other end was connected to a 40 mm
diameter, 35 mm working distance 4x, Schwardchild design reflective microscope objective
(Optique Peter, Lentilly France). The spectroscopy spot size is a convolution of the optical fiber
diameter and the magnification of the objective, which in this case produced 28, 50, 100, or 150
µm diameter spots, respectively. Photons that passed through the crystal were collected with a
second, aligned objective that was connected to a similar optical fiber or one with a slightly
larger internal diameter. The spectrum was then recorded with either an Ocean Optics USB4000
or QE65000 spectrometer. Anisotropic spectra and an image of the crystal/loop were collected as
a function of rotation angle in five-degree increments. These were analyzed by XREC (238) to
determine the flat face and optimum orientation.
Mass Spectrometry. To prepare samples for ESI mass spectrometry (MS), as-isolated E268A
AMSDH was buffer-exchanged to 10 mM Tris (pH 8.0) by running through a desalting column
(GE Healthcare). Intermediate bound E268A was obtained by mixing E268A with 3 eq. of 2HMS. Excess 2-HMS was removed by desalting chromatography using the same buffer.
Desalted proteins were concentrated to a final concentration of 20 µM. Freshly prepared samples
were rinsed by acetonitrile and 0.1% formic acid (1:1 ratio) before injection. MS experiments
were conducted using a Waters (Milford, MA) Micromass Q-TOF micro (ESI-Q-TOF)
instrument operating in positive mode. The capillary voltage was set to 3500 V, the sample cone
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voltage to 35 V, and the extraction cone voltage to 2 V. The source block temperature and the
desolvation temperature were set to 100 and 120 °C, respectively. The samples were introduced
into the ion source by direct injection at a flow rate of 5 µL/min. The raw data containing
multiple positively charged protein peaks were deconvoluted and smoothed using MassLynx 4.1.
6.4 Results
Catalytic activity of wild-type AMSDH. Due to the unstable nature of its substrate, 2-AMS,
activity of AMSDH was detected using a coupled enzyme assay that employed its upstream
partner, α-amino β-carboxymuconate ε-semialdehyde decarboxylase (ACMSD), to generate 2AMS in situ. ACMSD transforms α-amino β-carboxymuconate ε-semialdehyde (ACMS) (λmax at
360 nm) to 2-AMS (λmax at 380 nm) (10,14). As seen in Figure 6.1B, in an assay which uses only
ACMSD, the absorbance peak of its substrate, ACMS, red-shifts to 380 nm as 2-AMS is formed.
The absorbance at 380 nm then quickly decays as 2-AMS decays to picolinic acid, which has no
absorbance features above 200 nm. In a coupled-enzyme assay, ACMSD, AMSDH, and NAD+
are included in the reaction system. As shown in Figure 6.1C, ACMS is still consumed, however
there is no red shift observed because 2-AMS is enzymatically converted to 2-AM (λmax at 325
nm) rather than accumulating and decaying. The production of 2-AM requires that an equimolar
amount of NAD+ be reduced to NADH (λmax at 339 nm). A stable alternative substrate, 2hydroxymuconate-6-semialdehyde (2-HMS), was used to pursue kinetic parameters (Figure
6.1D), when using saturating NAD+ concentrations (≥ 1 mM), the kcat and Km of AMSDH for 2HMS were 1.30 ± 0.01 s-1 and 10.4 ± 0.2 μM, respectively (Figure 6.1E).
Crystal structures of AMSDH. Five crystal structures of wild-type AMSDH, including the
ligand-free (2.20 Å resolution), NAD+-bound binary complex (2.00 Å), ternary complex with
NAD+ and substrate 2-AMS (2.00 Å) or 2-HMS (2.20 Å), and a thioacyl intermediate (1.95 Å),
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have been solved by molecular replacement. All five structures belong to space group P212121.
Data collection and refinement statistics are listed in Table 6.1. The complete AMSDH model
includes four polypeptides per asymmetric unit describing one homo-tetramer (Figure 6.2A).
Each monomer of AMSDH contains three domains: a subunit interaction domain, a catalytic
domain, and an NAD+ binding domain (Figure 6.2B).

Figure 6.2. Overall crystal structure of AMSDH. (A) View of the tetramer. (B) Structure of one
AMSDH subunit with NAD+ and substrate 2-AMS. (C) Topology diagram showing the AMSDH
secondary structure.
Each polypeptide contains 500 amino acids, but the first 16 - 17 amino acids are not included
in our model due to missing electron density even though full-length AMSDH was used for
crystallization. It is most likely that these N-terminal residues belong to a random coil as in most
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other ALDH structures. The first 135 residues comprise a cap which surrounds the cofactor
binding domain. This cap region starts with two β-hairpin motifs (residues 22 - 50) and is
followed by four α-helixes (residues 51 - 134). The sequence then extends to the subunit
interaction domain with two beta strands (residues 138 -158). The central strand of the cofactor
binding domain starts at residue 161 and stops at residue 266 and resembles a distorted
Rossmann fold. The catalytic domain (residues 267 - 476) is based on a topologically related βαβ
polypeptide fold and contains a thiol, Cys302, in the catalytic center. The sequence ends with a
C-terminal helix and a beta strand (residue 477 - 500), which is part of the oligomerization
domain. The active site is located in the region between the NAD+ binding domain and the
catalytic domain with entrances for NAD+ and substrate on two separate sides.
In the structure of the co-crystallized binary complex, an NAD+ molecule is present in an
extended, anti-conformation in the N-terminal, co-substrate binding domain of each monomer
(Figure 6.3A). The electron density map of NAD+ is well defined, and the interactions between
the protein and NAD+ are equivalent in all four subunits as shown in Figure 6.3E. The NAD+bound AMSDH structure is similar to the ligand-free structure with an aligned RMSD of 0.239
Å. Residues which belong to the NAD+ binding pocket are also well aligned with the exception
of Cys302, Arg108, and Leu116 (Figure 6.4). Upon binding NAD+, the thiol moiety of Cys302
rotates so that the sulfur is 2.3 Å closer to the substrate binding pocket and away from the
nicotinamide head of NAD+.
The adenine ribose ring and the two phosphate groups are the main components that stabilize
the NAD+ position by interacting with protein residues which all belong to the surrounding
loops, except Thr250, which belongs to the 8th α-helix. The nicotinamide half of NAD+ has less
interaction with local residues. Two oxygen atoms (O2 and O3) of the ribose ring form H-bonds
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with OE2 and OE3 of Glu404, respectively. On the other ribose ring, the O3 atom forms an Hbond with the Nz of Lys192 while its O2 atom forms H-bonds with both Lys192 (Nz) and
Glu195 (OE1). The O1 belonging to the phosphate group nearer the nicotinamide is H-bonded to
NE1 of Trp168. The anionic O2 of the other phosphate group forms H-bonds with both Thr250
(OG1) and Glu247 (N) (Figure 6.3E).

Figure 6.3. Crystal structures of wild-type AMSDH and single-crystal electronic absorption
spectrum of a catalytic intermediate. Active site structure of AMSDH-NAD+ complex (A),
ternary complex of AMSDH-NAD+-2-AMS (B), ternary complex of AMSDH-NAD+-2-HMS
(C), and thioacyl intermediate (D). (E) 2D-interaction diagram for NAD+ binding. (F) Close-up
of the thioacyl intermediate in D. (G) Single-crystal electronic absorption spectrum of D.

127

Figure 6.4. Local changes at the active site of AMSDH induced by NAD+ binding.
Crystal structures of enzyme substrate ternary complexes. Structures of AMSDH in ternary
complex with co-substrate NAD+ and its primary substrates, 2-AMS or 2-HMS, were obtained
by soaking co-crystallized AMSDH-NAD+ crystals with substrate for 5 and 10 min for 2-AMS
and 2-HMS, respectively. Extra density which fits with the corresponding substrate molecule
was observed in the active site of each subunit. The co-substrate NAD+ in the ternary complex
structures is bound in the same manner as in the binary complex. Binding of the primary
substrates introduced minimal change to the protein structure; the RMSD for the superimposed
structures of substrate-free with 2-AMS- and 2-HMS-bound ternary complex structures are 0.170
and 0.276 Å, respectively. These two primary substrates bind to AMSDH in an identical fashion,
with two arginine residues, Arg120 and Arg464, playing important roles in stabilizing the
substrate by forming four H-bonds with one of the carboxyl oxygens and the 2-amino or hydroxy
group of 2-AMS (Figure 6.3B) or 2-HMS (Figure 6.3C), respectively. Mutation of Arg120 to
alanine causes a moderate decrease of the kcat to 0.7 ± 0.2 s-1 from 1.30 ± 0.01 s-1 and a dramatic
increase of the Km with a lower bound of 446.3 ± 195.9 µM (an accurate determination of the Km
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is hindered by insufficient 2-HMS concentrations) compared to 10.4 ± 0.2 μM in the wild-type
(Figure 6.5, top). Mutation of Arg464 to alanine decreased the kcat to ~ 0.3 s-1, and not only
increased the Km to ~ 170 µM, but also leads to a substrate inhibition effect with a Ki of ~ 6 µM
(Figure 6.5, bottom). This substrate inhibition effect is likely caused by unproductive binding of
a second substrate molecule in the space created by the deletion of arginine.

Figure 6.5. Kinetic assays of R120A and R464A with 2-HMS. Top, activity of R120A fit
with the Michaelis-Menten. Bottom, activity of R464A fit with the Michaelis-Menten
equation with substrate inhibition.
Catalytic intermediates trapped after ternary complex formation. Enzyme-NAD+ binary
complex crystals were soaked in mother liquor containing 2-HMS for a range of time points
from 5 minutes to more than 3 hours before flash-cooling in liquid nitrogen. In a crystal which
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was soaked for 40 min, an intermediate was trapped and refined to the resolution of 1.95 Å
(Figure 6.3D). Crystals soaked for longer time points gave a similar intermediate with poorer
resolution. In this structure, 2-HMS has isomerized from the (2E, 4E)-2-hydroxymuconate-6semialdehyde of the substrate-bound ternary structure to a (2Z, 4E) conformation and interacts
with Arg120 and Arg464 with both of its carboxyl oxygens rather than one carboxyl oxygen and
the 2-hydroxy oxygen as shown in the 2-HMS ternary complex structure. Fitting this density
with the 2E, 4E conformation resulted in unsatisfactory 2Fo - Fc and Fo - Fc density maps as
shown in Figure 6.6A. Likewise, attempting to fit the 2Z, 4E isomer to the ternary complex
structure did not produce satisfactory results (Figure 6.6B). Upon E to Z isomerization, the
carbon chain of the substrate extends, and the distance between its 6th carbon and Cys302’s
sulfur is now at 1.8 Å, which is within covalent bond distance for a carbon-sulfur bond. Also, the
continuous electron density between Cys302-SG and 2-HMS-C6 indicates the presence of a
covalent bond (Figure 6.3F).

Figure 6.6. Alternate fitting of substrate-bound ternary complex and thioacyl intermediate.
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Another feature of this intermediate is that the nicotinamide ring of NAD+ has moved 4.6 Å
away from the active site and adopted a bent conformation (Figure 6.3D) compared to the
position in the binary or ternary complex structures (Figure 6.3A, B, and C), indicating that it has
been reduced to NADH. Thus, this intermediate is assigned as a thioacyl enzyme-substrate
adduct. The single crystal electronic absorption spectrum of the sample has an absorbance
maximum at 394 nm (Figure 6.3G). The same absorbance band was observed in crystals soaked

Figure 6.7. Single-crystal electronic absorption spectra of wtAMSDH and E268A AMSDH cocrystallized with NAD+ and soaked with 2-HMS before flash-freezing.
with 2-HMS from 30 min to 2 h (Figure 6.7A). However, this long-lived intermediate in the
crystal was not observed in solution with millisecond to second time resolution in stopped-flow
experiments (Figure 6.8A). Thus, it is either present in an earlier time domain (sub-
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milliseconds), or alternatively, it may not accumulate in solution because NADH can readily
dissociate in solution, whereas it may be trapped in the active site when in the crystalline state.

Figure 6.8. Time-resolved, stopped-flow UV-Vis spectra of the reactions catalyzed by
wtAMSDH and E268A for 1 s.
Another notable change in the intermediate structure is the movement of the side chain of
Glu268, which rotates 73° towards the active site. In order to probe the function of Glu268, we
constructed an alanine mutant and found that it exhibited no activity in steady-state kinetic
assays. Interestingly, E268A exhibits completely different pre-steady state activity than the wildtype enzyme. As shown in Figure 6.8B, a peak at 422 nm was formed concomitant with decay of
the 2-HMS peak within the one second of reaction. This new species is generated
stoichiometrically upon titration of 2-HMS with E268A (Figure 6.9D). The moiety which gives
rise to this new absorbance band is stable for minutes at room temperature and cannot be
separated from the protein by membrane filtration-based methods (26), suggesting that it is
covalently bound to the protein. The formation of an enzyme-substrate adduct in the E268A
mutant was investigated by mass spectrometry. For as-isolated E268A, the resultant multiply
charged states (Figure 6.10) were deconvoluted to obtain a molecular weight (MW) of 56,252 Da
(Figure 6.11, top). This value is in good agreement with the predicted MW of E268A AMSDH
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plus an N-terminal His-tag and linking residues, 56,251 Da. The second largest peak in the
deconvoluted spectrum has a MW 177 Da greater than that of the most abundant signal. This is
likely due to post translational modification of the His-tag; α-N-Gluconoylation of His-tags has
been observed in E. coli expressed proteins which cause 178 Da extra mass (239). The mutant
protein was then treated with the alternate substrate, 2-HMS, and the mass spectrum shows a
new major peak at 56,390 Da (Figure 6.11, bottom), 138 Da heavier than the as-isolated mutant.
Similarly, the second most abundant peak corresponds to a His-tag modified mutant plus 139 Da.
In this spectrum, the peaks arising from the as-isolated mutant are substantially reduced,
indicating that 2-HMS, 141 Da, has formed a covalent adduct with the E268A mutant enzyme.

Figure 6.9. Crystal structures of the E268A mutant and its solution and UV-vis spectra. Structure
of the active site of (A) E268A-NAD+ binary complex, (B) thiohemiacetal intermediate, (C)
thioacyl intermediate. (D) Solution UV-vis spectra of a titration of 2-HMS with E268A. (E)
Single-crystal UV-vis spectrum of the intermediate in B (top panel) and C (bottom panel).
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Figure 6.10. Raw ESI mass spectra of as-isolated E268A AMSDH (top) and E268A treated with
2-HMS (bottom). Narrow range scans corresponding to the proteins are shown in the insets.

Figure 6.11. Deconvoluted positive-mode electrospray ionization (ESI) mass spectra of asisolated E268A (top) and 2-HMS treated E268A (bottom).
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We determined the crystal structure of E268A and refined it to 2.00 Å resolution. The overall
structure aligns very well with the wild-type binary complex structure with a RMSD of 0.139 Å.
The active site of E268A also resembles the native AMSDH structure (Figure 6.12). The nature
of the absorbing species was further investigated by soaking co-crystallized E268A-NAD+
crystals in mother liquor containing 2-HMS. By doing so, two temporally, structurally, and
spectroscopically distinct intermediates were identified.

Figure 6.12. Superimposition of E268A (pink) active site with wtAMSDH (light blue).
When E268A-NAD+ crystals are soaked with 2-HMS for 40 min or less, their single crystal
electronic absorption spectra show an absorbance maximum at 422 nm (Figure 6.7B), as was
observed in the solution-state titration and the stopped-flow assays. An individual electronic
absorption spectrum for an E268A-NAD+ crystal soaked with 2-HMS for 15 min can be found in
Figure 6.9E. The structure of E268A-NAD+ soaked with 2-HMS for 30 minutes before flashcooling was solved and refined to 2.15 Å resolution. In this structure, a continuous electron
density between Cys302-SG and 2-HMS-C6 is observed, similar to the thioacyl intermediate
observed in the wild-type enzyme. However, in contrast to the thioacyl intermediate, the density
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around C6 is not flat, indicating an sp3- rather than sp2-hybridized carbon (Figure 6.13A). More
importantly, the C6 of 2-HMS and the C4N of NAD+ are very close (2.4 - 2.8 Å), making it
unlikely that the hydride has been transferred from the substrate. Taken together, these data
allow us to assign this intermediate to a thiohemiacetal enzyme adduct (Figure 6.9B). A similar
intermediate has only been trapped once previously in a crystal which contains no co-substrate
(116). Hence, this is the first time for this intermediate to be trapped in the presence of NAD+.

Figure 6.13. Crystal structures of two distinct catalytic intermediates. Electron density map of
(A) the thiohemiacetal intermediate and (B) the thioacyl intermediate.
If the E268A-NAD+ crystals are soaked with 2-HMS for longer than 1 hour, their singlecrystal UV-Vis spectra begin to resemble that of the wild-type thioacyl intermediate with a
corresponding absorbance maximum at 394 nm (Figure 6.7B), as seen in wild-type thioacyl
intermediate crystals. An individual electronic absorption spectrum for an E268A-NAD+ crystal
soaked with 2-HMS for 120 min can be found in Figure 6.9E, bottom. The structure of an
E268A-NAD+ crystal soaked with 2-HMS for 180 minutes was solved and refined to 2.20 Å.
The structure of this intermediate is also similar to the wild-type thioacyl enzyme adduct with
NADH, rather than NAD+ found at the active site. The distance between the C4N of NADH and
C6 of 2-HMS is longer than 6.1 Å (Figure 6.9C). The electron density around C6 is flatter

136
(Figure 6.13B) compared with the thiohemiacetal intermediate and similar to the thioacyl
intermediate trapped in the wild-type AMSDH structure (Figure 6.3F). Based on the similarities
in their absorbance and structures, we conclude that this latter intermediate is equivalent to the
wild-type thioacyl intermediate. It is also worth noting that the strictly conserved asparagine 169
is seen to stabilize both the thiohemiacetal and thioacyl intermediates.
6.5 Discussion
The substrate of AMSDH, 2-AMS, is an unstable aldehyde which can decay to picolinic acid
and water, presumably through an electrocyclization reaction as its upstream intermediate does
(193). So, to assay enzymatic activity, the upstream enzyme was utilized in the reaction mixture
to generate substrate, and it was shown that AMSDH is catalytically active. Unfortunately, no
kinetic parameters can be reliably determined because the concentration of 2-AMS is not welldefined in the coupled-enzyme assay. To circumvent this issue, a previously-identified, stable
alternative substrate, 2-HMS (236,240), in which a hydroxyl group replaces the amino group in
2-AMS to prevent cyclization, was used to characterize the activity of AMSDH and to examine
the activity of the mutants.
Substrate bound ternary complex structures were obtained by soaking co-crystallized protein
and NAD+ with 2-AMS or 2-HMS. 2-AMS is an unstable compound which decays with a t1/2 of
about 9 s at pH 7.4 and 37 °C or 35 s at pH 7.0 and 20 °C. Notably, this is its first reported
structure. It appears to be stabilized in the enzyme active site by interactions with Arg120 and
Arg464 so that the electrocyclization reaction cannot occur. Both arginine residues are close to
the protein surface and in good positions to serve as gatekeepers, bringing the substrate into the
active site. As a residue residing on a loop, Arg464 should be relatively flexible. The electron
density for the side chain of Arg120 is partially missing in the binary complex structure but very
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well resolved in both ternary complex structures. This observation indicates that the presence of
substrate can stabilize what may be a flexible residue. It becomes evident from the coordinates
that Arg120 and Arg464 play an important role in substrate recognition, stabilization, and
possibly product release. Two arginine residues are rarely observed in such close proximity,
stabilizing one end of the same molecule with multiple H-bonds. With the exception of the Hbonds provided by Arg120 and 464, the substrate-binding pocket is mostly composed of
hydrophobic residues (Figure 6.14 B). Based on sequence alignment (Figure 6.14A), these two
arginine residues are strictly conserved throughout the HMSDH family but are not found in other
members of the ALDH superfamily. We propose that these dual arginines combined with the
size restrictions provided by the hydrophobic pocket endow this enzyme with its specificity
towards small α-substituted carboxylic acids with an aldehyde moiety, such as 2-AMS and 2HMS.

Figure 6.14. Identification of substrate binding residues for the hydroxymuconic semialdehyde
dehydrogenase (HMSDH) family. (A) Sequence alignment of several enzymes from the
HMSDH family. (B) Substrate binding pocked of 2-AMS, left, and 2-HMS, right, ternary
complex crystal structures.
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Two strictly conserved catalytic residues, Cys302 and Glu268, are present at the interior of
the substrate-binding pocket. General features regarding these residues in the ALDH superfamily
are (1) that the cysteine serves as a catalytic nucleophile which is anticipated to form a covalentadduct intermediate with the substrate by a nucleophilic addition during catalysis (113,115,241),
and (2) that the glutamate serves as a base to activate water for hydrolysis of the thioacyl-enzyme
adduct (108,117,119,242). In the ternary complex structures, Cys302 is located at an ideal
position to initiate catalysis. It is proposed to attack the aldehydic carbon (C6) of the substrate. In
the two ternary complex structures, the distance between the sulfur of Cys302 and the C6 of
substrate is ca. 3.3 Å. Cys302 and the aldehydic carbon form covalent bond in both thioacyl and
thiohemiacetal intermediates. Mutation of Cys302 to serine led to completely inactive enzyme,
further confirming its catalytic significance.
Examining the wild-type AMSDH structures shows that in the NAD+-bound binary complex,
Glu268 adopts a ‘passive’ conformation, pointing away from the substrate binding pocket, and
forms H-bonds with both NE of Trp177 (3.2 Å distance) and the backbone oxygen of Phe470
(3.6 Å) to leave space for the reduction of NAD+. Its electron density is very well resolved and
the side chain B-factor is close to average: 28.2 Å2/28.5 Å2. The thiol moiety of Cys302 is 7.14
Å from Glu268 and is unlikely to form interactions. Interestingly, in both substrate bound
structures, Glu268 becomes more flexible and exhibits much weaker electron density and
increased side chain B-factors compared to average protein B-factors: 37.8 Å2/28.5 Å2 and 66.37
Å2/39.7 Å2. In the thioacyl intermediate structure, the electron density of Glu268 becomes very
well defined again, but its side chain rotates 73° towards the bound substrate and seems to be in
an ‘active’ position to abstract a proton from a deacylating water (Figure 6.3D). At this point in
the reaction cycle, the NADH molecule needs to leave the active site to make room for the
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catalytic water molecule. Movement of the nicotinamide ring of NAD+ coupled with the rotation
of an active site glutamate has previously been observed in other aldehyde dehydrogenases
during catalysis (108,117,119).
Mutation of Glu268 to alanine led to the accumulation of the thiohemiacetal intermediate in
both solution and crystal structure. The strictly conserved glutamate residue in the active site of
ALDH enzymes has been proposed to play up to three possible roles during catalysis. It is
strictly required to activate the deacylating water which allows for product release, it is in a
‘passive’ conformation during NAD(P)+ reduction, and in some cases, it may serve to activate
cysteine for nucleophilic attack (120). Based on these roles, mutation to alanine would be
expected to decrease the rate of hydrolysis of the thioacyl adduct, have no effect on the rate of
reduction of NADH, and possibly decrease the rate of nucleophilic attack by cysteine. Based on
these understandings, deletion of the active site glutamate should cause an accumulation of the
thioacyl intermediate. However, in this work the E268A mutant is shown to accumulate the
preceding thiohemiacetal intermediate both in crystal and in solution. This finding suggests an
additional catalytic role for this residue: rotation of Glu268 towards the active site facilitates the
hydride transfer from the tetrahedral thiohemiacetal adduct to NAD+. The rapid formation of the
intermediate in solution indicates that Glu268 of AMSDH does not play a role in activating
cysteine. However, it does appear necessary to complete hydride transfer from the substrate to
NAD+, and its removal turns the native substrate into a suicide inhibitor.
Based on previous studies of the ALDH mechanism and the eight high-resolution crystal
structures solved, we propose a catalytic mechanism for AMSDH. As shown in Figure 6.15,
NAD+ binds to the enzyme, 1, to form an NAD+-bound AMSDH complex, 2. The substrate, 2AMS, is then recognized by Arg120 and Arg464 through multiple hydrogen-bonding
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interactions, 3. At this point, it is not yet clear whether the E/Z isomerization of the 2,3 double
bond takes place before, during, or after the nucleophilic attack by Cys302 on the aldehydic
carbon, which produces the tetrahedral thiohemiacetal intermediate, 4. The isomerization drives
a rotation of the substrate at the C1 end so that only the carboxylate group interacts with the two
arginine residues. Next, NAD+ is reduced to NADH by abstraction of a hydride from 4, forming
a thioacyl intermediate, 5. Upon reduction, the nicotinamide portion of NADH moves away from
the substrate as Glu268 rotates into position to activate a water molecule to perform a
nucleophilic attack on the same carbon that was previously attacked by Cys302, forming a
second tetrahedral intermediate, 6. Finally, the second tetrahedral intermediate collapses,
breaking the C-S bond and releasing the final products, 2-AM and NADH. In the present work,
species 1 – 5 are spectroscopically and structurally characterized while intermediate 6 was not
seen to accumulate.

Figure 6.15. Proposed catalytic mechanism for the oxidation of 2-AMS by AMSDH.
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In this work, five catalytically relevant structures of the wild-type AMSDH and three mutant
structures yield a comprehensive understanding of the protein’s overall structure, co-substrate
binding mode, and elucidate the primary reason for substrate specificity among the HMSDH
family of the ALDH superfamily. The structural and spectroscopic snapshots capture the crystal
structure of a highly unstable kynurenine metabolite, 2-AMS, and two catalytic intermediates,
including stabilizing a tetrahedral intermediate in a mutant protein, which was further verified by
mass spectrometry. Another interesting finding revealed through solving the ternary complex and
intermediate crystal structures is that an E to Z isomerization of the substrate occurs in this
dehydrogenase before hydride transfer. This is the first piece of structural evidence illustrating an
aldehyde dehydrogenase which proceeds via an E/Z isomerization on its substrate during
catalysis.
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Table 6.1. X-ray crystallography data collection and refinement statistics.
Data
collection

ApoAMSDH

NADAMSDH

NAD2-AMSAMSDH

NAD2-HMSAMSDH

WTThioacyl

E268AAMSDH

E268AHemiacetal

E268AThioacyl

detector type

MAR300
CCD

MAR225
CCD

MAR300
CCD

MAR300
CCD

MAR225
CCD

MAR225
CCD

MAR225
CCD

source

APS
22-ID

APS
22-BM

APS
22-ID

APS
22-ID

APS
22-BM

APS
22-BM

APS
22-BM

space group

P222121

P222121

P222121

P222121

P222121

P222121

P222121

MAR225
CCD
APS,
Sector 22BM
P222121

unit cell
lengths (Å)

a=88.27
b=141.89
c=172.92

a=88.58
b=142.00
c=174.38

a=88.40
b=142.12
c=174.41

a=88.57
b=142.72
c=175.01

a=88.36
b=141.75
c=174.37

a=88.53
b=141.98
c=173.80

a=88.57
b=141.56
c=174.63

a=88.33
b=141.35
c=173.53

α=β=γ=90

α=β=γ=90

α=β=γ=90

α=β=γ=90

α=β=γ=90

α=β=γ=90

α=β=γ=90

α=β=γ=90

0.8

1.0

0.8

0.8

1.0

1.0

1.0

1.0

100

100

100

100

100

100

100

100

45.002.20
(2.242.20)

35.002.00
(2.072.00)

35.001.98
(2.031.98)

45.002.15
(2.192.15)

45.001.95
(1.981.95)

50.002.00
(2.032.00)

50.002.15
(2.152.19)

50.002.20
(2.242.20)

99.8
(99.4)
8.0
(53.5)
45.2
(4.4)
14.0
(11.6)

99.8
(98.9)
11.2
(8.9)
27.3
(2.3)
13.7
(9.1)

95.2
(99.7)
10.7
(78.3)

99.9
(100.0)
12.2
(84.1)

94.9
(88.8)
10.4
(84.3)

97.2
(97.4)
10.8
(74.5)

99.9
(100)
14.8
(58.7)

99.6
(99.2)
9.9
(71.7)

22.7 (2.2)

27.1 (2.7)

28.4 (2.2)

13.3 (3.2)

17.7 (3.9)

36.9 (3.7)

9.8(7.8)

12.5(10.3)

10.5(6.4)

11.9(10.5)

8.8(7.6)

11.4(10.3)

unit cell
angles (˚)
wavelength
(Å)
temperature
(K)
resolution
(Å) a
completenes
s (%)a
Rmerge (%)a, b
I/σI a
multiplicity a

Refinement
resolution
(Å)
no.
reflections;
working/test
Rwork (%)c
Rfree (%)d
no. of
protein
atoms
no. of ligand
atoms
no. of
solvent sites
protein
NAD+
NA+
EG/GOL/A
MS/HMS
solvent
PDB code

2.20

2.00

2.00

2.15

1.95

2.00

2.15

2.20

109619/
5469

149298/
7485

140017/
7401

114123/
6029

145080/
7649

144988/
7303

119216/
5973

110312/
5518

18.6
23.9

17.2
21.8

16.2
20.8

18.0
23.7

17.6
21.6

19.5
23.7

19.2
23.5

18.4
22.7

14651

14684

14684

14684

14684

14668

14668

14668

23

188

220

220

220

204

220

220

702

1682

1397

802

1702

1188

1136

882

31.7
37.0
34.0

29.2
41.4
43.6

36.2
56.4
43.9

2

Average B-factor (Å )
39.7
27.9
56.7
37.5
41.6
30.7

41.1
N/A
35.3

28.5
28.8
N/A

28.5
40.1
32.3

38.4

42.7

32.4

45.6

23.0

42.1

25.1

28.1

42.7
4I26

37.3
4I1W

37.5
4I25

43.3
4I2R

35.4
4NPI

37.4
4OE2

34.9
4OU2

39.2
4OUB
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a

Values in parentheses are for the highest resolution shell.
Rmerge = Σi |Ihkl,i - ‹Ihkl›|/Σhkl Σi Ihkl,i, where Ihkl,i is the observed intensity and ‹Ihkl› is the average intensity of
multiple measurements.
c
Rwork = Σ||Fo|-|Fc||/Σ|Fo|, where |Fo| is the observed structure factor amplitude, and |Fc| is the calculated structure
factor amplitude.
d
Rfree is the R factor based on 5% of the data excluded from refinement.
e
Based on values attained from refinement validation options in COOT.
b
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CHAPTER 7 SUMMARY
Work in this dissertation focuses on two enzymes in the kynurenine pathway and 2-NBA
biodegradation pathway: ACMSD and AMSDH. Substrates for both of the enzymes are unstable
metabolic intermediates and spontaneously decay to QUIN and PIC, respectively. Structure and
mechanistic studies on these two enzymes may shed light on the mechanism for regulation of
side product formation in both pathways.
ACMSD is the first transition metal dependent, oxygen independent decarboxylase. The
unique cofactor dependency requires a novel catalytic mechanism. Hence, a new working model
has been proposed for ACMSD based on the findings described in the earlier chapters, in which
a metal bound water ligand activated by His228 residue acts as a nucleophile to initiate the
reaction. Investigation of the His228 residue reveals two roles: tuning metal selectivity and
interacting with the metal bound water molecule. Anion inhibition experiments further
demonstrated that replacing of the metal bound water ligand by bromide leads to the loss of
enzyme activity. These results are consistent with the proposed ACMSD mechanism.
Since the substrate for ACMSD, ACMS, is an unstable aldehyde compound, the question of
how ACMS is stabilized during catalysis is worth study. In the crystal structure of homodimer
PfACMSD, we found two conserved arginine residues in the active site are in good position to
bind ACMS by forming hydrogen bonding interactions with its carboxyl groups. Interestingly,
one of the arginines is inserted from the neighboring subunit. Mutation of either of the arginine
residues leads to the loss of enzyme activity. Simply mixing the two inactive arginine mutants
can partially rescue ACMSD activity by forming hybridized heterodimers, indicating the dimeric
state is the active form of ACMSD. A membrane based experiment demonstrated that these two
arginine residues are involved in substrate binding. In the crystal structures of hACMSD we
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solved later, two arginine residues are also observed in the active site. Both of the arginines form
hydrogen bonds with a competitive inhibitor in the co-crystallized structure. Hence, ACMSD
harnesses its unstable substrate by stabilizing it through two active site arginine residues, one of
which is contributed by a neighboring subunit, and thus, the dimeric state is required for enzyme
activity. The dimer dissociation constant calculated based on our experiments is in the range for
“weak” transient complexes that show a dynamic mixture of both monomer and dimer states in
vivo. Hence, ACMSD activity could be tuned by local protein concentration and physiological
environmental factors such as pH and local protein or ligand concentrations in vivo.
Unlike ACMSD, AMSDH has not been studied at molecular level before our work. We have
cloned and expressed PfAMSDH in E.coli and isolated it as soluble and active enzyme. We have
crystallized PfACMSD in both its apo form and co-substrate NAD+ bound binary complex form.
Substrates 2-AMS and 2-HMS bound ternary complex structures are also obtained by substrate
soaking and reveal two arginine residues that play a major role in substrate binding. Mutagenesis
and sequence alignment further indicate that these two arginine residues are responsible for
substrate selectivity in the whole HMSDH family. We have also trapped a covalent bound
thioacyl intermediate in WT-AMSDH, in which the substrate molecule tautomerized to a
different conformation, suggesting an innate isomerase activity of AMSDH. Mutation of a
conserved active site glutamate leads to the accumulation of a new intermediate. Crystal
structure of this intermediate reveals a thiohemiacetal tetrahedral covalent adduct, which is then
further verified by single crystal spectroscopy and MS spectrometry. Hence, it becomes clear
that this glutamate residue facilitates hydride transfer during catalysis. Based on the crystal
structures we have solved and intermediates we have trapped, a better understanding of AMSDH
is achieved and a working model for its mechanism of action is proposed.
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